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Abstract 
 
Part 1. Concise Synthesis of Highly Substituted Isoquinolin-1(2H)-ones via IMDA 
 
The primary goal of this DPhil research project was to further investigate the mechanism of a 
novel thermally activated cyclisation reaction discovered within the Parsons’ research group. 
Through the synthesis and cyclisation of the substituted pyrrole rings 2.38a-c we have 
investigated the mechanism and increased the scope of the cyclisation reaction. 
 
 
 
Reagents and Conditions: (a) Pyridine, LiI, reflux. 
 
We have also developed a robust route to advanced intermediate 2.10 in the synthesis of 
hymenialdisine 2.1.  
 
 
Part 2. Investigation and Development of a Novel Cascade Reaction 
 
The aim of this DPhil research project was to devise and execute a series of experiments to 
gain a better mechanistic understanding of the novel thermal cyclisation, discovered within 
the Parsons’ research group. To further investigate the mechanism and scope of the 
cyclisation, the model system 2.1 was initially selected.  
 
13 
 
 
 
Reagents and Conditions: (a) Toluene, reflux, 0.01M, 38%. 
 
Through extensive modification and manipulation of the cyclisation precursor 2.1, we have 
increased the scope of the cyclisation and postulated a reaction pathway. During these studies 
remarkable transformation of ketone 2.81 to alkyne 2.82 was also observed. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux, 6h, 30%. 
 
The repeatability of the above reactions was also investigated by synthesising various 
analogues.  
 
 
 
 
 
 
 
 
 
 
14 
 
Abbreviations 
 
Å Ångstrom 
Ac acetyl 
AcOH acetic acid 
AIBN azobisisobutyronitrile 
AN 
aq. 
acceptor number 
aqueous 
Ar aromatic 
BC Bergman cyclisation 
Bn benzyl 
Boc tert-butoxycarbonyl 
b.p.   boiling point 
Bu butyl 
t-Bu tert-butyl 
n-Bu butyl 
n-BuLi butyllithium 
Bz benzoyl 
°C  degrees Celsius 
cat.   catalytic 
CDI 1,1’-carbonyldiimidazole 
conc.   concentrated 
cy cyclohexyl 
D deuterium 
15 
 
D-A 
DCC 
Diels-Alder 
1,3-dicyclohexylcarbodimide 
DCE 1,2-dichloroethene 
DCM dichloromethane 
DIPEA N,N-diisopropylethylamine 
DMA 
DMAP 
dimethylacetamide 
4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMP Dess-Martin periodinane 
DMS dimethyl sulphide 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
Ea activation energy 
EDCl 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide  
EI+ electron impact 
EPR electron paramagnetic resonance 
Et ethyl 
eq. equivalents 
FMO 
g 
Frontier Molecular Orbital 
gram(s) 
h hour(s) 
HBTU O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate 
HOMO highest occupied molecular orbital 
HOBt N-hydroxybenzotriazole 
HRMS high resolution mass spectrum 
16 
 
Hz Hertz 
IEDDA 
IMDA 
IR 
inverse electron demand Diels-Alder  
intramolecular Diels-Alder  
infrared spectroscopy 
IRC 
J 
kDa 
intrinsic reaction coordinate 
coupling constants 
Daltons 
LED light-emitting diode 
LDA lithium di-iso-propylamide 
LUMO 
M 
lowest unoccupied molecular orbital 
molar 
Me methyl 
MeI methyl iodide 
MeLi methyllithium 
MeOH methanol 
min. minute(s) 
mL millilitre 
mol mole 
mmol millimole 
MOM 
m.p. 
methoxy methyl 
melting point 
Ms methanesulfonyl 
M.S. molecular sieve 
MS mass spectrometry 
MRSA methicillin-resistant staphylococcus aureus 
17 
 
MW microwave 
NDA 
NMR 
normal electron demand Diels-Alder  
nuclear magnetic resonance 
Nu
-
 nucleophile 
p para 
P 
Ph 
protecting group 
phenyl 
PMB 
ppm 
para-methoxy benzyl 
parts per million 
PPTS pyridinium para-toluenesulfonate 
i-Pr isopropyl 
i-PrOH isopropyl alcohol 
pTSA 
rt 
para-toluenesulfonic acid 
room temperature 
SM starting material 
SOI 
TADA 
TBAF 
secondary orbital interaction 
transannular Diels-Alder 
tetra-n-butylammonium fluoride 
TBS tert-butyldimethylsilyl 
TBSOTf 
TDP 
tert-butyldimethylsilyl triflate 
photodynamic therapy 
TES triethylsilyl 
tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
18 
 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMS trimethylsilyl 
TMSOH 
Tol. 
trimethylsilanol 
toluene 
TS 
Ts 
transition state 
tosyl 
TsOH 4-methylbenzenesulfonic acid 
THP tetrahydropyran 
UV ultraviolet 
W-H Woodward-Hoffmann 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part 1 
Concise Synthesis of Highly Substituted 
Isoquinolin-1-(2H)ones via IMDA 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
Chapter 1. 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
1.1. General Introduction 
 
Chemical synthesis deals with the transformation of matter to create new or already known 
molecules. This occurs via the breaking and forming of chemical bonds in predictable ways. 
The patterns that are applied for manipulating such changes are named chemical reactions. 
Therefore, chemical synthesis is comprised of two aspects; it can be used as a method to 
obtain a particular outcome (a desired molecule) or it can be perceived as an art that deserves 
improvement. To improve chemical synthesis, a deeper understanding of a reaction is 
necessary, so that its potency can be utilised in more productive ways (fewer side products 
leading to higher yields, reduced reaction time, a more comprehensive substrate scope, etc.). 
Chemical reactions which are more controlled will enable improved accessibility of desired 
molecules. These molecules have the potential for numerous applications such as plastics, 
dyes, drugs, etc. 
A highly significant subgroup of chemical synthesis is organic synthesis. This field 
concentrates on the transformation of carbon-based chemical bonds. As a result of its close 
relationship with living systems (life being predominately based on carbon), organic 
synthesis has had a vast impact on medicine over the past century. 
This thesis refers to the aspect of organic synthesis which aims to improve the art of 
methodology. In particular, the work aims to improve the field by achieving a better 
understanding of chemical processes and developing new methods based on the acquired 
knowledge.  
This thesis is divided into two main projects; the first project is focused on the development 
of a new synthetic method based on the concise synthesis of highly functionalised 
isoquinoline-1(2H)-one derivatives. Concurrently, a second project was carried out with the 
aim of investigating and developing a thermal novel cascade reaction discovered within the 
Parsons’ research group.  
 
 
1.2. Introduction to Alkaloids 
 
Alkaloids form a collection of complex nitrogen-containing compounds, derived from a range 
of sources such as microbes, marine organisms and plants through complex biosynthetic 
pathways. Alkaloids are a structurally varied class of nitrogen containing compounds and 
over 12,000 of these structures are derived from plants.
1
 Alkaloids are located in 20% to 30% 
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of all flowering plants and are particularly common in some plant families such as Fabaceae, 
Liliaceae, Solanaceae and Ranunculaceae.
1
 In addition, all species of Papaveraceae produce 
alkaloids. Alkaloids can emerge in all parts of the plant, although this depends on the plant 
species. More frequently, alkaloids accumulate in specific organs of the plant e.g. in bark, 
roots, leaves and fruits. Well known alkaloid compounds include purine alkaloids (caffeine 
1.4), tropane alkaloids (scopolamine 1.3 and cocaine 1.7), benzylisoquinoline alkaloids 
(morphine 1.9 and berberine 1.13) and monoterpenoid indole alkaloids (vinblastine 1.1 and 
ajmaline 1.2).
2
 
 
 
 
Figure 1.1: Examples of Well-Known Alkaloids 
 
The function of alkaloids in plants is not always detectable and can vary, nevertheless it is 
believed that alkaloids contribute to a plants defence system against herbivores, improving 
the plants’ overall growth, reproduction and survival.3 For example, liriodenine 1.5 
demonstrates antifungal activity defending the plant from parasitic fungi.
4
 Alternatively, 
alkaloid substances such as serotonin 1.6, perform an integral function in neurotransmission 
in both animals and humans.
5
 The majority of alkaloids have a very bitter and disagreeable 
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taste, yet it is also put forward that alkaloids may function as a storage form of nitrogen and 
act as a protective agent against UV light damage.
3
 
Alkaloids are moderately stable compounds, accumulating as the result of diverse 
biosynthetic pathways from amino acids e.g. lysine, ornithine, tyrosine and tryptophan. A 
small number are derivatives of terpenoids such as Aconite and are named pseudoalkaloids. 
In chemical terms they can be differentiated from other components by the presence of at 
least one nitrogen atom, but the majority also consist of oxygen. They are predominantly 
alkaline in nature which accounts for the name alkaloids, although some exceptions occur 
such as berberine 1.13 which is acidic. Furthermore, they are not normally water soluble and 
require organic solvents to be dissolved into, with ephedrine as an exception.  
As the number of alkaloids reported has increased, so has the number of alkaloid families into 
which they are categorised. A nitrogen atom fixed in a specific carbon framework makes up 
the only defining structural feature of a given alkaloid.
6
 The majority of alkaloids consist of 
complex polycyclic core structures that are largely responsible for their powerful and highly 
specific biological activity. Accordingly, any approach applied to these molecules will 
undoubtedly meet the challenge of nitrogen heterocycle synthesis. In spite of the structural 
diversity of alkaloids, the essential structural components located in these molecules are 
limited in variability. These motifs can be generally categorised into monocyclic N-
heterocycles and benzannulated bicyclic systems. The majority of alkaloids such as the 
isoquinoline alkaloids are defined under the benzannulated bicyclic systems. 
Although the extensive use of plants consisting of alkaloids with medicinal value began many 
centuries ago, the applications of alkaloids as isolated and characterized compounds initiated 
a new age of drug discovery starting in the 19th century.
7
 A number of alkaloids of 
significant therapeutic value have been identified.
1
 If the difficulty of obtaining alkaloids 
from natural origins in large quantities is considered, the significance of chemical synthesis 
as a potent means for solving supply issues in clinical trials and marketing is apparent. 
Consequently, the synthesis of alkaloids and their analogues has emerged as one of the most 
active research areas in modern organic chemistry. 
 
 
1.2.1. Isoquinoline Alkaloids 
 
Isoquinoline, also referred to as benzo[c]pyridine or 2-benzanine, comprises of a benzene 
ring fused to a pyridine ring. Initially, it was isolated by Hoogewerf and van Dorp in 1885 as 
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a component of coal tar.
8
 Additionally, it was disovered in the plants Cistanche salsa 
(Orobanchaceae), Nicotiana tabacum cv (Solanaceae), Papaver somniferum (Papaveraceae), 
and Spigelia anthelmia (Loganiaceae).
9
 Isoquinoline is a significant structural mainstay in 
alkaloid natural products with the total number of isoquinoline alkaloids reported today 
reaching over 1,200. Alkaloids containing the isoquinoline ring as such or as part of a more 
complex ring system are not only numerous but also widely distributed. In addition, 
numerous classes of isoquinolines may occur simultaneously in plant families rich in 
alkaloids. 
As a result of their biological activities, they are commonly utilised as building blocks in 
pharmaceutical compounds.
10
 Also, they are used as chiral ligands for transition-metal 
catalysts
11
 and their iridium complexes are applied in organic light-emitting diodes (LED).
12
 
For the purposes of refined natural product synthesis and the perfecting of biological and/or 
physical properties of those compounds for final use, a broad and malleable approach to this 
category of heterocycles is much desired. In addition, the approach must tolerate an extensive 
variety of functional groups. 
 
 
Figure 1.2: Biologically Active Natural Products Containing Isoquinoline Scaffold 
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1.2.1.1. Isoquinolin-1(2H)-ones 
 
Isoquinolin-1(2H)-one is a regularly encountered structural sub-unit of many biologically 
active natural products e.g. narciclasine 1.14, pancratistatin 1.15, lycoricidine 1.16, dorianine 
1.17, ruprechstyril 1.18 and thalifoline 1.19 as illustrated in Figure 1.3.
13
  
 
 
Figure 1.3: Biologically Active Natural Products Containing Isoquinolin-1(2H)-one Scaffold 
 
Isoquinolin-1(2H)-one derivatives have gained considerable attention on account of their 
antihypertensive and anticancer activities.
14
 The wide range of biological activities 
demonstrated by the isoquinolin-1(2H)-one derivatives constitute an appealing and 
perplexing synthetic goal. Consequently, synthesis of substituted isoquinolin-1(2H)-one 
derivatives has accumulated notable attention.  
 
In 1992, Fisher et al.
15
 demonstrated that the reaction of dilithio species derived from N-allyl-
2-methylbenzamide with DMF, or other N,N-dimethyl amides, succeeded by acidic workup, 
yielded 2-propenylisoquinolin-l(2H)-one 1.24 or the 3-substituted derivatives. 
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Reagents and Conditions: (a) LDA (2.2 eq.), -70 °C to 0 °C, THF; (b) sec-BuLi (2.2 eq.), -70 
°C, THF; (c) DMF (excess); (d) 1 M HCI (excess). 
 
Scheme 1.1: Synthesis of 2-Propenylisoquinolin-l(2H)-one 1.24 
 
The well-known Ugi four-component condensation between aldehydes, isocyanides, amines 
and carboxylic acids typically affords N-substituted α-acylamino carboxamides.16 Recently, 
Routier et al.
17
 adopted this approach and synthesised new tetrazinoimidazoisoquinolinones 
1.28a-f by a microwave-assisted three-component reaction using aminotetrazine 1.25, an 
isocyanide 1.27 and an ortho-carboxybenzaldehyde 1.26. 
 
 
 
Reagents and Conditions: (a) Toluene, MW, 100 °C, 10 min., yields, see Table 1.1. 
 
Scheme 1.2: Synthesis of Tetrazinoimidazoisoquinolinones 1.28a-f by a Microwave-Assisted 
Three-Component Reaction 
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Compound R
1
 R
2
 Yields(%) 
 
1.28a 
 
3,5-dimethyl-1H-pyrazol-1-yl 
 
c-Hexyl 
 
76 
1.28b 3,5-dimethyl-1H-pyrazol-1-yl p-methoxyphenyl 62 
1.28c 3,5-dimethyl-1H-pyrazol-1-yl 2-Pentyl trace 
1.28d Cl c-Hexyl 61 
1.28e Cl p-methoxyphenyl trace 
1.28f Cl 2-Pentyl 53 
 
Table 1.1: Synthesis of Tetrazinoimidazoisoquinolinones 1.28a-f  
 
Guchhait et al.
18
 reported in-situ cyclisation of primary amine functionality mediated by de-
tert-butylation in MCR products with tethered internal functional group. To this aim, 
Guchhait and co-workers selected phthalaldehydic esters 1.29 as the aldehyde component. 
The resultant Ugi-type multicomponent reaction with heterocyclic-2-amidines 1.30 and tert-
butyl isocyanide 1.31, together with the tandem dealkylation, generated the in-situ cyclised 
products isoquinolinoneimidazole-heterocycles 1.32a-c. 
 
 
Reagents and Conditions: (a) ZrCl4, n-BuOH, MW, 140 °C, 7 min.; (b) HBF4, MW, 160 °C, 
20 min., yields, see Table 1.2. 
 
Scheme 1.3: One-Pot MCR-de-tert-Butylation Cyclisation: Synthesis of N-fused 
Isoquinolinone-Imidazole Heterocycles 
 
Compound R
1
 R
2
 Yields 
 
1.32a 
 
H 
 
H 
 
85% 
1.32b H Br 72% 
1.32c OMe H 80% 
 
Table 1.2: Synthesis of N-fused Isoquinolinone-Imidazole Heterocycles 
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This original microwave-assisted tandem procedure of de-tert-butylation of the intermediate 
tert-butyl amine in an Ugi-type MCR product, yielded the effective implementation of tert-
butyl isocyanide as a valuable convertible isonitrile. The authors concluded that this method 
may supply access to a varied array of medicinally-related N-fused heterocycles. 
In 2004, Yang and co-workers also reported the synthesis of isoquinolin-1(2H)-one 
derivatives as a result of isocyanide based Ugi-MCR followed by a Heck reaction.
19
 It was 
put forward that substrates comprising functionalities such as the Ugi product 1.37 can 
sequentially undergo the Pd-catalysed intramolecular Heck and double-bond isomerization to 
produce isoquinoline scaffolds 1.39 in one pot via the intermediates 1.38. 
 
 
Reagents and Conditions: (a) MeOH, 25 °C, 91%; (b) Pd(OAc)2, PCy3, DMA, 60 °C, N-
methyldicyclohexylamine, 94%. 
 
Scheme 1.4: Two-Step Synthesis of Isoquinoline 1.39 
 
During their studies on oxidative ruthenium-catalyzed homodehydrogenative arylations 
Ackermann and co-workers
20
 observed ruthenium-catalyzed direct annulations of alkynes. 
Following these findings, they investigated the effect of contrasting reaction parameters on 
the oxidative annulation of alkyne 1.40 by amide 1.41. Optimal yields of product 1.42 were 
obtained with [{RuCl2(p-cymene)}2], alongside Cu(OAc)2·H2O as the terminal oxidant and t-
AmOH (t-Am = tert-amyl) as the solvent. 
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Reagents and Conditions: (a) [{RuCl2(p-cymene)}2],  Cu(OAc)2·H2O, t-AmOH, 100 °C, 22h, 
76%. 
 
Scheme 1.5: Ruthenium-Catalysed Synthesis of Isoquinolone 1.42 
 
Furthermore, Fu and co-workers established a copper catalysed procedure for the synthesis of 
isoquinolin-1(2H)-one derivatives via cascade reactions of o-halobenzamides with β-
ketoesters.
21
 A selected example is show in Scheme 1.6 below. 
 
 
 
Reagents and Conditions: (a) CuI, Cs2CO3, dioxane, 80 °C, 16 h, 80%. 
 
Scheme 1.6: Copper-Catalyzed Coupling of 2-Bromobenzamide with Ethyl Acetoacetate 
 
Nevertheless, there are numerous methods available for the preparation of isoquinolin-1(2H)-
one derivatives, yet a large majority endure a poor precursor scope with less points of 
diversity. A succinct synthetic methodology consisting of commercially accessible and 
affordable starting materials is still necessary for their practical synthesis. 
 
 
1.3. The Diels-Alder Reaction  
 
The product of a Diels-Alder (D-A) reaction (referred to as the “diene synthesis” in earlier 
accounts) is comprised of a six-membered ring, formed via fusion of a four-π component, 
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normally a diene and a two-π component, which is typically named the dienophile (Scheme 
1.7). 
 
 
 
Scheme 1.7: Schematic Representation of the Diels-Alder Reaction (Structures A and B 
Indicate Two Regioisomeric Products) 
 
The synthetic properties of the Diels-Alder reaction have proven to be of great significance, 
developing an important step in the formation of compounds comprised of six-membered 
rings.
22
 Furthermore, configuration of the reacting double bonds are totally retained in the 
configuration of the product thus the reaction is stereospecific. Respectively, six novel 
stereocentres can be generated in a single reaction step and the absolute configuration of the 
two newly generated asymmetric centres can be effectively controlled. 
The originally observed intermolecular Diels-Alder reaction has been expanded to consist of 
intramolecular reactions, hetero-Diels-Alder reactions, transannular reactions (TADA) and 
also diene-regenerative Diels-Alder reactions. The Diels-Alder reaction has been widely 
applied to the synthesis of natural products in account of its ability to produce increased 
molecular complexity.
22
 Consequently, it is frequently used as the integral step during a 
synthetic strategy. 
An early example of the Diels-Alder reaction in natural product synthesis was demonstrated 
by Woodward et al.
23
 in 1956 in the total synthesis of reserpine. In this striking application, 
the Diels-Alder was used to establish the first three of the six stereocenters of the molecule in 
one novel step. Following this first step, the rest of the molecule was expounded in fifteen 
more chemical steps, illustrating the utility of the Diels-Alder reaction in attaining products 
of high complexity. 
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Scheme 1.8: The Total Synthesis of Reserpine by Woodward et al.
23
 
 
 
1.3.1. The History  
 
The synthetic and theoretical aspects of this reaction were studied in great detail by the 
German chemists Otto Diels and Kurt Alder, whose names were subsequently given to the 
reaction. On the contrary to popular belief, the reaction was not the discovery of Diels and 
Alder, yet they were awarded the Nobel Prize in 1950 for their extensive work towards its 
investigation. The original example of a Diels-Alder reaction (specifically the dimerisation of 
tetrachlorocyclopentadienone) dates from 1892.
24
 Von Euler was the first chemist to 
recognise the significance of the reaction in 1920,
25
 although the structures of the products 
were inaccurate. In 1928, Otto Diels and Kurt Alder were responsible for identifying the 
accurate structure of the products (1.53 and 1.55), resulting from the reaction of 
cyclopentadiene 1.51 with quinone 1.47.
26
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Scheme 1.9: The Discovery of the Diels-Alder (D-A) Reaction in 1928
26
 
 
Diels and Alder were clearly aware of the significance of this discovery, particularly as 
applied to natural product synthesis and predicted the realisation of new-found possibilities; 
“Thus it appears to us that the possibility of synthesis of complex compounds related to or 
identical with natural products such as terpenes, sesquiterpenes, perhaps even alkaloids, has 
been moved to the near prospect”.26 
 
 
1.3.2. Mechanistic Aspects 
 
The Diels-Alder reactants can comprise of only hydrocarbon fragments (homo-Diels-Alder 
reaction), but it is also possible that they contain one or more heteroatoms on any of the 
positions a-f (hetero-Diels-Alder reaction) culminating in heterocyclic ring systems (Scheme 
1.7). The combinations of carbon and hetero atoms which was readmitted are highly varied, 
reflecting the significant versatility of this reaction.
22
  
In Diels-Alder reactions, a notable division is made between normal electron demand and 
inverse electron demand additions. The basis for this distinction is the rate of the reaction 
response to the introduction of electron withdrawing and electron donating substituents. 
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Normal electron demand Diels-Alder reactions (NDA) are advocated by electron donating 
substituents on the diene and electron withdrawing substituents on the dienophile. On the 
contrary, inverse electron demand Diels-Alder reactions (IEDDA) are expedited by electron 
withdrawing substituents on the diene and electron donating ones on the dienophile. In 
addition, there is an intermediate class; the neutral Diels-Alder reaction that is expedited by 
both electron withdrawing and donating substituents. 
The Frontier Molecular Orbital (FMO) theory can rationalise the way in which the 
substituents affect the rate of the reaction.
27
 The FMO theory emerged during a study of the 
role of orbital symmetry in pericyclic reactions by Woodward and Hoffmann
28
 and 
independently, by Fukui.
29
 Subsequently, Houk
30
 advanced knowledge on the reactivity and 
selectivity of these processes.  
Two modes of interaction are possible when FMO is applied to the Diels-Alder reactions, the 
reaction is controlled by either the HOMO of the diene and the LUMO of the dienophile 
(normal electron demand) or the interaction between the LUMO of the diene and the HOMO 
of the dienophile (inverse electron demand). In the first mode, a decrease in the HOMO 
diene–LUMO dienophile energy gap can be enhanced by either increasing the energy of the 
HOMO of the diene via the addition of electron donating substituents, or decreasing the 
energy of the LUMO of the dienophile by the addition of electron withdrawing substituents. 
The HOMO diene–LUMO dienophile interaction exerts a greater influence on the energetics 
of the Diels-Alder reaction when compared with the HOMO dienophile–LUMO diene 
interaction.
31
 Perhaps the most persuasive experimental evidence for this hypothesis comes 
from the observation by Spiro et al.
32
 that normal electron demand Diels-Alder 
cycloadditions are consistently preferred over inverse electron demand Diels-Alder 
cycloadditions in the cross-Diels-Alder cycloaddition between an electron-poor and an 
electron-rich diene.
32 
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Figure 1.4: The NDA is always favoured over the IEDDA in Cross-Diels-Alder 
Cycloadditions 
 
Although many reactions do not adhere to the FMO rule of reactivity,
33
 inverse electron 
demand Diels-Alder cycloadditions have an excessive amount of examples in that category. 
For instance, the dimerization of acrolein competes successfully with its cycloadditions with 
electron-rich dienophiles in spite of typical energy gaps that gives the latter 1.5-2.0 eV 
advantage.
34
 Also, 2-carbomethoxy-1,3-butadiene dimerises much faster than it reacts with 
dihydropyran and other electron-rich dienophiles.
35
 In the example of normal electron 
demand Diels-Alder cycloadditions, the FMO theory may estimate the relative reactivities 
between dienophiles, although in the example of inverse-electron demand Diels-Alder 
reactions, it may not. Interestingly, Spiro et al.
32 
demonstrated that the dissymmetry in 
electron-rich dienophiles escalates their reactivities. 
According to Woodward and Hoffmann (W-H), the formation of two new δ-bonds preserves 
orbital symmetry thus enabling the reaction to be concerted; this is illustrated in Figure 1.5. 
This is in line with the general idea that needless geometric distortions in the course of 
reactions should be avoided as much as possible to take the minimum-energy trajectories. In 
other words, no intermediate is included in pericyclic processes like the Diels-Alder 
reaction.
36
 Furthermore, a significant number of computer simulations were consistant with a 
concerted mechanism.
37
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Figure 1.5: Distinction between Normal- and Inverse-Electron Demand Diels-Alder 
Reactions 
 
Regardless of this vast body of evidence, two-step mechanisms have been proposed for the 
Diels-Alder reaction. It is likely that special cases have accounted for this, where highly 
substituted dienes and/or dienophiles have been observed to react via zwitterionic
38
 or’ 
biradical
39
 intermediates (Scheme 1.10). 
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Scheme 1.10: Schematical Representation of a zwitterionic and a biradical Pathway of a 
Diels-Alder Reaction 
 
In comparative kinetic studies, the rate of ion formation from p-substituted α,α-
dimethylbenzyl chloride was shown to increase by 10
9
 when the para substituent reforms 
from a methoxy into a nitro group. Similarly, a change in substituent in the Diels-Alder 
reaction of p-substituted 1-phenylbutadienes with maleic anhydride renders an increase in the 
rate by only tenfold (10
1
). This difference suggests that the cycloaddition is not ensuing via a 
zwitterionic mechanism. Furthermore, [4+2] reaction rates in the gas phase are analogous to 
those in solution, from which follows the conclusion that any intermediate could only be 
marginally more polar than the ground state as solvation is unnecessary. The prospect of a 
biradical singlet intermediate has been implied by some studies, although this may be 
dependent on the type of substrates used in the reaction.
40
 
One of the more notable arguments in support of the multicentered mechanism is the 
universal, stereospecific cis addition of dienophile to diene known as the “cis” principle. In 
this example, the steric arrangements of substituents on both reactants are conserved within 
the adduct. If the substituents are trans on the dienophile for instance, they will stay trans in 
the product. This observation is typically understood to indicate a synchronous formation of 
bonds. However, Sauer et al.
41
 suggested that this does not entirely rule out the possibility of 
a two-step reaction. If the ring closure step is very fast, the prospect for rotation about the     
C-C bond axis during an intermediate transition step would be non-existent and the cis 
principle would remain upheld. However, following extensive calculations an agreement was 
reached in preference of the concerted mechanism.
42,43,44
 The concerted nature of the reaction 
does not indicate that in the activated complex the magnitude of formation of the two new δ-
bonds is necessarily equivalent. Asymmetric substitution arrangements on the diene and/or 
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dienophile can result in an asynchronous activation process.
45
 The magnitude of 
asynchronicity can be estimated from the FMO-coefficients of the terminal carbons of diene 
and dienophile. The FMO coefficients also permit qualitative estimation of the kinetically 
controlled regioselectivity. 
Although the Woodward-Hoffmann rule and FMO theory both share a degree of success, 
there remain issues of clarity in both accounts. To address this uncertainty, Fukui put forward 
a theory of intrinsic reaction coordinate (IRC)
46
 and aimed to connect analytically the 
perturbative region with TS. The current progress on IRC calculations
47
 enables the 
possibility of tracing the symmetry-allowed paths in realistic reacting systems.  
Diels–Alder reactions consisting of asymmetrically substituted reactants will proceed through 
an asymmetric transition state.
48
 However, even symmetrically substituted reactants can 
induce an asymmetric transition state. In recent work, Yamabe et al.
49
 examined paths of a 
variety of normal electron demand Diels-Alder reactions with density functional theory 
calculations. In this work, paths of Diels-Alder reactions of dienes and olefins with 
symmetric geometries were discerned.  
 
 
 
Scheme 1.11: Diels-Alder Reaction between Linear Dienes and Dienophiles 
 
In accordance with the symmetry-allowed condition, TS geometries of parts 1.68a, 1.68b and 
1.68c have Cs-symmetry. However, that of part 1.68d was found to be asymmetric. In part 
1.68d, one bond-forming C···C distance is 1.926 Å and the other is 2.564 Å. The 
combination between a highly nucleophilic diene; (E,E)-1,4-dimethoxy-1,3-butadiene (DMB) 
and a highly electrophilic olefin; tetracyanoethylene (TCNE), has broken the W-H rule. 
While many reactions take the Cs-symmetry paths obeying the W-H rule, those of strong 
nucleophilic dienes and electrophilic olefins do not follow the symmetry-conservation rule. 
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Figure 1.6: Transition-State (TS) Structure of Diels-Alder Reaction between Linear Diene 
and Dienophile 
 
When symmetrically distributed substituents are placed on Diels–Alder adducts, the 
reaction’s transition state can be of Cs-symmetry or it can be asymmetric.49 The symmetry 
nature of the TS depends on an interplay between orbital interactions, aromaticity (which 
favors a Cs structure) and strain (which tends to break symmetry).  Bachrach and co-workers 
examined several Diels-Alder reactions involving only alkyl substituents to minimize the role 
of orbital interactions.
48
 The approximation of strain energy was reached by taking the 
difference in energy between either reactants or products in their most constant conformation 
and relating them to the energy of the symmetry-constrained conformation. This measure of 
strain energy was subsequently used to separate the reactions into two divergent groups. The 
reactions with a strain energy of less than 10 kcal mol
-1
 occur with a symmetric transition 
state and those reactions with a strain energy in excess of 10 kcal mol
-1
 proceed with an 
asymmetric transition state. As a first approximation, authors estimated that the aromatic 
stabilisation energy in the TS is about 10 kcal mol
-1
.
48
 
A particularly significant factor in the concerted Diels-Alder reaction is the conformation of 
the diene. In order for the dienophile to interact simultaneously with the orbitals on either end 
of the diene, the diene must adopt a “s-cis” conformation, though it need not be planar. A 
diene locked in the “s-trans” conformation will not undergo a Diels-Alder reaction. In a large 
number of acyclic dienes such as 1,3-butadiene, the “s-trans” conformation takes control and 
the Diels-Alder reaction is a slow procedure. Consequently, dienes locked in the “s-cis” 
conformation are considerably more reactive. Understanding that the “s-cis” conformation is 
normally higher in energy than the “s-trans” conformation makes the association with strain 
energy apparent. For example, some strain is intrinsic in a Diels–Alder reaction consisting of 
any acyclic diene. A symmetric transition state must overcome even more strain, given that 
constraining the diene to be planar and all substituents to totally eclipse will demand 
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additional energy. The driving-force for adopting this symmetrical arrangement is the 
stabilization related to aromaticity. The occurrence of the reaction via an asymmetric TS is 
not strain-free but rather it selects this path so as to minimise the strain. Cyclopentadiene is a 
key example of a locked “s-cis” diene and accordingly, is a highly reactive diene for the 
Diels-Alder reaction. 
 
 
 
Figure 1.7: Diene Conformation Affecting the Reactivity in Diels-Alder Reactions 
 
 
A classical, demonstrative example of the use of cyclopentadienes in the Diels-Alder context 
is E. J. Corey’s ground-breaking work on the total synthesis of the prostaglandins.50 The 
retrosynthesis of the desired prostaglandin core derives from the late disconnection of the top 
side-chain. Subsequently, the bottom side-chain is disconnected which leads to a 
cyclopentane core. 
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 Scheme 1.12: Retrosynthetic Analysis of the Corey Approach to the Prostaglandins 
 
 
Alternatively, the aromatic five-membered-ring heterocycles are also defined as 1,3-
butadiene derivatives. The diene-like chemical behaviour may be demonstrated in such a 
manner. Primary examples of locked “s-cis” aromatic five-membered-ring heterocycles are 
furan and pyrrole. Pyrrole is an aromatic ring and is unreactive towards the Diels-Alder 
reaction. Nevertheless, pyrrole derivatives develop into good dienes in the Diels-Alder 
reaction with electron-poor dienophiles when an electron-withdrawing group is installed at 
the N1 position. Accordingly, formal syntheses of Tamiflu® from the Diels-Alder adduct of a 
pyrrole and acetylene was recently reported by Kamimura et. al.
51
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Scheme 1.13: Retrosynthetic Analysis of the Kamimura Approach to Tamiflu
®
 
 
An additional form of selectivity can emerge when substituted dienes and dienophiles are 
utilised in the Diels-Alder reaction. Two alternative cycloadducts denoted as endo and exo 
can subsequently be formed (Scheme 1.14). Alder and Stein discerned that there usually 
exists a propensity for formation of the endo isomer,
52
 although this has been the subject of 
some criticism.
53
 According to Alder's rule, the major stereoisomer in Diels-Alder reactions 
is the one that is formed by maximum accumulation of double bonds in the transition state 
(through-space).
54
 On the other hand, the endo product is usually less stable than exo. While 
the stereoelectronic interactions involved in the transition state stability are widely studied in 
the literature,
55
 the same attention has not been dedicated to understand the stability of the 
products. One of the most used examples of the Diels-Alder reaction
56
 is the reaction between 
cyclopentadiene 1.51 and maleic anhydride 1.86. At room temperature, this reaction gives 
only the endo adduct that is then converted at 200 ºC to the thermodynamically more stable 
exo adduct through a retro Diels-Alder reaction.
57
 Similarly, according to several authors
58
  
the Diels-Alder reaction between cyclopentadiene 1.51 and 1,4-benzoquinone 1.47 produces 
only the kinetic endo adduct 1.84, although the exo adduct 1.85 has higher stability than the 
endo adduct 1.84 due to the steric repulsive interaction present in the endo form.  
42 
 
 
 
Scheme 1.14: Endo/Exo Selectivity in [4+2] Cycloaddition of 1,4-Benzoquinone and Maleic 
anhydride with Cyclopentadiene 
 
 
Nevertheless, the theoretical calculation for the cycloaddition reaction of 1,4-benzoquinone 
1.47 and cyclopentadiene 1.51 indicates that the energy for exo transition state structure is 1.8 
kcal mol
-1
 higher than for endo which supports the observed experimental results (Figure 
1.8).
59
 On the contrary, recent analysis on the energies of the products indicated that the endo 
adduct was more stable (thermodynamic product) than exo which discounts the literature 
data.
60
 Also, the data supported that in the endo adduct the steric repulsive interactions are 
greater than in exo. However, the attractive delocalization interaction in endo is higher than in 
exo and counterbalances the steric repulsion. This explains why the endo 1.84 and not the exo 
1.85 is additionally the thermodynamic product, as confirmed in the current literature. 
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Figure 1.8: Energies for endo and exo Reaction Pathways of the Cycloaddition Reaction of 
Cyclopentadiene 1.51 and 1,4-Benzoquinone 1.47 
 
The interactions intrinsic to this behaviour have been the topic of extensive research. 
Considering that the reactions leading to endo and exo products have the same initial state in 
common, the discrepancies between the respective transition-state energies completely justify 
the reported selectivity. The theory that Secondary Orbital Interactions are of primary 
significance was proposed by Woodward and Katz.
61
  Cossio et al.
62
 presented a method to 
measure the Secondary Orbital Interaction (SOI). The application of this method to the 
cyclopentadiene 1.51 - maleic anhydride 1.86 cycloaddition, indicates notable stabilization of 
the endo transition state in account of Secondary Orbital Interaction. As a result of these 
findings the authors concluded that “SOI do exist and are responsible for at least an 
important part of the observed stereocontrol”. 
 
 
 
Figure 1.9: The endo Approach for the Cyclopentadiene 1.51 – Maleic anhydride 1.86 
Reaction  
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In contrast, analysis of the parallel approximation between s-trans butadiene and 
fumaronitrile indicated that SOI was overrun by closed-shell repulsions.
63
 Additionally, the 
research of several reactions (cyclobutadiene-norbornadiene, cyclopentadiene-maleic 
anhydride, cyclobutadiene-cyclobutenedione) reported the absence of a net attraction for the 
atom pairs associated in SOI. In conclusion of these results the authors stated “the endo 
preference is not due to the occurrence of an attractive interaction between the atom pairs 
involved in SOI and so this concept is unnecessary”. 
 
 
Figure 1.10: s-trans-Butadiene + fumaronitrile Complexes that have (A) or lack (B) SOI 
 
This account has also been criticised by Mellor, who accredited the endo selectivity to steric 
interactions.
64
 Steric effects are commonly suggested as significant in determining the 
selectivity of Diels-Alder reactions, especially of substituted dienophiles and may eventually 
lead to exo-selectivity.
65
 In the case of other systems, steric effects in the exo activated 
complex can augment endo selectivity.
66,67  
For instance, the endo preference observed in the 
cycloadditions of cyclopentadiene 1.51 with some alkenes (such as cyclopentene or cis-3,4-
dichlorocyclobutene) is commonly attributed to steric repulsion between the methylene group 
of the diene and the substituents of the dienophile.
68
 
 
 
Figure 1.11: Alternative Interactions Proposed in Order to explain the endo Preference 
Found in the Diels-Alder Reactions of Cyclopentadiene 1.51 with Various Dienophiles 
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Nonetheless, it can be suggested that the endo preference of Diels-Alder reactions of 
cyclopentadiene with numerous α,β-unsaturated carbonyl compounds could also be justified 
in terms of SOI (Figure 1.11).
69
 However, experimental data (shown in Table 1.3) illustrate 
that a methyl group induces a greater endo preference than carbonyl-bearing substituents 
(COOH, CHO, COOCH3).
70
 This outcome is in accordance with the greater size of the 
methyl group as construed from experimental data on the axial/equatorial conformational 
equilibria in cyclohexane derivatives.
71
 
 
R X % endo (at 25 °C) ΔΔHǂ (kcal mol-1) 
 
H 
 
COOH 
 
80.2 
 
0.65 ± 0.01 
CH3 COOH 29.2 -0.74 ± 0.01 
H CHO 74.4 0.57 ± 0.06 
CH3 CHO 17.0 -1.21 ±0.04 
H COOCH3 74.3 0.56 ± 0.04 
CH3 COOCH3 30.1 -0.25 ± 0.08 
 
Table 1.3: endo Percentage and Relative Activation Enthalpy (endo/exo) of the Diels-Alder 
Reactions of Cyclopentadiene with Various Dienophiles 
 
Apeloig and Matzner have conducted a theoretical study on the reactions of cyclopropene 
with numerous dienes.
72
 In this study, the authors accredited the endo/exo selectivity to the 
presence of SOI in a LUMO diene–HOMO dienophile interaction. In an alternative 
theoretical investigation into the reactions of cyclopropene with open-chain dienes, it was 
demonstrated that the endo/exo selectivity can be accredited to an amalgamation of electron 
delocalization and electrostatic forces.
73
 Another supportive explanation involves the 
existence of a destabilising interaction in the exo transition state. This culminates from the 
repulsion (due to electrostatic and/or van der Waals interactions) between a hydrogen atom of 
the methylene group of cyclopropene and the inner hydrogen atoms of butadiene (situated at 
a distance of 2.3 Å). 
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Figure 1.12: Alternative Interactions Proposed in Order to Explain the endo Preference 
Found in the Diels-Alder Reaction Between 1,3-Butadiene and Cyclopropene. 
 
Furthermore, electrostatic forces have been ardent, here for example, the minor endo 
preferences calculated for the reactions of butadiene with simple α,β-unsaturated carbonyl 
compounds (such as acrolein
74
 or methyl acrylate
75
) can be accredited to electrostatic 
repulsions.  These occur in the exo transition states between the positive charges associated 
with the “in” hydrogens of butadiene and the carbonyl carbon of the dienophile (Figure 
1.13). A further example of the influence of electrostatic interactions on the endo/exo 
selectivity of Diels-Alder reactions is the furan + cyclopropenone cycloaddition. Therefore, 
the high exo preference has been accredited to the existence of a potent electrostatic 
stabilization between the furan oxygen and the carbonyl carbon of cyclopropenone.
76
 
 
 
 
Figure 1.13: The Influence of Electrostatic Interactions on the endo/exo Selectivity of Diels-
Alder Reactions. 
 
The importance of the dienophile transoid-cisoid conformational equilibrium in determining 
the endo/exo selectivity is emphasised by Mattay.
77
 The transoid conformation is preferred in 
solution and is demonstrated to lead to endo product, however, the cisoid conformation 
(favoured in the gas phase) generates the exo adduct.  
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1.3.3. Solvent Effect on Diels−Alder Reactions 
 
The effects of solvents on Diels–Alder reactions are well reported with studies focusing on 
the theoretical and experimental treatment of solvation effects on such reactions.
78
 In a 
common approach, a particular property of a reaction (e.g. its rate or selectivity) is examined 
in a large variety of solvents. These solvents contain unique features, quantified by their 
physical properties (e.g. refractive index, dielectric constant) or empirical parameters. 
A number of sources, when debating solvent effects on organic reactions, put forward the 
Diels-Alder cycloaddition as a common example of a reaction indifferent to the selection of a 
solvent. This characteristic is demonstrated by the data in Table 1.4 which refers to the rate 
of dimerisation of cyclopentadiene 1.51.  
In this reaction, the second-order rate constants in a wide range of organic solvents are 
similar to each other and also to the rate constant in the absence of a solvent. The data in 
Table 1.4 illustrates the very unique example of a Diels-Alder reaction between two purely 
hydrocarbon reactants. Typically, Diels-Alder reactions only occur at a substantial rate when 
either diene or dienophile is activated by an electron donating or withdrawing substituent. 
These substituents almost consistently comprise of heteroatoms. These atoms interact 
effectively with the solvent, causing an intensification of the solvent effect on the reaction. A 
large number of these processes have been examined; originally the correlation of the rate of 
Diels-Alder reactions with solvent parameters was reported in 1974.
79
 
 
solvent / state K2 (M
-1
 s
-1
) 
 
gas phase 
 
6.9·10
-7
 
Neat 5.6·10
-7
 
Carbon tetrachloride 7.9·10
-7
 
Nitrobenzene 13·10
-7
 
Ethanol 19·10
-7 
  
Table 1.4: Second-Order Rate Constants k2 for the Dimerisation of Cyclopentadiene in 
Solution and in the Gas Phase at 25 °C 
 
Desimoni and Mayoral have reported comprehensive analyses of solvent effects on Diels-
Alder reactions.
80
  Initially, Desimoni supported the Acceptor Number (AN) as the prevailing 
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solvent parameter. Additional investigation exposed the rate constants for Diels-Alder 
reactions as not yielding satisfactory correlations with the AN.
81
 These investigations 
demonstrated either reactions that were almost insensitive to solvent effects (like the 
dimerisation of cyclopentadiene, Table 1.4) or reactions that responded predominantly to the 
electron-pairdonor property of the solvent. As a result of these findings, the authors divided 
Diels-Alder reactions into three categories. In type I, the rate constants rise with increasing 
Lewis-acidic character of the solvent quantified by the AN. This behaviour mirrors LUMO 
solvent–HOMO solute interactions and is comparable to Lewis-acid catalysis. In type II, 
electron donation by the solvent through soft-soft interactions delays the reaction and HOMO 
solvent–LUMO solute interactions account for this observation. Type III comprises of Diels-
Alder reactions which exhibit very slight solvent effects and are relatively indifferent to 
specific solute-solvent interactions.  
The significance of solvent density in the unique case of intramolecular Diels-Alder reaction 
in extremely viscous media was demonstrated by Firestone et al.
82
 An intriguing new 
medium for the Diels-Alder reaction was presented in 1990 by Grieco et al;
83
 a 5 molar 
solution of lithium perchlorate in diethyl ether. The substantial accelerations of Diels-Alder 
reactions in this medium were accredited to a high internal pressure by Grieco and later also 
by Kumar.
84
 This viewpoint has been questioned and alternative accounts put forward. In 
particular, Lewis-acid catalysis by the lithium cation has been presented
85
 and efficient 
stabilisation of the Diels-Alder transition state by this extremely polar medium.
86
 Faita et al.
87
 
have illustrated that only when Diels-Alder reactions are not responsive to Lewis-acid 
catalysis, internal pressure can account for the (in this case always modest) accelerations. 
Additionally, a valuation of the Lewis acidity of this ion in organic media has been 
published.
88
  
The first to examine systematically the influence of the solvent on the endo/exo selectivity of 
the Diels-Alder reaction were Berson and co-workers.
89
 The authors deduced the solvent 
reliance of the endo/exo ratio by considering the dissimilar polarities of the individual 
activated complexes involved. In the endo activated complex, the dipole moments of diene 
and dienophile are aligned, while in the exo activated complex they are facing in opposed 
directions. Therefore, the endo activated complex is of higher polarity than the exo activated 
complex and polar solvents diminish the preference for the formation of endo cycloadduct. 
In some examples, solvent effects can be understood as the origin of the endo preference in 
solution. A common example of an endo preference incited by the effect of the medium is the 
cyclopentadiene + acrylonitrile reaction. Accordingly, experimental data for the reaction in 
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nonpolar solvents and approximations for the gas-phase cycloaddition suggest a very minor 
exo preference (by 0-0.4 kcal mol
-1
). Remarkably, a correlation between the endo/exo ratio 
and solvent polarisability has been detected by Nakagawa and co-workers.
90
 Consequently, 
an endo preference is identified when the reaction occurs in a large quantity of typical 
solvents. The Diels-Alder cycloaddition between acrylonitrile and piperylene manifests a 
behaviour pattern comparable to the analogous reaction with cyclopentadiene. Therefore, a 
preference for the ortho-trans adduct (corresponding to an exo approach) is identified in 
benzene solution, while the ortho-cis product (formed through an endo transition state) is 
favoured in polar solvents (e.g. methanol, ethanol, and acetone). 
According to Mayoral et al., the extensive multiparameter analyses indicated that a 
comprehensive report of the solvent effect on the endo/exo ratio requires numerous and 
differing interactions.
91,92,93,94
 A significant contribution is hydrogen bonding by the solvent, 
additionally, solvent polarity and solvent solvophobicity are of importance.  
 
 
1.3.4. Lewis-acid Catalysis of Diels-Alder Reactions 
 
The catalysis of Diels-Alder reactions via formation of supramolecular assemblies is well 
established. Large molecules comprising of a cavity (e.g. cyclodextrins
95,96
 or related basket
97
 
or capsule-like
98
 structures) can bind both Diels-Alder reagents simultaneously and stimulate 
their reaction. Also, heterogeneous systems such as clays,
99
 alumina
100
 or silica gels
101
 
possess catalytic potential. Furthermore, catalysis by Brønsted acids,
102
 Brønsted bases
103
 and 
radicals
104
 has established application in some special Diels-Alder reactions.  
However, the most effective method by far is catalysis via Lewis-acids. In organic solvents, 
accelerations of the order of 10
4
 to 10
6
 supplemented by a significant increase in selectivity 
are not the exception. The striking effects that Lewis-acids apply on the rate of Diels-Alder 
reactions were identified by Yates and Eaton in 1960.
105
 They examined the reaction between 
maleic anhydride and anthracene in the presence of aluminium trichloride. The reaction was 
completed in 1.5 minutes, whereas the estimated reaction time under equivalent conditions 
and in the absence of the catalyst was approximately 4800 hours. The FMO theory aids the 
understanding of the mechanism of activation by Lewis-acids. The electron withdrawing 
character of the catalyst lowers the energy of the LUMO of the reactant to which it is 
coordinated. As a result, the HOMO-LUMO energy difference decreases and in turn, the rate 
of the Diels-Alder reaction increases.  
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The influence of Lewis-acids on the selectivity was originally revealed by Sauer and Kredel 
in 1966.
106
 The addition of AlCl3·OEt2 activated improvement of the endo/exo selectivity of 
the reaction between cyclopentadiene and methyl acrylate from 82% to 98% endo. The 
influences of Lewis-acids on selectivity can be granted by acknowledging one of the simplest 
dienophile-Lewis-acid complexes; protonated acrolein.
107
  
 
 
 
Figure 1.16: The Effect of Lewis-acids on Selectivity 
 
In reference to FMO theory, the complexation of Lewis-acids to the dienophile or the 
protonation of the dienophile affects both the energy and orbital coefficients of carbon atoms 
of the LUMO of dienophile.
108
  This interaction increases the coefficient in this orbital and as 
a result, improves the reactivity and stereoselectivity in comparison to their thermal 
equivalents. Generally, the endo/exo ratio is tightly controlled by selection of catalyst. For 
instance, cycloaddition of 1,3-bis(silyloxy)cyclohexadiene with chiral acrylamides, e.g., 1-
[(2R,5R)-trans-bis(methoxymethyl)pyrrolidin-1-yl]-propenone demonstrated  high endo/exo 
selectivity (4:1) when tert-butyldimethylsilyl triflate (TBSOTf) was applied as the catalyst. 
Furthermore, reversed selectivity is detected with 100% exo selectivity being achieved when 
Eu(fod)3 catalyst is employed. Remarkably, the thermal reaction at 170 ºC was less selective 
with 1:3 endo/exo ratio being reached.
109
 In the majority of cases, Lewis-acid catalysed 
cycloadditions are beneficially performed under extremely moderate conditions, often below 
0 ºC which will often improve the diastereoselectivity.
110,111 
Furthermore, the 
regioselectivity
112
 and the diastereofacial selectivity
113
 will increase in the presence of Lewis-
acids.
 
 
The highly useful Diels-Alder reactions between dienes and heterodienes often yield two 
different pericyclic products. The experimental work of Denmark
114
 and Hanessian
115
 
demonstrated that the reactions between crotonoyl phosphonates 1.89a and nitroalkenes 
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1.89b with cyclopentadiene 1.51 can lead to combinations of Diels-Alder 1.90a-b and hetero-
Diels-Alder 1.91a-b cycloadducts. In the thermal reactions, cyclopentadiene functions as a 4π 
component and primarily yields the endo and exo Diels-Alder cycloadducts, accompanied by 
minor quantities of the hetero-Diels-Alder cycloadducts (anti and syn). In the example of 
trans-phenylnitroethylene, the Diels-Alder cycloadduct is generated exclusively. Lewis-acids 
such as SnCl4, reverse the periselectivity and cyclopentadiene now functions as the 
dienophile. The main products generated are the hetero-Diels-Alder cycloadducts with just 
minor quantities of Diels-Alder products. 
 
 
 
Scheme 1.15: Possible Diels-Alder and Hetero-Diels-Alder Reactions of Cyclopentadiene 
with 1.89a-b 
 
A number of Lewis-acids have been used in Diels-Alder reactions; however, the influence of 
a Lewis-acid on reaction outcome is not always advantageous and is highly substrate 
specific.
116
 The majority of studies demonstrate that the appropriate Lewis-acid to use with a 
set of substrates is usually best determined by experimentation. 
 
 
1.3.5. Intramolecular Diels-Alder Reactions 
 
The [4+2] pericyclic reaction, as described by Diels and Alder, was originally examined in 
the context of the intermolecular reaction, concentrating on the stereospecific and 
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regiospecific combination of two distinct entities. In contrast, the intramolecular Diels-Alder 
(IMDA) reaction, where the diene is connected to the dienophile via a tether was not 
examined thoroughly until the 1960s. The initial application of the IMDA reaction in the 
context of natural product synthesis was reported in 1963, with the preparation of γ-
apopicropodophyllin 1.93.
117
 The cinnamyl phenyl propiolate 1.92 was prepared via 
esterification of the respective E-cinnamyl alcohol and acid chloride. When 1.92 was 
subjected to vigorous conditions it culminated in the desired intramolecular cyclisation. 
 
 
 
Reagents and Conditions: Ac2O, heat, 48%. 
 
Scheme 1.16: The Application of an IMDA to form γ-apopicropodophyllin 1.93 
 
The intramolecular form of the Diels-Alder reaction has numerous distinct benefits over the 
intermolecular form. The synthetic benefits of employing an intramolecular Diels-Alder 
reaction (IMDA) emerge from the finding that many of the limiting electronic and steric 
necessities of the intermolecular Diels-Alder reaction and the chemoselectivity and 
regioselectivity of the outcomes, can be positively altered using an intramolecularly tethered 
triene system. The example in Scheme 1.16 demonstrates the high regioselectivity attainable 
in IMDA reactions, largely as a result of the torsional and geometric restrictions enforced by 
the dienophile tether.  
The pre-organisation and orientation of the diene and dienophile reduces the entropy 
demands, relative to the analogous intermolecular reaction enabling the IMDA reaction to 
progress more easily. Furthermore, by including a stereocenter in the triene precursor, 
discernment between the diastereotopic faces of the diene and dienophile can be attained. The 
nature of the linking tether is also significant in effecting the rate of reaction. These benefits 
have led to the comprehensive use of the IMDA in total synthesis and these applications have 
been reviewed.
118,119
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The IMDA reaction can be defined as either type I or type II, although this is dependent on 
the position of attachment of the dienophile to the diene (Scheme 1.17). 
 
 
 
Scheme 1.17: Type I and Type II IMDA Connectivity and Products 
 
The type I IMDA reaction, consisting of a C1 terminally attached diene and dienophile 
system 1.94, forms a fused bicyclic ring system (bicyclo[n.4.0]alkene) 1.95 with a connective 
bond in common upon cyclisation. In the preparation of a variety of organic targets, type I 
reactions have been applied to excellent  effect and are well reported.
120,121
  In contrast, the 
type II IMDA reaction which exhibits C2 connectivity 1.96 and produces a bridged bicycle 
(bicyclo[n.3.1]alkene) 1.97 upon cyclisation, has been the subject of less synthetic 
investigation.
122
  Predominantly, it has been demonstrated that both Type I and Type II 
IMDA reactions occur if the tether consists of three or more atoms. This is in account of the 
high level of strain present in the transition states of reactions of precursors with one or two 
atoms in the connecting chain.  
The intramolecular Diels-Alder reaction does not typically suffer from the issue of 
regioselectivity that marks the intermolecular reaction. The attack of the dienophile (Scheme 
1.18) is constrained by the length of the tether that joins the two reacting centres; the reaction 
of (E)-dienes 1.98 generate exclusively fused products 1.99 and not bridged products 
1.101.
123
 Examples in the literature indicate that the reaction is more likely to form the 
bridged product if a (Z)-diene such as 1.102 is used
124
 or if the tether connecting the two 
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reacting centres is considerably long (greater than ten atoms).
125
 However, the number of 
reactions that form bridged products remains a small minority of those that have been 
reported.  
 
 
 
Scheme 1.18: Type I Intramolecular Diels-Alder Reactions 
 
An inherent regiochemical bias favouring the 1,4-disubstituted product 1.103 over the 1,3-
adduct 1.104 is exhibited by intermolecular Diels-Alder cyclisations of 2-substituted dienes 
and dienophiles with electronwithdrawing groups. This outcome is typically understood in 
terms of FMO theory, via the calculated orbital coefficients of the HOMO diene–LUMO 
dienophile interaction.
126
  Alternatively, preference for the formation of the meta-cycloadduct 
1.105 is demonstrated by type II IMDA reactions forming small bicyclic rings. This is partly 
on account of torsional and geometric strain acquired in meeting the requirements for the 
effective overlap interaction of the relevant orbitals (1.107 vs 1.108). In addition, it is also 
due to the meta-regioisomer 1.105 which consists of the transcycloalkene in the larger ring 
(1.109 vs 1.110) (vide infra) (Figure 1.17).
126  
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Figure 1.17: Formation of meta- and para-regioisomers 
 
As the tether size increases, difference in energy between the meta and para isomers 1.105 
and 1.106 decreases. Also, the IMDA cycloaddition is rapidly affected by the steric, 
conformational and electronic factors that influence intermolecular pericyclic reactions. If the 
tether consists of 3-5 atoms, the meta regioisomer is the selected product of cycloaddition 
irrespective of the dienophile’s activation pattern and cyclisation method (thermal or Lewis-
acid catalysis).
126
 
The IMDA reaction is capable of stereoselectively generating up to four new contiguous 
stereocenters. The subject of stereoselectivity naturally takes place, as both cis and trans-
fused cycloadducts are potential in the example of (E)-diene, the most commonly observed 
class of substrates.
127
  In the case of substrates 1.111 and 1.116 in the IMDA reaction leading 
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to [4.3.0] and [4.4.0] systems, two transition states (endo and exo) are possible. The cis-fused 
products are resultant from the exo mode of cycloaddition and the endo transition state of 
1.111 and 1.116 induces trans-fused bicycles. In the [4.4.0] system, a chair-like transition 
state is typically suggested. 
 
Bicyclo[4.3.0]system 
 
 
 
 Bicyclo[4.4.0]system 
 
 
Figure 1.18:  endo and exo Transition States for the [4+2] Reaction of 1.111 and 1.116 
Leading to Bicyclo[4.3.0] and [4.4.0]systems 
 
In the bicyclo[4.3.0]system, cis-fused cycloadducts normally dominate in the thermal 
cyclisation of unsubstituted trienes.
128
 However, if substituted, trans-fused products 
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originating from the endo mode of addition usually prevail. The example in Scheme 1.19 
illustrates this, in which the reaction of 1.120 preferentially generates 1.121 over 1.122.
129
 
 
 
 
Scheme 1.19: IMDA Reaction of 1.120 Preferentially Generates 1.121 over 1.122 
 
Although this reaction does externally conform to the Alder endo rule, the selectivity is 
unexpectedly low. Indeed, there are a number of reactions that completely disregard the endo 
rule such as the isomer of ester 1.120 with the dienophile in the Z-form, as illustrated in 
Scheme 1.20. 
 
 
Scheme 1.20: IMDA Reaction of 1.123 Preferentially Generates 1.124 over 1.125 
 
In reference to the endo rule, ester 1.123 is expected to yield cis-hydrindene 1.125 but the 
dominant form is trans-hydrindene 1.124. It is understood that this and a number of other 
reactions do not adhere to the endo rule because of asynchronous bond formation.
130
 
Although the Diels-Alder reaction forms both bonds in a concerted manner; they are 
frequently generated at considerably different rates. In an intramolecular Diels-Alder reaction 
with a tether connecting the two reacting centres less than four atoms long, it has been 
calculated that synchronous bond formation is not likely because of the restrictive nature of 
the tether.
131
 
According to FMO theory, the most progressive bond formation in a concerted reaction of 
this kind will be between the termini of the diene and dienophile that contain the highest 
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orbital coefficients. The coefficient at Cb is higher than at Ca and the coefficient at Cc is 
higher than at Cd in ester 1.123 (Figure 1.19, with orbital coefficients shown in plain view). 
As a result, the bond formation between Cb and Cc (indicated with a dotted line) is 
significantly more progressive than between Ca and Cd. 
 
 
 
Figure 1.19: Orbital Coefficients of 1.123 (Shown in Plain View) 
 
Transition state 1.125a illustrates that to form cis-hydrindene 1.125 (with reference to the 
endo rule), the two carbon chains on Cb and Cc in the cyclopentane ring need to be eclipsed, 
which does not occur in 1.124a. It is probable that the energy of the staggered configuration 
of transition state 1.124a will be significantly lower than that of the eclipsed transition state 
1.125a. Therefore, in transition state 1.124a the more advanced bond forms more readily, 
culminating in compound 1.124 being preferentially formed. 
The origins of stereoselectivity in the intermolecular Diels-Alder reaction are generally 
accounted for by Secondary Orbital Interactions between the diene and dienophile. Despite 
being usually less than several kcal mol
-1
 in magnitude, the outcome of these interactions is 
the dominant formation of the endo adduct under kinetic control.
132
 Type II IMDA reactions 
demonstrate total stereoselectivity with cycloaddition occurring from a conformation where 
the tether occupies the endo position 1.127. The reduction of torsional strain energy related 
with the exo tether 1.130 controls support from Secondary Orbital Interactions (Figure 1.20) 
affording an “out”-bridging adduct 1.128. 
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Figure 1.20: Stereoselectivity in Type II IMDA Reactions  
 
Similar to intermolecular Diels-Alder reactions, the IMDA reactions are catalysed by Lewis-
acids. A moderate method for the synthesis of bicyclco[n.3.1] bridgehead alkenes by Lewis-
acid catalysed IMDA cycloadditions, has been reported by Shea and Gilmanl.
133
 
Intramolecular cycloaddition of 1.131 in methylene chloride comprising of diethylaIuminium 
chloride at 21 °C for 2 hours, yielded bicycloundecenone 1.132 (Scheme 1.21). 
 
 
 
Reagents and Conditions: (a) CH2Cl2, Et2AlCl, 21 °C, 2h. 
 
Scheme 1.21: Lewis-acid Catalysed IMDA reaction of 1.131  
 
However, IMDA reactions do not always supply the optimum levels of stereoselectivity and 
reactivity. As illustrated in Scheme 1.22, triens like 1.133, typically need high reaction 
temperature, long reaction times and produce complex mixtures of cycloadducts.
134,135 
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Scheme 1.22: IMDA Reaction with no tether-Control Group 
 
In order to enhance the cyclisation of substituted trienes in IMDA reactions, the
 
enforcement 
of a conformational constraint on the molecule by the inclusion of a planar moiety such as an 
aromatic ring
136
 or isopropylidene acetals
137
 should be effective. The diene and the dienophile 
would both hold closer via the limited flexibility of the tether, thus enhancing the interactions 
in the transition state. As a result, these interactions would enable the IMDA reaction based 
on entropic grounds.
 
 
 
Scheme 1.23: IMDA with Planar Aromatic tether-Control Group 
 
The aromatic ring moiety has been installed by Fallis and co-workers, with the aim of 
synthesising Taxol
® 
analogues (Scheme 1.23).
140
 Upon mild heating during an oxidation 
reaction, the reaction occurs spontaneously.   
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1.3.6. Transannular Diels-Alder (TADA) Reactions 
 
The most frequent studies on the TADA reaction has been with 13-, 14- and 15-membered 
macrocycles under thermolytic reaction conditions. In addition, research on the effects of 
Lewis-acids and high pressures has been applied to the TADA reaction. The vigorous 
thermolytic conditions (200 °C to over 300 °C) occasionally employed, incite competitive 
[1,5] hydrogen shifts. This yields new dienes which can also undergo the TADA reaction and 
produce complex mixtures of cycloadducts. The utility of Lewis-acid catalysis is 
advantageous as the considerably lower temperatures constrain the hydrogen shifts and do not 
promote Alder-ene rearrangements of the C=C enophiles.
138,139 
An enduring synthetic challenge, with a unique tetracyclic stemodane framework and 10 
stereocentres is the (+)-Maritimol 1.141. The first asymmetric synthesis was reported by 
Deslongchamps et al.
140
 and utilised a TADA reaction as a key step in the retrosynthetic 
analysis. Applying the group's previous skill in this area, it was predicted that the synthesis of 
maritimol would include stereospecific transformation of a 13-membered trans-cis-cis-
(TCC)-macrocyclic triene 1.139. Triene 1.139 was estimated to undergo cyclisation to yield 
the trans-syn-cis-(TSC)-ring system identified in the natural product. 
 
 
Reagents and Conditions: a) Me2AlCl, CH2Cl2, 75%; b) p-TSA; c) Dess-Martin. 
 
Scheme 1.24: Syntehsis (+)-Maritimol 1.141 by Deslongchamps et al.
140
 
 
It is evident that the TADA approach allows a considerably high increase in molecular 
complexity during the process of macrocyclisation and succeeding cycloaddition. 
Furthermore, this is only dependant on the ease of stereoselective triene macrocycle 
synthesis.  
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Chapter 2. 
Results & Discussion 
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2.1.1.  Previous Work and Overview of the Investigation 
 
2.1.2. Previous Work 
 
Hymenialdisine 2.1 is a metabolite isolated from the marine sponge Stylissa Massa.
141
 It 
exhibits potent activity against murine P388 lympocytic leukaemia.
142,143
 The Parsons’ 
research group has been interested in the total synthesis of hymenialdisine 2.1 for some 
years.
144
 The chosen retrosynthetic analysis for the synthesis of hymenialdisine 2.1 is shown 
below in Scheme 2.1. 
 
  
Scheme 2.1: Retrosynthetic Analysis of Hymenialdisine 2.1  
 
It was envisaged that the tricyclic hymenialdisine 2.1 could be formed from precursor 2.2 
using a tandem radical cyclisation reaction as outlined in Scheme 2.2. Reaction of the 
electron-rich guanidine portion of precursor 2.2 with copper(II) salts was expected to 
generate a guanidinium radical 2.6. This radical could then react with the proximal alkyne to 
afford an alkenic radical 2.7. In turn, this alkenic radical could react with the pyrrole ring to 
afford the hymenialdisine 2.1. 
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Scheme 2.2: Tandem Radical Cyclisation 
 
The ethyl ester 2.8 was constructed with the aim of forming the cyclisation precursor 2.2. 
Subsequently, direct coupling of the ethyl ester 2.8 with the guanidine hydrochloride using 
sodium methoxide was attempted. This is outlined in Scheme 2.3 below. 
 
 
 
Reagents and Conditions: (a) NaOMe, guanidine hydrochloride, MeOH, 50 °C, 48h. 
 
Scheme 2.3: Attempted Coupling of Ethyl Ester 2.8 with Guanidine 
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Unfortunately, none of the required product was isolated from this reaction. However, the 
coupling of carboxylic acid with guanidine using CDI was proposed. In order to test this 
reaction, several attempts were made to convert the ethyl ester 2.8 to the corresponding 
carboxylic acid 2.10. 
 
 
 
Scheme 2.4: Attempted Synthesis of Carboxylic Acid 2.10  
 
The saponification reaction was attempted with both KOH and LiOH in methanol. However, 
in both cases none of the required acid was isolated. The use of TMSOH in THF was 
attempted as a milder method of saponification. Unfortunately, none of the carboxylic acid 
was isolated. An acid catalysed saponification was also attempted but the yield of the 
required carboxylic acid was low (16%).  
When ethyl ester 2.8 was treated with lithium iodide in refluxing pyridine the isoquinolin-
1(2H)-one 2.11 was obtained in 48% yield as outlined in Scheme 2.5.  
 
 
 
Reagent and Conditions: (a) LiI, pyridine, reflux, 16h, 48%. 
 
Scheme 2.5: Synthesis of Isoquinolin-1(2H)-one Derivative 2.11 
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The unexpected product was formed cleanly, no other products were observed by TLC 
analysis. The structure of isoquinolin-1(2H)-one 2.11 was originally deduced using NMR 
analysis and mass spectroscopy. However, as isoquinolin-1(2H)-one 2.11 was a solid it was 
possible to obtain a crystal structure which confirmed the proposed structure as shown in 
Figure 2.1. 
 
 
 
Figure 2.1: Crystal Structure of Isoquinolin-1(2H)-one 2.11 
 
 
2.1.3. Overview of the Investigation 
 
It has been shown that the reaction of ethyl ester 2.8 with lithium iodide in pyridine afforded 
isoquinolin-1(2H)-one 2.11 in moderate yield (48%). Firstly, the aim of this project was to 
test if a cyclisation reaction with substituted pyrrole rings 2.12 is a viable option. 
 
 
 
Reagent and Conditions: (a) LiI, pyridine, reflux. 
 
Scheme 2.6: Generalised Substrate for the Investigation of Cyclisation Reactions 
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Previous work in the Parsons group developed a robust route to an advanced intermediate in 
the synthesis of hymenialdisine 2.1. However, further steps were required to achieve 
formation of the desired cyclisation precursor 2.2 for the key tandem cyclisation. Subsequent 
work aimed to find a new route for the synthesis of carboxylic acid 2.10. 
 
 
 
Scheme 2.7: Formation of Carboxylic Acid 2.10 
 
 
2.2. Synthesis of Isoquinolin-1(2H)-one 2.11 
 
2.2.1. New Route for Synthesis of Ethyl Ester 2.8 
 
Previously, the Parsons’ research group focused on the synthesis of amide 2.4 and bromide 
2.5 which could then be coupled (Scheme 2.1). However, difficulties were encountered 
therefore a different route was proposed. Instead, it was suggested that the advanced 
intermediate 2.16 could be formed by coupling the acid chloride 2.14 with amine 2.15. 
 
 
 
Scheme 2.8: Revised Synthesis of Ethyl Ester 2.16 
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2.2.1.1. Synthesis of Amine Fragment 2.22 
 
The first task was the synthesis of amine fragment 2.22. The synthesis of this fragment was 
based on the reported synthesis of a similar molecule by Fuerstner et al.
145
 The synthesis of 
amine fragment 2.22 is outlined in Scheme 2.9 below. 
 
 
Reagent and Conditions: (a) TsCl, pyridine, CHCl3, 0 °C to rt, 16h, 90%; (b) NaI, DMSO, 4-
methoxybenzylamine, rt, 16h, 83%; (c) Di-tert-butyl dicarbonate, pyridine, CH2Cl2, 0 °C to 
rt, 16h,  97%; (d) n-BuLi, THF then ethyl chloroformate, -78 °C to rt, 16h, 80%; (e) 4M HCl 
in dioxane, CH2Cl2, 0 °C to rt, 4h, 95%. 
 
Scheme 2.9: Synthesis of Amine Fragment 2.22 
 
The first step involved the protection of 3-butyn-1-ol 2.17 with para-toluenesulfonyl chloride 
to produce the corresponding tosylate 2.18 (90% yield). The tosylate moiety was then 
displaced using 4-methoxybenzylamine and catalytic sodium iodide to afford amine 2.19 in 
83% yield. Boc protection of amine 2.19 was then carried out prior to the reaction of the 
substrate with n-BuLi and ethylchloroformate. The yield of this alkylation step was found to 
be variable and several issues were encountered in obtaining a good yield. For example, the 
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n-BuLi must be freshly titrated. The order of addition of the reagents was also important. n-
BuLi was added to a solution of alkyne 2.20 in THF at -78 °C under nitrogen. This cooled 
solution was then added drop-wise (via cannula) to a flask containing an excess of neat ethyl 
chloroformate at -78 °C under nitrogen. In general, the more slowly the anion solution was 
added to the ethyl chloroformate the greater the yield (addition times over 2 hours). 
Initial attempts at N-Boc deprotection utilised trifluoroacetic acid in dichloromethane.
146
 
Although this method was effective on a small scale (83%), on a large scale the required 
product was not isolated. Indeed, TLC indicated that the free amine isolated on a small scale 
was decomposing over time, presumably due to the 1,4-addition taking place within the 
sample. To overcome this problem it was decided that HCl in dioxane should be used to 
deprotect the N-Boc group.
147
 This would afford the required product as the HCl salt and 
would avoid the possibility of intermolecular 1,4-addition. This method afforded the required 
HCl salt 2.22 as a stable white solid in excellent yield (95%). 
 
 
2.2.1.2. Synthesis of Acyl Chloride 2.24 
 
The next step was to couple amine fragment 2.22 to the required acyl chloride 2.24. 
Formation of the acyl chloride 2.24 was carried out as detailed by Kakushima et al.
 148
using 
AlCl3 and oxalyl chloride. 
 
 
 
Reagent and Conditions: (a) AlCl3, (COCl)2, DCE, 0 °C to rt, 6h, 95%. 
 
Scheme 2.10: Formation of the Acyl Chloride 2.24 
 
In this acylation reaction, oxalyl chloride was added drop-wise to a stirring suspension of 
AlCl3 in DCE at 0 °C. After 20 minutes a solution of phenylsulfonyl pyrrole 2.23 in DCE was 
added. The reaction was quenched with ice-water and the product extracted into diethyl ether. 
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The required acyl chloride 2.24 was isolated as a brown oil (95%) which was used directly in 
the next step without further purification. 
 
 
2.2.1.3. Amide Coupling 
 
Once the amine 2.22 and acyl chloride 2.24 fragments were in hand, it was possible to 
attempt the coupling reaction. The amine salt 2.22 was first treated with saturated aqueous 
NaHCO3 solution to afford the corresponding free base 2.25. Amino ester 2.25 was then 
reacted with the acyl chloride 2.24 to produce the amide 2.8. 
 
 
 
Reagent and Conditions: (a) Et3N, CH2Cl2, 0 °C to rt, 8h, 90%. 
 
Scheme 2.11: Amide Coupling 
 
 
2.2.1.4. Investigation into the Role of LiI in the Cyclisation 
 
When ethyl ester 2.8 was treated with lithium iodide in refluxing pyridine the isoquinolin-
1(2H)-one 2.11 was obtained in 52% yield as outlined in Scheme 2.12. Prolonging the 
reaction time up to 48 hours did not affect the yield. 
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Reagent and Conditions: (a) LiI, pyridine, reflux, 16h, 52%. 
 
Scheme 2.12: Synthesis of Isoquinolin-1(2H)-one Derivative 2.11 
 
The expected product was formed cleanly, no other products were observed by TLC analysis. 
The structure of isoquinolin-1(2H)-one 2.11 was deduced using NMR analysis and mass 
spectroscopy.  
Following this result an investigation into the role of lithium iodide in the cyclisation reaction 
was carried out.  
 
 
 
Reagents and Conditions: (a) Solvent, time, yield, see Table 2.1. 
  
Scheme 2.13: Investigation into the Role of Lithium Iodide 
 
The first experiment conducted, simply omitted the lithium iodide to observe what effect this 
had on the product of the reaction. Upon refluxing 2.8 in anhydrous pyridine for 24 hours, no 
reaction took place and all of ethyl ester 2.8 was recovered. Refluxing 2.8 in toluene for 24 
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hours in the absence of lithium iodide also failed to yield the desired compound. These 
reactions demonstrated that the lithium iodide is necessary for the formation of the 
isoquinolin-1(2H)-one 2.11.  
 
 
2.2.1.5. Proposed Mechanisms for the Cyclisation 
 
On the basis of these results, plausible reaction mechanisms that are consistent with our 
experimental data are depicted in Scheme 2.14a-b.  
 
 
 
Scheme 2.14a: First Proposed Mechanism for the Novel Cyclisation 
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LiI might react with acetylenic ester 2.8 (step 1) to yield the desired β-iodovinyl ester 2.26. 
The preferential α-vinyl enolisation (step 2) of 2.26 using mild base pyridine, provides an 
allenol 2.27 that subsequently undergoes elimination through an allylic C(sp
3
)-H 
deprotonation (step 3) to cumulenol 2.28.
149
 The pyridine-promoted isomerisation of 
cumulenol 2.28 leads to the formation of alkynyl enol(ate) 2.29 which can protonate to 
allenyl ester 2.30.
149
 The next step is the intramolecular Diels-Alder reaction between the 
pyrrole and the allenyl ester moiety to afford the tricyclic intermediate 2.31. Removal of an 
allylic proton by base affords intermediate 2.32. Removal of second proton instigates the loss 
of the electron withdrawing phenylsulfonyl amine group and results in the formation of 2.11.  
Base-mediated 1,2-eliminations to produce allenes, a significant pathway to unsaturated 
hydrocarbons, have been previously investigated.
150
 For those allenes that have been obtained 
from elimination reactions of vinyl halides, the presence of strong bases such as LDA and 
LiHMDS is necessary. The presence of strong bases could pose a problem in terms of 
functional group tolerance in the synthesis of functionalised allenes. Remarkably, the 
employment of mild organic base pyridine provided an allenyl ester which underwent 
intramolecular Diels-Alder reaction to form isoquinolin-1(2H)-one 2.11 (Scheme 2.12).  
The second proposed mechanism for the novel cyclisation is shown below in Scheme 2.14b.  
 
 
 
Scheme 2.14b: The Proposed Mechanism for the Novel Cyclisation 
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The first step is the intramolecular Diels-Alder reaction between the pyrrole and the alkyne 
moiety to afford the tricyclic intermediate 2.8b.
51
 Removal of an allylic proton affords 
intermediate 2.8c. Removal of second proton instigates the loss of the electron withdrawing 
phenylsulfonyl amine group and results in the formation of 2.11. The driving force for this 
reaction is the formation of the stable aromatic ring. 
 
 
2.3. Synthesis of Various Diels-Alder Products 
 
It has been shown that the reaction of ethyl ester 2.8 with lithium iodide in pyridine afforded 
isoquinolin-1(2H)-one 2.11 in moderate yield (52%). Our target was to develop this IMDA 
reaction by using a series of precursors with substituted pyrrole rings 2.33 which should 
afford the corresponding isoquinolin-1(2H)-ones 2.34 as shown below in Scheme 2.15.  
 
 
 
Reagent and Conditions: (a) LiI, pyridine, reflux. 
 
Scheme 2.15: Formation of Substituted Diels-Alder Products  
 
 
2.3.1. Synthesis of Ethyl Substituted Coupling Precursor 2.37a 
 
The ethyl substituted precursor was selected to test the repeatability of this cyclisation. The 
construction of desired material 2.37a is detailed below in Scheme 2.16. 
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Reagent and Conditions: (a) BF3·OEt2, acetic anhydride, DCE, rt, 16h, 87%; (b) AlCl3, 
t-BuNH2·BH3, CH2Cl2, rt, 16h, 90%; (c) AlCl3, (COCl)2, DCE, 0 °C to rt, 6h, 95%. 
 
Scheme 2.16: Formation of the Acyl Chloride 2.37a 
 
The commercially available phenylsulfonyl pyrrole 2.23 was converted to 1-(1-
phenylsulfonyl-1H-pyrrol-2-yl) ethanone 2.35a.
151
 In this reaction, acetic anhydride was 
added to a stirring suspension of BF3·OEt2 in DCE at room temperature. After 15 minutes a 
solution of phenylsulfonyl pyrrole 2.23 in DCE was added. After stirring for 16 hours column 
chromatography afforded a bright-yellow solid (87%). The newly formed ketone 2.35a was 
reduced using t-BuNH2·BH3 in the presence of AlCl3 at room temperature (90%).
152
 The acyl 
chloride 2.37a was formed as before by using AlCl3 and oxalyl chloride (95%).
149
 
 
 
2.3.2. Synthesis of Coupling Precursors 2.37b-c 
 
The optimised route to acyl chloride 2.37a was then applied to the synthesis of alternative 
coupling precursor analogues. The isobutyl and butyl substituted precursors were selected to 
test the repeatability of this cyclisation. 
The synthesis commenced with the construction of desired materials 2.35b-c as detailed 
below in Scheme 2.17. 
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Reagent and Conditions: (a) Butyric anhydride, BF3·OEt2, DCE, rt, 16h, 80%; (b) iso-Butyric 
anhydride, BF3·OEt2, DCE, rt, 16h, 81%. 
 
Scheme 2.17: Synthesis of Aryl Ketones 2.35b-c 
 
Yields for all the analogues were very satisfactory. Subsequently, t-BuNH2·BH3-AlCl3 in 
dichloromethane was used to reduce arylalkyl ketones 2.35b-c to the corresponding 
hydrocarbons (ArCH2R) 2.36b-c.  
 
 
 
Reagent and Conditions: (a) AlCl3, t-BuNH2·BH3, CH2Cl2, rt, 16h, yields, see Table 2.2. 
 
Scheme 2.18: Reduction of Various Ketone Analogues  
 
Entry R Compound  reference Yield (%) 
 
1 
 
Butyl 
 
2.36b 
 
86 
2 iso-Butyl 2.36c 88 
 
Table 2.2: Reduction of Ketone Analogues 2.35b-c 
 
The acyl chlorides 2.37b-c were formed as before by using AlCl3 and oxalyl chloride. The 
results are presented in Table 2.3. 
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Reagent and Conditions: (a) AlCl3, (COCl)2, DCE, 0 °C to rt, 6h, yields, see Table 2.3. 
 
Scheme 2.19: Acylation of Various Aryl Analogues  
 
Entry R Compound  reference Yield (%) 
    
1 Butyl 2.37b 91 
2 iso-Butyl 2.37c 86 
 
Table 2.3: Acylation of Aryl Analogues 2.36b-c  
 
 
2.3.3. Synthesis of Cyclisation Precursors 2.38a-c 
 
Yields for all three steps and for all the analogues were very satisfactory. The next step was 
to couple previously synthesised amine fragment 2.25 to the required acyl chlorides 2.37a-c. 
The results are presented in Table 2.4. 
 
 
 
Reagent and Conditions: (a) Et3N, CH2Cl2, 0 °C to rt, 16h, yields, see Table 2.4. 
 
Scheme 2.20: Amide Coupling of Different Analogues 
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Entry R Compound reference Yield (%) 
 
1 
 
Ethyl 
 
2.38a 
 
88% 
2 Butyl 2.38b 87% 
3 iso-Butyl 2.38c 90% 
 
Table 2.4: Amide Coupling of Different Analogues 
 
 
2.3.4. Thermal Cyclisations 
 
The next step in the synthetic sequence was the thermal cyclisation reaction of the newly 
formed amide analogues 2.38a-c. Compound 2.38a was chosen as a test substrate for the 
cyclisation model. The newly formed cyclisation precursor 2.38a was heated in anhydrous 
pyridine in the presence of LiI, resulting in the clean cyclisation of 2.38a to form the 
isoquinolin-1(2H)-one derivative 2.39a in moderate yield (56%). NMR and mass analysis of 
the product obtained revealed its structure to be isoquinolin-1(2H)-one derivative 2.39a 
(Scheme 2.21). 
 
 
 
Reagent and Conditions: (a) LiI, pyridine, reflux, 16h, 56%. 
 
Scheme 2.21: Synthesis of Isoquinolin-1(2H)-one Derivative 2.39a 
 
The other two cyclisation precursor analogues 2.38b-c were also subjected to cyclisation 
conditions and the results are shown below in Table 2.5. 
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Reagent and conditions: (a) LiI, pyridine, reflux, 16h, yields, see Table 2.5. 
 
Scheme 2.22: Thermal Cyclisation of Various Analogues   
 
Entry R Compound reference Yield (%) 
 
1 
2 
 
Butyl 
iso-Butyl 
 
2.39b 
2.39c 
 
51 
54 
 
Table 2.5: Thermal Cyclisation of Precursors 2.38b-c   
 
This method for the synthesis of isoquinolin-1(2H)-one derivatives has proven highly 
effective. Furthermore, it can be utilised in studies towards the total synthesis of a number of 
biologically active natural products (for example see Chapter 3).   
 
 
2.4. New Route for Synthesis of Carboxylic Acid 2.10 
 
2.4.1. Outline of Investigation 
 
Having failed to find suitable conditions for the synthesis of carboxylic acid 2.10, our 
attention was directed to finding an alternative route. Instead, it was suggested that the 
required carboxylic acid 2.10 could be formed by initially coupling the acyl chloride 2.24 
with amine 2.41, as shown in Scheme 2.23. The carboxylic acid moiety in compound 2.10 
could then react with guanidine to form the desired compound 2.9. 
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Scheme 2.23: Formation of Coupling Precursor 2.10 
 
 
2.4.2. Synthesis of Carboxylic Acid 2.10 
 
Scheme 2.24 below illustrates the synthesis of desired amine 2.41. 
 
     
Reagents and Conditions: (a) KOH, MeOH, 0 °C to rt, 48h, 62%; (b) 4M HCl in dioxane, 
CH2Cl2, 0 °C to rt, 85%. 
 
Scheme 2.24: Synthesis of Amine 2.41 
 
The saponification reaction was attempted with KOH in methanol and the required acid 2.40 
was isolated in 62% yield. The Boc group was cleanly removed from the compound 2.40 
with a solution of hydrogen chloride in dioxane. The amine salt of the compound formed was 
used without further purification for the subsequent coupling reaction. Once amine 2.41 was 
in hand, formation of carboxylic acid 2.10 could then be attempted through an amide 
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coupling reaction. Reaction of amine 2.41 with the acyl chloride 2.24 derived from 1-
(phenylsulfonyl)-1H-pyrrole 2.23 in the presence of Et3N as a base, yielded desired 
carboxylic acid 2.10. This result corresponds with Dr. Nicola Chessum’s previous work.144 
 
 
Reagent and Conditions: (a) Et3N, CH2Cl2, 0 °C to rt, 16h, 44%. 
 
Scheme 2.25: Amide Coupling  
 
The development of a route for the synthesis of carboxylic acid 2.10 has been developed and 
its syntheses successfully achieved. Once carboxylic acid 2.10 is in hand, the standard 
coupling conditions should provide the desired product 2.9. 
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Chapter 3. 
Conclusion & Future Work 
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This DPhil project has developed a robust route to an advanced intermediate in the synthesis 
of hymenialdisine 2.1. Following the coupling reaction, two steps remain to achieve 
formation of the required cyclisation precursor 2.2 for the key tandem cyclisation as outlined 
in Scheme 3.1. The radical cascade reaction should afford the hymenialdisine 2.1 as initially 
proposed in Scheme 2.2. In addition, once compound 2.9 is obtained the utility of the radical 
tandem cyclisation can be tested. 
 
 
Reagent and Conditions: (a) CDI, DMF, guanidine carbonate. 
 
Scheme 3.1: Formation of Cyclisation Precursor 2.2 
 
The overall findings from this DPhil project will enable the rapid construction of complex 
ring systems as templates for drug design. This evidence gives support to the theory that a 
range of structures, richly substituted with functional groups can be synthesised using the 
thermal cyclisation reaction developed within the Parsons’ research group.  
 
 
 
Reagent and conditions: (a) LiI, pyridine, reflux. 
 
Scheme 2.15: Formation of Substituted Diels-Alder Products  
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For example, Matsui et al.
153
 described the pharmacological evaluation of a series of 
isoquinolin-1(2H)-one derivatives which can be readily synthesized using the thermal 
cyclisation reaction developed.  
 
 
 
Scheme 3.2: Retrosynthetic Analysis of a Series of Isoquinolin-1(2H)-ones  
 
We have reported the development of an efficient method for the in-situ conversion of 
conjugated alkynyl esters to conjugated allenyl esters, through the use of pyridine/LiI. The 
allenes have been previously obtained from elimination reactions of vinly halides in the 
presence of strong bases such as LDA and LiHMDS. These strong bases could pose a 
problem in terms of functional group tolerance in the synthesis of functionalized allenes. 
Given the high synthetic potential of donor/acceptor-substituted allenes in organic 
synthesis,
154
 it would be interesting to investigate the elimination pathway of β-iodovinyl 
esters. 
 
 
 
 
 
85 
 
 
 
 
 
 
 
Chapter 4. 
Experimental 
Section 
 
 
 
 
 
86 
 
4.1. General Procedure 
 
Reactions were carried out under a nitrogen atmosphere in oven–dried glassware at room 
temperature (rt) unless otherwise stated. Standard inert atmosphere techniques were used in 
handling all air and moisture sensitive reagents. Flash column chromatography was carried 
out on Merck Kieselgel (230-400 mesh). All reactions were followed by thin-layer 
chromatography (TLC) where possible; using Merck aluminium backed sheets coated with 
Merck Kieselgel 60 F254 (230-400 mesh) fluorescent treated silica. These were visualised 
under UV light (λmax= 254 or 365 nm) and developed using potassium permanganate or 
vanillin stains. 
Reaction solvents were purified and dried according to literature methods; tetrahydrofuran 
and diethyl ether were distilled from sodium with benzophenone as an indicator. CH2Cl2, 
toluene, methanol and acetonitrile were distilled from CaH2 under a positive pressure of dry 
nitrogen. Et3N and pyridine were also distilled from CaH2 and stored over KOH under 
nitrogen. Petroleum ether refers to the fraction boiling at 40-60 °C. Bulk solutions were 
evaporated under reduced pressure using a rotary evaporator. Other solvents and reagents 
were used as supplied. Brine refers to a saturated aqueous solution of NaCl. Salicylaldehyde 
phenylhydrazone was used as an indicator for the titration of organometallic species, 
including Grignard reagents.  
1
H NMR spectra were recorded on a Varian 500 MHz machine (operating at ambient probe 
temperature using an internal deuterium lock). Chemical shifts (δ) are given in parts per 
million (ppm), and coupling constants (J) are given in Hertz (Hz). The 
1
H NMR spectra are 
reported as follows: δ/ppm (multiplicity, coupling constant J/Hz (where appropriate), number 
of protons). Multiplicity is abbreviated as follows: s = singlet, br s = broad singlet, d = 
doublet, br d = broad doublet, app br d = apparent broad doublet, dd = doublet of doublets, t 
= triplet, dt = doublet of triplet, q = quartet, dq = doublet of quartet, quint = quintet, m = 
multiplet, app s = apparent singlet, app d = apparent doublet, app t = apparent triplet, app q = 
apparent quartet. 
13
C NMR spectra were recorded at 126 MHz. The 
13
C NMR spectra are 
reported in δ/ppm. Two-dimensional (COSY, HSQC, H2BC, HMBC) NMR spectroscopy 
were used to assist the assignment of signals in the 
1
H and 
13
C NMR spectra.  
ESI Mass spectra were recorded on a Bruker Daltonics Apex III spectrometer with methanol 
or diethyl ether as solvents. EI mass spectra were recorded on a Fisons VG Autospec 
spectrometer by the internal service at the Department of Chemistry, University of Sussex.   
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IR spectra were recorded neat on a Perkin Elmer Spectrum One FT-IR spectrometer with a 
diamond ATR module and only selected maximum absorbances (νmax) of the most intense 
peaks are reported (cm
-1
).   
Melting points were recorded using a Leica Galen III hot-stage microscope apparatus and are 
reported uncorrected in degrees Celsius (°C). 
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4.2. Compounds 
 
But-3-yn-1-yl 4-methylbenzenesulfonate: (2.18) 
 
 
 
To a stirred solution of 3-butyn-1-ol 2.17 (10.0 g, 10.80 mL, 142.67 mmol) and pyridine 
(22.57 g, 22.97 mL, 285.34 mmol) in dry CH2Cl2 (100 mL) at 0 °C was added para-
toluenesulfonyl chloride (40.8 g, 214.00 mmol). The reaction was allowed to warm to rt and 
left to stir for 16 hours. Subsequently, the reaction mixture was concentrated in vacuo and the 
resultant residue partitioned between diethyl ether and water. The phases were separated and 
the aqueous phase was extracted twice with diethyl ether. The organic layers were combined, 
washed once with 1.0M aqueous HCl solution, washed once with saturated aqueous NaHCO3 
solution, washed once with water and washed once with brine. The solution was dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.18 was purified by flash chromatography on a silica gel 
column eluting with 40% ethyl acetate in petroleum ether to give the title compound 2.18 
(31.09 g, 97%) as a yellow oil. 
Spectroscopic data are in agreement with the literature values.
155
 
 
IR (neat) v (cm
-1
) 3294, 2963, 2928, 2156, 1323, 1175, 981, 905, 637.  
 
1
H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 4.04 (t, J = 
6.9 Hz, 2H), 2.49 (td, J = 6.9, 2.6 Hz, 2H), 2.38 (s, 3H), 1.95 (t, J = 2.7 Hz, 1H).  
 
13
C NMR (126 MHz, CDCl3) δ 145.0 (C), 132.7 (C), 129.9 (CH), 127.8 (CH), 78.5 (C), 70.8 
(CH), 67.5 (CH2), 21.5 (CH3), 19.3 (CH2). 
 
HMRS (ESI) calculated for C11H13O3S [M+H]
+
 225.0585, found 225.0583. 
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N-(4-Methoxybenzyl)but-3-yn-1-amine: (2.19) 
 
 
 
To a stirred solution of 4-methoxybenzylamine (34.07 g, 32.44 mL, 248.34 mmol) and 
tosylate 2.18 (27.85 g, 124.17 mmol) in anhydrous DMSO (300 mL) was added sodium 
iodide (0.69 g, 4.59 mmol). The reaction was left to stir at rt for 16 hours, subsequently the 
reaction mixture was poured into 2% aqueous NaOH solution. The phases were separated and 
the aqueous phase was extracted twice with diethyl ether. The organic layers were combined, 
washed once with brine, dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure to give a yellow oil. The crude product 2.19 was purified by flash 
chromatography on a silica gel column eluting with 100% diethyl ether to give the title 
compound 2.19 (19.51 g, 83%) as a pale yellow oil. 
Spectroscopic data are in agreement with the literature values.
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IR (neat) v (cm
-1
) 3292, 3061, 3031, 2952, 2916, 2835, 2116, 1611, 1585, 1512, 1462, 1300, 
1246, 1176, 1109, 1035, 815, 638. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.24 (d, J = 8.6 Hz, 2H), 
6.84 (d, J = 8.6 Hz, 2H), 3.78 (s, 3H), 3.74 (s, 2H), 2.78 (t, J = 6.6 Hz, 2H), 2.39 (dt, J = 6.6, 
2.6 Hz, 2H), 1.99 (t, J = 2.6 Hz, 1H), 1.62 (br s, 1H).
  
 
13
C NMR (126 MHz, CDCl3) δ 158.6 (C), 132.5 (C), 129.5 (CH), 114.1 (CH), 82.9 (C), 70.0 
(CH), 55.5 (CH3), 53.1 (CH2), 47.5 (CH2), 19.9 (CH2). 
 
HMRS (ESI) calculated for C12H15NONa [M+Na]
+
 212.1046, found 212.1046. 
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tert-Butyl but-3-yn-1-yl(4-methoxybenzyl)carbamate: (2.20) 
 
 
 
To a stirred solution of N-(4-methoxybenzyl)but-3-yn-1-amine 2.19 (16.58 g, 87.6 mmol) and 
pyridine (8.67 g, 8.82 mL, 109.5 mmol) in dry diethyl ether (200 mL) at 0 °C was added di-
tert-butyl dicarbonate (23.9 g, 25.19 mL, 109.5 mmol). The resultant solution was allowed to 
warm to rt and left to stir for 16 hours. Subsequently, the reaction mixture was quenched with 
water. The phases were separated and the aqueous phase was extracted three times with ethyl 
acetate. The organic layers were combined, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude product 2.20 was purified by flash chromatography on a silica gel column eluting with 
10% ethyl acetate in petroleum ether to give the title compound 2.20 (24.59 g, 97%) as a pale 
yellow oil. 
Spectroscopic data are in agreement with the literature values.
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IR (neat) v (cm
-1
) 3294, 3064, 3002, 2975, 2934, 2836, 2119, 1692, 1612, 1513, 1465, 1411, 
1366, 1248, 1166, 1121, 1036, 882, 774, 638. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.16 (br s, 2H), 6.85 (d, J = 
8.6 Hz, 2H), 4.43 (s, 2H), 3.77 (s, 3H), 3.31 (br d, J = 36.3 Hz, 2H), 2.35 (br d, J = 27.1 Hz, 
2H), 1.94 (t, J = 2.3 Hz, 1H), 1.47 (br s, 9H). 
  
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 159.2 (C), 155.7 
(C), 130.6 (C), 129.4 (CH), 114.5 (CH), 82.1 (C), 80.0 (C), 70.1 (CH), 55.4 (CH3), 50.9 
(CH2), 45.6 (CH2), 28.7 (CH3), 18.6 (CH2); Rotamer B; 155.6 (C), 128.9 (CH), 82.2 (C), 50.0 
(CH2), 45.9 (CH2), 18.3 (CH2). 
 
HMRS (ESI) calculated for C17H23NO3Na [M+Na]
+
 312.1570, found 312.1547. 
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Ethyl 5-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)pent-2-ynoate: (2.21) 
 
 
 
To a stirred solution of alkyne 2.20 (21.10 g, 72.92 mmol) in dry THF (200 mL) at -78 ºC 
was added n-BuLi (2.3 M solution in hexanes, 33.29 mL, 76.56 mmol). The reaction was 
stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -
78 °C before the addition of ethyl chloroformate (11.87 g, 10.41 mL, 109.38 mmol). The 
reaction mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched at 0 °C with a saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, then brine, dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure to give a yellow liquid. The crude product 
2.21 was purified by flash chromatography on a silica gel column eluting with 30% ethyl 
acetate in petroleum ether to give the title compound 2.21 (25.18 g, 91%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 3063, 2977, 2935, 2837, 2237, 1704, 1612, 1513, 1468, 1408, 1366, 1282, 
1250, 1164, 1072, 1036, 887, 845, 755. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.13 (br s, 2H), 6.81 (d, J = 
8.2 Hz, 2H), 4.40 (s, 2H), 4.15 (app. dd, J = 13.6, 6.7 Hz, 2H), 3.74 (s, 3H), 3.33 (br d, J = 
21.0 Hz, 2H), 2.46 (br d, J = 35.5 Hz, 2H), 1.45 (s, 9H), 1.24 (t, J =7.1 Hz, 3H).  
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 159.3 (C), 155.7 
(C), 153.8 (C), 130.3 (C), 129.4 (CH), 114.3 (CH), 86.5 (C), 80.3 (C), 74.7 (C), 62.1 (CH2), 
55.6 (CH3), 50.1 (CH2), 44.7 (CH2), 28.6 (CH3), 18.6 (CH2), 14.5 (CH3); Rotamer B; 155.6 
(C), 129.0 (CH), 114.0 (CH), 87.0 (C), 80.2 (C), 60.6 (CH2), 51.1 (CH2), 45.0 (CH2), 28.4 
(CH3), 18.6 (CH2), 14.3 (CH3). 
 
HMRS (ESI) calculated for C20H27NO5Na [M+Na]
+
 384.1781, found 384.1783. 
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Ethyl 5-((4-methoxybenzyl)amino)pent-2-ynoate hydrochloride: (2.22) 
 
 
 
To a stirred solution of carbamate 2.21 (22.0 g, 60.87 mmol) in dry CH2Cl2 (80 mL) at 0 °C 
was added a 4M solution of HCl in dioxane (182.6 mL, 730.0 mmol). The reaction was 
allowed to warm to rt and left to stir for 4 hours, during which time the formation of white 
precipitates were observed. The solvent was removed in vacuo to afford a pale brown solid. 
This solid was triturated with diethyl ether to afford a white solid which was collected by 
filtration and washed well with diethyl ether, after drying under high vacuum the title product 
obtained was a white solid. The crude product 2.22 was used directly in the next step without 
further purification (17.22 g, 95%). 
 
m.p.: 148 - 149 °C 
 
IR (neat) v (cm
-1
) 2978, 2923, 2854, 2237, 1703, 1612, 1586, 1517, 1457, 1261, 1161, 1074, 
1035, 884, 754. 
 
1
H NMR (500 MHz, DMSO-d6, broadened signals were observed) δ 9.57 (br s, 1H), 7.48 (d, 
J = 8.6 Hz, 2H), 6.96 (d, J = 8.6 Hz, 2H), 4.15 (q, J = 7.1 Hz, 2H), 4.06 (s, 2H), 3.76 (s, 3H), 
3.08 (t, J = 7.4 Hz, 2H), 2.93 (t, J = 7.5 Hz, 2H), 1.20 (t, J = 7.1 Hz, 3H). 
 
13
C NMR (126 MHz, DMSO-d6) δ 160.1 (C), 153.0 (C), 132.0 (C), 124.0 (CH), 114.4 (CH), 
85.2 (C), 74.7 (C), 62.3 (CH2), 55.6 (CH3), 49.7 (CH2), 43.9 (CH2), 15.8 (CH2), 14.23 (CH3). 
 
HMRS (ESI) calculated for C15H19NO3Na [M-HCl+Na]
+
 284.1257, found 284.1285. 
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1-(Phenylsulfonyl)-1H-pyrrole-2-carbonyl chloride: (2.24) 
 
 
 
To a stirred suspension of aluminium chloride (6.66 g, 50 mmol) in dry 1,2-dichloroethane 
(60 mL) at 0 °C was added oxalyl chloride (6.34 g, 4.30 mL, 50 mmol). The reaction was left 
to stir for 30 minutes at 0 °C before the addition of 1-phenylsulfonyl-1H-pyrrole 2.23 (2.07 g, 
10 mmol) in dry 1,2-dichloroethane (15 mL). The resultant solution was allowed to warm to 
rt and left to stir for 2 hours. Subsequently, it was poured into a mixture of ice and water and 
the product was extracted twice with diethyl ether. The organic layers were combined, 
washed once with water, dried over anhydrous sodium sulfate, filtered and concentrated 
under reduced pressure to give a brown oil. The crude product 2.24 was used directly in the 
next step without future purifications (2.55 g, 95%).  
Spectroscopic data are in agreement with the literature values.
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IR (neat) v (cm
-1
) 3140, 2923, 2854, 1756, 1446, 1423, 1372, 1188, 1170, 1027. 
 
1
H NMR (300 MHz, CDCl3, broadened signals were observed) δ 7.91 (br s, 1H), 7.82 (app. 
dd, J = 3.0, 2.0 Hz, 2H), 7.57 (app. tt, J = 7.5, 1.0 Hz, 1H), 7.48 (app. tt, J = 7.5, 1.0 Hz, 2H), 
7.41 (app. dd, J = 4.0, 2.0 Hz, 1H), 6.35 (app. dd, J = 4.0, 3.0 Hz, 1H). 
 
13
C NMR (75.5 MHz, CDCl3) δ 155.1 (C), 137.8 (C), 135.0 (CH), 133.7 (CH), 132.4 (CH), 
129.5 (CH), 128.7 (CH), 126.6 (C), 112.0 (CH).  
 
m/z (EI
+
) 269 (M
+
, 11%), 234 (98), 141 (59), 93 (78), 77 (100), 51 (72). 
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Ethyl 5-(N-(4-methoxybenzyl)-1-(phenylsulfonyl)-1H-pyrrole-2-carboxamido)pent-2-
ynoate: (2.8) 
 
 
 
Initially, the free base of amine 2.25 was prepared by partitioning the salt between saturated 
aqueous NaHCO3 solution and CH2Cl2. The aqueous and organic layers were separated and 
the aqueous layer was extracted three times with CH2Cl2. The combined extracts were 
washed once with brine, dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo. The free base of amine 2.25 was then used in the next step. 
To a stirred solution of free base of amine 2.25 (2.19 g, 8.15 mmol) and triethylamine (1.50 
g, 2.07 mL, 14.82 mmol) in dry THF (30 mL) at 0 °C was added acid chloride 2.24 (2.0 g, 
7.41 mmol) in dry THF (15 mL). The reaction was allowed to warm to rt and left to stir for 8 
hours. The reaction was then quenched with cold water, the phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with 10% aqueous citric acid solution, washed once with 10% 
aqueous K2CO3 solution, dried over anhydrous sodium sulfate, filtered and concentrated 
under reduced pressure to give an orange oil. The crude product 2.8 was purified by flash 
chromatography on a silica gel column eluting with 50% diethyl ether in hexanes to give the 
title compound 2.8 (3.29 g, 90%) as a pale yellow foam. 
 
Spectroscopic data are in agreement with the literature values
144
 
 
IR (neat) v (cm
-1
) 2923, 2855, 2239, 1706, 1643, 1455, 1365, 1255, 1236, 1150. 
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1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 7.90 (d, J = 7.0 Hz, 
2H), 7.55 – 7.45 (m, 2H), 7.43 –7.38 (m, 1H), 7.15 (br s, 1H), 7.05 (d, J = 8.0 Hz, 2H), 6.80 
(d, J = 8.0 Hz, 2H), 6.25 (br s, 0.7H), 6.12 (br s, 0.7H), 4.45 (s, 1.4H), 4.11 (q, J = 7.0 Hz, 
2H), 3.71 (s, 3H), 3.49 (t, J = 6.5 Hz, 1.4H), 2.60 (t, J = 6.5 Hz, 1.4H), 1.19 (t, J = 7.0 Hz, 
3H); Rotamer B; 6.30 (br s, 0.3H), 6.17 (br s, 0.3H), 4.68 (s, 0.6H), 3.40 – 3.30 (m, 0.6H), 
2.45 – 2.35 (m, 0.6H). 
 
13
C NMR (126 MHz, CDCl3) δ
 
164.0 (C), 159.7 (C), 153.9 (C), 138.7 (C), 134.6 (CH), 129.5 
(CH), 129.2 (CH), 128.4 (CH), 128.2 (C), 123.3 (CH), 114.7 (CH), 114.2 (CH), 112.5 (CH), 
86.8 (C), 74.6 (C), 62.3 (CH2), 55.6 (CH3), 53.3 (CH2), 43.0 (CH2), 17.1 (CH2), 14.4 (CH3). 
 
HMRS (ESI) calculated for C26H26N2O6SNa [M+Na]
+
 517.1403, found 517.1393. 
 
m/z (EI
+
) 495 (M+H
+
, 25%), 450 (75), 260 (41), 234 (73), 121 (100), 77 (76). 
 
 
 
 
 
Ethyl 2-(4-methoxybenzyl)-1-oxo-1,2-dihydroisoquinoline-5-carboxylate: (2.11) 
 
 
 
To a stirred solution of amide 2.8 (1.5 g, 3.03 mmol) in anhydrous pyridine (30 mL) was 
added lithium iodide (0.40 g, 3.03 mmol). The mixture was heated at reflux for 16 hours, 
cooled to rt and diluted with CH2Cl2. The reaction mixture was then quenched with saturated 
aqueous NH4Cl solution. The phases were separated and the aqueous phase was extracted 
three times with CH2Cl2. The organic layers were combined, washed once with saturated 
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aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give a yellow tinted solid. The crude 
product 2.11 was purified by flash chromatography on a silica gel column eluting with 50% 
diethyl ether in hexanes to give the title compound 2.11 (0.53 g, 52%) as white solid. 
Spectroscopic data are in agreement with the literature values
144
 
 
IR (neat) v (cm
-1
) 2926, 1708, 1651, 1621, 1591, 1513, 1254, 1126. 
 
1
H NMR (500 MHz, CDCl3) δ 8.59 (d, J = 8.0 Hz, 1H), 8.22 (d, J = 8.0 Hz, 1H), 7.54 (d, J = 
8.0 Hz, 1H), 7.41 (t, J = 8.0 Hz, 1H), 7.19 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.0 Hz, 1H), 6.77 
(d, J = 8.5 Hz, 2H), 5.06 (s, 2H), 4.32 (q, J = 7.0 Hz, 2H), 3.72 (s, 3H), 1.33 (t, J = 7.0 Hz, 
3H). 
 
13
C NMR (126 MHz, CDCl3) δ 166.4 (C), 161.7 (C), 159.3 (C), 136.6 (C), 135.1 (CH), 132.7 
(CH), 132.6 (CH), 129.4 (CH), 128.5 (C), 127.3 (C), 125.7 (C), 125.6 (CH), 114.1 (CH), 
103.9 (CH), 61.1 (CH2), 55.1 (CH3), 51.1 (CH2), 14.1 (CH3). 
 
HMRS (ESI) calculated for C20H19NO4Na [M+Na]
+
 360.1212, found 360.1215. 
 
 
 
 
 
1-(1-(Phenylsulfonyl)-1H-pyrrol-2-yl)ethanone: (2.35a) 
 
 
 
To a stirred solution of acetic anhydride (2.17 g, 2.0 mL, 21.23 mmol) in dry 1,2-
dichloroethane (60 mL) was added boron trifluoride diethyl etherate (BF3∙Et2O; 5.48 g, 4.76 
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mL, 38.6 mmol). The reaction mixture was left to stir at rt for 10 minutes before the addition 
of 1-phenylsulfonyl-1H-pyrrole 2.23 (4.0 g, 19.30 mmol) in dry 1,2-dichloroethane (20 mL). 
The resultant solution was allowed to stir for a further 8 hours. Subsequently, it was poured 
into a mixture of ice and water and the product was extracted twice with diethyl ether. The 
organic layers were combined, washed once with brine, dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure to give a dark yellow liquid. The 
crude product 2.35a was purified by flash chromatography on a silica gel column eluting with 
20% ethyl acetate in petroleum ether to give the title compound 2.35a (4.18 g, 87%) as a dark 
yellow solid. 
Spectroscopic data are in agreement with the literature values.
158
 
 
m.p.: 96.1 - 98.0 °C 
 
IR (neat) v (cm
-1
) 3165, 2972, 2925, 2854, 1676, 1583, 1436, 1358, 1322, 1180, 1142, 1060. 
 
1
H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 8.1 Hz, 2H), 7.83 (dd, J = 1.8, 3.2 Hz. 1H), 7.60 
(t, J = 7.4 Hz, 1H), 7.53 (t, J = 7.7 Hz, 2H), 7.06 (dd, J = 1.8, 3.4 Hz, 1H), 6.35 (t, J = 3.4 Hz, 
1H), 2.36 (br s, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 185.7 (C), 138.9 (C), 133.6 (CH), 133.3 (C), 130.3 (CH), 
128.6 (CH), 128.1 (CH), 124.3 (CH), 110.4 (CH), 26.9 (CH3). 
 
HMRS (ESI) calculated for C12H11NO3SNa [M+Na]
+
 272.0351, found 272.0350. 
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2-Ethyl-1-(phenylsulfonyl)-1H-pyrrole: (2.36a) 
 
 
 
To a stirred suspension of aluminium chloride (6.17 g, 45.13 mmol) in CH2Cl2 (100 mL) was 
added borane tert-butylamine complex (t-BuNH2·BH3; 7.85 g, 90.26 mmol). The reaction 
was left to stir for 2 hours at rt before the addition of 1-(1-(phenylsulfonyl)-1H-pyrrol-2-
yl)ethanone 2.35a (3.75 g, 15.04 mmol) in CH2Cl2 (25 mL). The resultant solution was 
allowed to stir at rt for a further 16 hours. Subsequently, it was poured into a mixture of ice 
and water and the product was extracted twice with diethyl ether. The organic layers were 
combined, washed once with 3.0 M aqueous HCl solution, washed once with saturated 
aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give a pale yellow solid. The crude 
product 2.36a was purified by flash chromatography on a silica gel column eluting with 25% 
diethyl ether in petroleum ether to give the title compound 2.36a (3.25 g, 92%) as a white 
solid. Spectroscopic data are in agreement with the literature values.
159
 
 
m.p.: 57.0 - 58.0 °C 
 
IR (neat) v (cm
-1
) 3140, 2924, 2855, 1605, 1447, 1390, 1361, 1169, 1043. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.75 (d, J = 8.2 Hz, 2H), 
7.57 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.32 (br s, 1H), 6.22 (t, J = 3.0 Hz, 1H), 
6.01 (br s, 1H), 2.70 (q, J = 7.4 Hz, 2H), 1.16 (t, J = 7.4 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 139.4 (C), 137.3 (C), 133.6 (CH), 129.3 (CH), 126.6 (CH), 
122.2 (CH), 111.4 (CH), 111.1 (CH), 20.5 (CH2), 12.7 (CH3). 
 
HMRS (ESI) calculated for C12H13NO2SNa [M+Na]
+
 258.0565, found 258.0559. 
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5-Ethyl-1-phenylsulfonyl-1H-pyrrole-2-carbonyl chloride: (2.37a) 
 
 
 
To a stirred suspension of aluminium chloride (3.4 g, 25.50 mmol) in dry 1,2-dichloroethane 
(50 mL) at 0 °C was added oxalyl chloride (3.24 g, 2.19 mL, 25.50 mmol). The reaction was 
left to stir for 30 minutes at 0 °C before the addition of 2-Ethyl-1-(phenylsulfonyl)-1H-
pyrrole 2.36a (1.2 g, 5.10 mmol) in dry 1,2-dichloroethane (5 mL). The resultant solution was 
allowed to warm to rt and left to stir for 2 hours. Subsequently, it was poured into a mixture 
of ice and water and the product was extracted twice with diethyl ether. The organic layers 
were combined, washed once with water, dried over anhydrous sodium sulfate, filtered and 
concentrated under reduced pressure to give a brown oil (1.44 g, 95%). The crude product 
2.37a was used directly in the next reaction without further purification. 
 
 
 
 
Ethyl 5-(5-ethyl-N-(4-methoxybenzyl)-1-(phenylsulfonyl)-1H-pyrrole-2-
carboxamido)pent-2-ynoate: (2.38a) 
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To a stirred solution of free base of amine 2.25  (1.39 g, 5.32 mmol) and triethylamine (0.98 
g, 1.35 mL, 9.68 mmol) in dry THF (25 mL) at 0 °C was added acid chloride 2.37a (1.44 g, 
4.84 mmol) in dry THF (15 mL). The reaction was allowed to warm to rt and left to stir for 
16 hours. The reaction was then quenched with water, the phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with 10% aqueous citric acid solution, washed once with 10% 
aqueous K2CO3 solution, dried over anhydrous sodium sulfate, filtered and concentrated 
under reduced pressure to give an pale orange oil. The crude product 2.38a was purified by 
flash chromatography on a silica gel column eluting with 40% diethyl ether in hexanes to 
give the title compound 2.38a (2.22 g, 88%) as a yellow foam. 
 
IR (neat) v (cm
-1
) 2936, 2235, 1705, 1634, 1512, 1448, 1365, 1245, 1174, 1071. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 8.16 (d, J = 7.7 Hz, 
1.4H), 7.57 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.7 Hz, 2H), 7.18 (d, J = 8.6 Hz, 1.4H), 6.87 – 
6.82 (m, 1.4H), 6.28 (d, J = 3.4 Hz, 0.7H), 5.92 (d, J = 3.4 Hz, 0.7H), 4.56 (s, 1.4H), 4.16 (q, 
J = 7.1 Hz, 2H), 3.75 (s, 2.1H), 3.59 (br s, 1.4H), 2.69 (app. t, J = 6.9 Hz, 3.4H), 1.24 (t, J = 
7.1 Hz, 3H), 1.15 – 1.10 (m, 3H); Rotamer B; 8.19 (d, J = 7.7 Hz, 0.6H), 7.33 (d, J = 8.5 Hz, 
0.6H), 6.87 – 6.82 (m, 0.6H), 6.32 (d, J = 3.4 Hz, 0.3H), 5.96 (d, J = 3.1 Hz, 0.3H), 4.76 (s, 
0.6H), 3.73 (s, 0.9H), 3.50 (t, J = 7.0 Hz, 0.6H), 2.52 (t, J = 7.2 Hz, 0.6H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 164.7 (C), 159.3 
(C), 153.4 (C), 139.1 (C), 138.6 (C), 134.0 (CH), 129.3 (C), 129.2 (CH), 128.9 (CH), 127.9 
(C), 127.7 (CH), 114.2 (CH), 112.3 (CH), 110.1 (CH), 86.6 (C), 74.1 (C), 61.7 (CH2), 55.2 
(CH3), 52.8 (CH2), 42.5 (CH2), 20.8 (CH2), 18.3 (CH2), 13.9 (CH3), 12.4 (CH3); Rotamer B; 
164.9 (C), 159.1 (C), 153.2 (C), 139.2 (C), 138.5 (C), 129.7 (CH), 128.4 (C), 127.6 (CH), 
114.0 (CH), 112.7 (CH), 110.1 (CH), 85.3 (C), 74,7 (C), 61.8 (CH2), 55.1 (CH3), 47.4 (CH2), 
45.6 (CH2), 16.4 (CH2).  
 
HMRS (ESI) calculated for C28H30N2O6SNa [M+Na]
+
 545.1722, found 545.1720. 
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Ethyl 6-ethyl-2-(4-methoxybenzyl)-1-oxo-1,2-dihydroisoquinoline-5-carboxylate: (2.39a) 
 
 
 
To a stirred solution of amide 2.38a (1.5 g, 2.89 mmol) in anhydrous pyridine (30 mL) was 
added lithium iodide (0.38 g, 2.89 mmol). The mixture was heated at reflux for 8 hours, 
cooled to rt and diluted with CH2Cl2. The reaction mixture was then quenched with saturated 
aqueous NH4Cl solution. The phases were separated and the aqueous phase was extracted 
three times with CH2Cl2. The organic layers were combined, washed once with saturated 
aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give a yellow tinted solid. The crude 
product 2.39a was purified by flash chromatography on a silica gel column eluting with 50% 
diethyl ether in hexanes to give the title compound 2.39a (0.59 g, 56%) as a yellow 
amorphous solid. 
 
IR (neat) v (cm
-1
) 2954, 2921, 2856, 1721, 1651, 1625, 1587, 1510, 1458, 1325, 1298, 1245, 
1128, 1021. 
 
1
H NMR (500 MHz, CDCl3) δ 8.45 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 7.25 (d, J = 
8.5 Hz, 2H), 7.09 (d, J = 7.7 Hz, 1H), 6.84 (d, J = 8.6 Hz, 2H), 6.47 (d, J = 7.6 Hz, 1H), 5.13 
(s, 2H), 4.46 (q, J = 7.1 Hz, 2H), 3.77 (s, 3H), 2.77 (q, J = 7.6 Hz, 2H), 1.41 (t, J = 7.2 Hz, 
3H), 1.30 – 1.25 (m, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 168.6 (C), 161.6 (C), 159.3 (C), 146.1 (C), 134.2 (C), 132.1 
(CH), 129.7 (CH), 129.4 (CH), 129.0 (C), 128.7 (C), 127.7 (CH), 124.6 (C), 114.2 (CH), 
103.2 (CH), 61.5 (CH2), 55.2 (CH3), 51.1 (CH2), 27.4 (CH2), 15.4 (CH3), 14.2 (CH3). 
 
HMRS (ESI) calculated for C22H23NO4Na [M+Na]
+
 388.1519, found 388.1520. 
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1-(1-(Phenylsulfonyl)-1H-pyrrol-2-yl)butan-1-one: (2.35b) 
 
 
 
To a stirred solution of butyric anhydride (3.36 g, 3.47 mL, 21.23 mmol) in dry 1,2-
dichloroethane (80 mL) was added boron trifluoride diethyl etherate (BF3∙Et2O; 5.48 g, 4.76 
mL, 38.6 mmol). The reaction was left to stir at rt for 10 minutes before the addition of 1-
phenylsulfonyl-1H-pyrrole 2.23 (4.0 g, 19.30 mmol) in dry 1,2-dichloroethane (20 mL). The 
resultant solution was allowed to stir at rt for a further 8 hours. Subsequently, it was poured 
into a mixture of ice and water and the product was extracted twice with diethyl ether. The 
organic layers were combined, washed once with brine, dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure to give a dark brown liquid. The 
crude product 2.35b was purified by flash chromatography on a silica gel column eluting 
with 15% ethyl acetate in petroleum ether to give the title compound 2.35b (4.28 g, 80%) as a 
brown oil. 
 
IR (neat) v (cm
-1
) 3152, 2967, 2875, 1674, 1596, 1467, 1440, 1365, 1172, 1143, 1090, 1063, 
669. 
 
1
H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 8.2 Hz, 2H), 7.82 (dd, J = 1.7, 3.2 Hz, 1H), 7.62 
(t, J = 7.4 Hz, 1H), 7.52 (t, J = 7.6 Hz, 2H), 7.06 (dd, J = 1.7, 3.2 Hz, 1H), 6.34 (t, J = 3.3 
Hz, 1H), 2.58 (t, J = 7.4 Hz, 2H), 1.69 – 1.58 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H).  
 
13
C NMR (126 MHz, CDCl3) δ 188.9 (C), 139.0 (C), 133.6 (CH), 133.5 (C), 130.0 (CH), 
128.6 (CH), 128.0 (CH), 123.2 (CH), 110.3 (CH), 41.2 (CH2), 18.3 (CH2), 13.6 (CH3).  
 
HMRS (ESI) calculated for C14H15NO3SNa [M+Na]
+
 300.0675, found 300.0666. 
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2-Butyl-1-phenylsulfonyl-1H-pyrrole: (2.36b) 
 
 
 
To a stirred suspension of aluminium chloride (5.48 g, 41.10 mmol) in dry CH2Cl2 (75 mL) 
was added borane tert-butylamine complex (t-BuNH2·BH3; 7.15 g, 82.21 mmol). The 
reaction mixture was left to stir at rt for 2 hours before the addition of 1-(1-(phenylsulfonyl)-
1H-pyrrol-2-yl)butan-1-one 2.35b (3.8 g, 13.70 mmol) in dry CH2Cl2 (25 mL). The resultant 
solution was allowed to stir at rt for a further 16 hours. Subsequently, it was poured into a 
mixture of ice and water and the product was extracted twice with diethyl ether. The organic 
layers were combined, washed once with 3.0 M aqueous HCl solution, washed once with 
saturated aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure to give a yellow solid. The crude 
product 2.36b was purified by flash chromatography on a silica gel column eluting with 20% 
diethyl ether in petroleum ether to give  the title compound 2.36b (3.21 g, 89%) as a yellow 
solid. 
 
m.p.: 57.3 - 57.8 °C 
 
IR (neat) v (cm
-1
) 3153, 2932, 2853,1484, 1448, 1365, 1247, 1189, 1175, 1156, 1090, 668. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.75 (d, J = 8.0 Hz, 2H), 
7.59 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.7 Hz, 2H), 7.30 (br s, 1H), 6.21 (t, J = 3.1 Hz, 1H), 
6.00 (br s, 1H), 2.66 (t, J = 7.7 Hz, 2H), 1.56 – 1.49 (m, 2H), 1.37 – 1.29 (m, 2H), 0.87 (t, J = 
7.4 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 139.5 (C), 136.0 (C), 133.5 (CH), 129.2 (CH), 126.6 (CH), 
122.2 (CH), 111.8 (CH), 111.3 (CH), 30.7 (CH2), 26.8 (CH2), 22.2 (CH2), 13.7 (CH3). 
 
HMRS (ESI) calculated for C14H17NO2SNa [M+Na]
+
 286.0883, found 286.0873. 
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5-Butyl-1-phenylsulfonyl-1H-pyrrole-2-carbonyl chloride: (2.37b) 
 
 
 
To a stirred suspension of aluminium chloride (3.04 g, 22.78 mmol) in dry 1,2-dichloroethane 
(50 mL) at 0 °C was added oxalyl chloride (2.89 g, 1.95 mL, 22.78 mmol). The reaction was 
left to stir for 30 minutes at 0 °C before the addition of 2-butyl-1-phenylsulfonyl-1H-pyrrole 
2.36b (1.2 g, 4.56 mmol) in dry 1,2-dichloroethane (15 mL). The resultant solution was 
allowed to warm to rt and left to stir for 2 hours. Subsequently, it was poured into a mixture 
of ice and water and the product was extracted twice with diethyl ether. The organic layers 
were combined, washed once with water, dried over anhydrous sodium sulfate, filtered and 
concentrated under reduced pressure to give a brown oil (1.38 g, 93%). The crude product 
2.37b was used directly in the next step without further purification. 
 
 
 
 
Ethyl 5-(5-butyl-N-(4-methoxybenzyl)-1-(phenylsulfonyl)-1H-pyrrole-2-
carboxamido)pent-2-ynoate: (2.38b) 
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To a stirred solution of free base of amine 2.25 (1.22 g, 4.67 mmol) and triethylamine (0.86 
g, 1.18 mL, 8.50 mmol) in dry THF (20 mL) at 0 °C was added acid chloride 2.37b (1.38 g, 
4.25 mmol) in dry THF (10 mL). The reaction was allowed to warm to rt and left to stir for 
16 hours. The reaction was then quenched with water, the phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with 10% aqueous citric acid solution, washed once with 10% 
aqueous K2CO3 solution, dried over anhydrous sodium sulfate, filtered and concentrated 
under reduced pressure to give an orange oil. The crude product 2.38b was purified by flash 
chromatography on a silica gel column eluting with 40% diethyl ether in hexanes to give the 
title compound 2.38b (2.04 g, 87%) as a pale yellow foam. 
 
IR (neat) v (cm
-1
) 2955, 2927, 2856, 1721, 1650, 1624, 1586, 1510, 1456, 1368, 1384, 1324, 
1297, 1245, 1170, 1128, 1104, 1022, 926, 839, 810, 775, 723. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 8.18 (d, J = 7.9 Hz, 
1.4H), 7.61 (t, J = 7.4 Hz, 1H), 7.54 (t, J = 7.7 Hz, 2H), 7.20 (d, J = 8.4 Hz, 1.4H), 6.87 – 
6.82 (m, 1.4H), 6.29 (d, J = 3.4 Hz, 0.7H), 5.93 (d, J = 3.4 Hz, 0.7H), 4.58 (s, 1.4H), 4.20 (q, 
J = 7.0 Hz, 2H), 3.80 (s, 2.1H), 3.60 (br s, 1.4H), 2.71 (app. t, J = 7.2 Hz, 3.4H), 1.53 – 1.44 
(m, 2H), 1.34 – 1.21 (m, 5H), 0.85 (t, J = 7.2 Hz, 3H); Rotamer B;  8.21 (d, J = 7.8 Hz, 
0.6H), 7.35 (d, J = 8.4 Hz, 0.6H), 6.87 – 6.82 (m, 0.6H), 6.32 (d, J = 3.3 Hz, 0.3H), 5.98 (d, J 
= 3.0 Hz, 0.3H), 4.76 (s, 0.6H), 3.79 (s, 0.9H), 3.52 (t, J = 7.0 Hz, 0.6H), 2.54 (t, J = 7.0 Hz, 
0.6H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 164.7 (C), 159.3 
(C), 153.4 (C), 138.7 (C), 137.8 (C), 133.9 (CH), 129.4 (C), 129.2 (CH), 128.9 (CH), 128.0 
(C), 127.7 (CH), 114.2 (CH), 112.4 (CH), 110.7 (CH), 86.6 (C), 74.1 (C), 61.6 (CH2), 55.1 
(CH3), 52.8 (CH2), 42.5 (CH2), 30.5 (CH2), 27.1 (CH2), 22.2 (CH2), 16.3 (CH2), 13.9 (CH3), 
13.7 (CH3); Rotamer B; 164.9 (C), 159.1 (C), 153.2 (C), 138.6 (C), 138.0 (C), 129.7 (CH), 
128.4 (C), 127.8 (CH), 114.0 (CH), 112.8 (CH), 110.9 (CH), 85.3 (C), 74.7 (C), 61.8 (CH2), 
55.1 (CH3), 47.4 (CH2), 45.6 (CH2), 29.6 (CH2), 27.1 (CH2). 
 
HMRS (ESI) calculated for C30H34N2O6SNa [M+Na]
+
 573.2029, found 573.2047. 
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Ethyl 6-butyl-2-(4-methoxybenzyl)-1-oxo-1,2-dihydroisoquinoline-5-carboxylate: 
(2.39b) 
 
 
 
To a stirred solution of amide 2.35b (1.5 g, 2.72 mmol) in anhydrous pyridine (30 mL) was 
added lithium iodide (0.36 g, 2.72 mmol). The mixture was heated at reflux for 8 hours, 
cooled to rt and diluted with CH2Cl2. The reaction mixture was then quenched with saturated 
aqueous NH4Cl solution. The phases were separated and the aqueous phase was extracted 
three times with CH2Cl2. The organic layers were combined, washed once with saturated 
aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give a yellow solid. The crude product 
2.36b was purified by flash chromatography on a silica gel column eluting with 50% diethyl 
ether in hexanes to give the title compound 2.36b (0.54 g, 51%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2954, 2921, 2865, 1721, 1651, 1625, 1586, 1510, 1455, 1300, 1245, 1128, 
1022. 
 
1
H NMR (500 MHz, CDCl3) δ 8.44 (d, J = 8.4 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.24 (d, J = 
8.6 Hz, 2H), 7.10 (d, J = 7.7 Hz, 1H), 6.85 (d, J = 8.7 Hz, 2H), 6.48 (d, J = 7.7 Hz, 1H), 5.12 
(s, 2H), 4.45 (q, J = 7.1 Hz, 2H), 3.75 (s, 3H), 2.74 (t, J = 7.9 Hz, 2H), 1.66 – 1.59 (m, 2H), 
1.44 – 1.33 (m, 5H), 0.92 (t, J = 7.4 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 168.6 (C), 161.6 (C), 159.3 (C), 144.9 (C), 134.2 (C), 132.0 
(CH), 129.5 (CH), 129.4 (CH), 129.2 (C), 128.6 (C), 128.3 (CH), 124.5 (C), 114.2 (CH), 
103.2 (CH), 61.4 (CH2), 55.2 (CH3), 51.1 (CH2), 34.0 (CH2), 33.3 (CH2), 22.6 (CH2), 14.2 
(CH3), 13.8 (CH3). 
 
HMRS (ESI) calculated for C24H27NO4Na [M+Na]
+
 416.1832, found 416.1838. 
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2-Methyl-1-(1-(phenylsulfonyl)-1H-pyrrol-2-yl)propan-1-one: (2.35c) 
 
 
 
To a stirred solution of iso-butyric anhydride (3.57 g, 3.74 mL, 22.56 mmol) in dry 1,2-
dichloroethane (75 mL) was added boron trifluoride diethyl etherate (BF3∙Et2O; 6.40 g, 5.72 
mL, 45.11 mmol). The reaction mixture was left to stir at rt for 10 minutes before the addition 
of 1-phenylsulfonyl-1H-pyrrole 2.23 (4.25 g, 20.51 mmol) in dry 1,2-dichloroethane (20 
mL). The resultant solution was allowed to stir for a further 8 hours. Subsequently, it was 
poured into a mixture of ice and water and the product was extracted twice with diethyl ether. 
The organic layers were combined, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a brown liquid. 
The crude product 2.35c was purified by flash chromatography on a silica gel column eluting 
with 10% ethyl acetate in petroleum ether to give the title compound 2.35c (4.72 g, 83%) as a 
brown oil. 
 
IR (neat) v (cm
-1
) 3150, 2972, 2877, 1673, 1542, 1467, 1436, 1400, 1364, 1247, 1168, 1141, 
1088. 
 
1
H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 7.8 Hz, 2H), 7.80 (dd, J = 1.6, 3.1 Hz, 1H), 7.60 
(t, J = 7.4 Hz, 1H), 7.53 (t, J = 7.7 Hz, 2H), 7.01 (dd, J = 1.5, 3.6 Hz, 1H), 6.34 (t, J = 3.5 Hz, 
1H), 3.20 – 3.11 (m, 1H), 1.09 (d, J = 6.9 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 193.2 (C), 139.1 (C), 133.4 (CH), 133.0 (C), 129.9 (CH), 
128.6 (CH), 128.0 (CH), 122.3 (CH), 110.3 (CH), 37.0 (CH), 19.1 (CH3). 
 
HMRS (ESI) calculated for C14H15NO3SNa [M+Na]
+
 300.0664, found 300.0675. 
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2-Isobutyl-1-phenylsulfonyl-1H-pyrrole: (2.36c) 
 
 
 
To a stirred suspension of aluminium chloride (5.77 g, 43.27 mmol) in dry CH2Cl2 (80 mL) 
was added borane tert-butylamine complex (t-BuNH2·BH3; 7.52 g, 86.54 mmol). The 
reaction mixture was left to stir at rt for 2 hours before the addition of 2-methyl-1-(1-
(phenylsulfonyl)-1H-pyrrol-2-yl)propan-1-one 2.35c (4.0 g, 14.42 mmol) in dry CH2Cl2 (20 
mL). The resultant solution was allowed to stir for a further 16 hours. Subsequently, it was 
poured into a mixture of ice and water and the product was extracted twice with diethyl ether. 
The organic layers were combined, washed once with 3.0 M aqueous HCl solution, washed 
once with saturated aqueous NaHCO3 solution, washed once with brine, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a yellow solid. The 
crude product 2.36c was purified by flash chromatography on a silica gel column eluting with 
15% diethyl ether in petroleum ether to give the title compound 2.36c (3.8 g, 91%) as off 
white solid. 
 
m p.: 62.1 - 64.0 °C 
 
IR (neat) v (cm
-1
) 3152, 2956, 2870, 1571, 1446, 1390, 1358, 1296, 1332, 1183, 1144, 1047. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 7.74 (d, J = 7.9 Hz, 2H), 
7.57 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 7.7 Hz, 2H), 7.30 (br s, 1H), 6.22 (t, J = 3.0 Hz, 1H), 
6.00 (br s, 1H), 2.54 (d, J = 7.0 Hz, 2H), 1.94 – 1.85 (m, 1H), 0.87 (d, J = 6.8 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 139.7 (C), 135.1 (C), 133.5 (CH), 129.2 (CH), 126.4 (CH), 
122.4 (CH), 113.3 (CH), 111.5 (CH), 36.3 (CH2), 28.1 (CH), 22.3 (CH3). 
 
HMRS (ESI) calculated for C14H17NO2SNa [M+Na]
+
 286.0872, found 286.0883. 
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5-Isobutyl-1-phenylsulfonyl-1H-pyrrole-2-carbonyl chloride: (2.37c) 
 
 
 
To a stirred suspension of aluminium chloride (3.04 g, 22.78 mmol) in dry 1,2-dichloroethane 
(50 mL) at 0 °C was added oxalyl chloride (2.89 g, 1.95 mL, 22.78 mmol). The reaction was 
left to stir for 30 minutes at 0 °C before the addition of 2-isobutyl-1-phenylsulfonyl-1H-
pyrrole 2.36c (1.2 g, 4.56 mmol) in dry 1,2-dichloroethane (15 mL). The resultant solution 
was allowed to warm to rt and left to stir for 2 hours. Subsequently, it was poured into a 
mixture of ice and water and the product was extracted twice with diethyl ether. The organic 
layers were combined, washed once with water, dried over anhydrous sodium sulfate, filtered 
and concentrated under reduced pressure to give a brown oil (1.41 g, 95%). The crude 
product 2.37c was used directly in the next step without further purification. 
 
 
 
 
Ethyl 5-(5-isobutyl-N-(4-methoxybenzyl)-1-(phenylsulfonyl)-1H-pyrrole-2-
carboxamido)pent-2-ynoate: (2.38c) 
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To a stirred solution of free base of amine 2.25 (1.25 g, 4.77 mmol) and triethylamine (0.88 
g, 1.21 mL, 8.68 mmol) in dry THF (20 mL) at 0 °C was added acid chloride 2.37c (1.41 g, 
4.34 mmol) in dry THF (10 mL). The reaction was allowed to warm to rt and left to stir for 
16 hours. The reaction was then quenched with water, the phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with 10% aqueous citric acid solution, washed once with 10% 
aqueous K2CO3 solution, dried over anhydrous sodium sulfate, filtered and concentrated 
under reduced pressure to give a dark yellow oil. The crude product 2.38c was purified by 
flash chromatography on a silica gel column eluting with 40% diethyl ether in hexanes to 
give the title compound 2.38c (2.15 g, 90%) as a pale yellow foam. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 8.15 (d, J = 7.9 Hz, 
1.4H), 7.62 (t, J = 7.4 Hz, 1H), 7.54 (t, J = 7.7 Hz, 2H), 7.20 (d, J = 8.5 Hz, 1.4H), 6.91 – 
6.86 (m, 1.4H), 6.31 (d, J = 3.4 Hz, 0.7H), 5.94 (d, J = 3.3 Hz, 0.7H), 4.55 (s, 1.4H), 4.16 (q, 
J = 7.1 Hz, 2H), 3.75 (s, 2.1H), 3.58 (br s, 1.4H), 2.68 (t, J = 7.0 Hz, 1.4H), 2.58 – 2.48 (m, 
2H), 1.80 – 1.70 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H), 0.79 (d, J = 6.5 Hz, 6H); Rotamer B; 8.18 
(d, J = 7.7 Hz, 0.6H), 7.35 (d, J = 8.4 Hz, 0.6H), 6.91 – 6.86 (m, 0.6H), 6.34 (d, J = 3.3 Hz, 
0.3H), 5.98 (d, J = 3.1 Hz, 0.3H), 4.76 (s, 0.6H), 3.73 (s, 0.9H), 3.47 (t, J = 6.8 Hz, 0.6H), 
2.58 – 2.48 (m, 0.6H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 164.7 (C), 159.3 
(C), 153.4 (C), 138.8 (C), 136.9 (C), 134.0 (CH), 129.4 (C), 129.2 (CH), 128.9 (CH), 128.0 
(C), 127.6 (CH), 114.2 (CH), 112.7 (CH), 112.2 (CH), 86.6 (C), 74.1 (C), 61.7 (CH2), 55.2 
(CH3), 52.7 (CH2), 42.5 (CH2), 36.5 (CH2), 28.0 (CH), 22.3 (CH3), 16.4 (CH2), 13.9 (CH3); 
Rotamer B; 164.9 (C), 159.1 (C), 153.2 (C), 138.7 (C), 137.2 (C), 129.7 (CH), 128.4 (C), 
127.6 (CH), 114.0 (CH), 113.4 (CH), 112.4 (CH), 85.2 (C), 74.6 (C), 61.8 (CH2), 55.1 (CH3), 
47.5 (CH2), 45.6 (CH2), 36.6 (CH2), 28.1 (CH), 18.3 (CH2). 
 
HMRS (ESI) calculated for C30H34N2O6SNa [M+Na]
+
 573.2030, found 573.2002. 
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Ethyl 6-isobutyl-2-(4-methoxybenzyl)-1-oxo-1,2-dihydroisoquinoline-5-carboxylate: 
(2.39c) 
 
 
 
To a stirred solution of amide 2.38c (1.5 g, 2.72 mmol) in anhydrous pyridine (30 mL) was 
added lithium iodide (0.36 g, 2.72 mmol). The mixture was heated at reflux for 8 hours, 
cooled to rt and diluted with CH2Cl2. The reaction mixture was then quenched with saturated 
aqueous NH4Cl solution. The phases were separated and the aqueous phase was extracted 
three times with CH2Cl2. The organic layers were combined, washed once with saturated 
aqueous NaHCO3 solution, washed once with brine, dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give a yellow solid. The crude product 
2.39c was purified by flash chromatography on a silica gel column eluting with 50% diethyl 
ether in hexanes to give the title compound 2.39c (0.57 g, 54%) as a white solid. 
 
m.p : 65.1 - 65.8 °C 
 
IR (neat) v (cm
-1
) 2956, 2922, 2857, 1721, 1650, 1624, 1587, 1512, 1461, 1368, 1327, 1300, 
1247, 1174, 1122, 911, 848, 817, 776, 727. 
 
1
H NMR (500 MHz, CDCl3) δ 8.44 (d, J = 8.3 Hz, 1H), 7.32 (d, J = 8.4 Hz, 1H), 7.26 (d, J = 
8.4 Hz, 2H), 7.09 (d, J = 7.7 Hz, 1H), 6.84 (d, J = 8.6 Hz, 2H), 6.45 (d, J = 7.6 Hz, 1H), 5.13 
(s, 2H), 4.45 (q, J = 7.1 Hz, 2H), 3.76 (s, 3H), 2.64 (d, J = 7.3 Hz, 2H), 2.00 – 1.90 (m, 1H), 
1.41 (t, J = 7.1 Hz, 3H), 0.91 (d, J = 6.6 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 168.6 (C), 161.6 (C), 159.3 (C), 143.7 (C), 134.2 (C), 132.0 
(CH), 129.7 (CH), 129.4 (CH), 129.1 (C), 128.9 (C), 128.7 (CH), 124.6 (C), 114.2 (CH), 
103.2 (CH), 61.4 (CH2), 55.2 (CH3), 51.1 (CH2), 43.1 (CH2), 30.0 (CH), 22.4 (CH3), 14.2 
(CH3). 
 HMRS (ESI) calculated for C24H27NO4Na [M+Na]
+
 416.1832, found 416.1829. 
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5-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)pent-2-ynoic acid (2.40) 
 
 
 
To a stirred solution of ethyl ester 2.21 (201 mg, 0.56 mmol) in MeOH (3 mL) was added 
20% aqueous KOH solution (20% w/v, 38 mg, 0.19 mL) at 0 °C. The reaction was allowed to 
warm to rt and left to stir for 2 days. The reaction mixture was then poured into ice-water and 
the aqueous layer washed with CH2Cl2. The aqueous layer was then acidified (pH 1) with 3M 
HCl solution and extracted with CH2Cl2. The organic fractions were combined and extracted 
with saturated aqueous NaHCO3 solution. The combined aqueous layer was acidified (pH 1) 
with 3M HCl and aqueous layer extracted with CH2Cl2. The organic layers were combined, 
washed once with brine, dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure to give a colourless oil (110 mg, 62%). The crude product 2.40 was 
used directly in the next step without further purification. 
 
IR (neat) v (cm
-1
) 3417, 2977, 2934, 2237, 1691, 1612, 1513, 1413, 1367, 1248, 1162.  
 
1
H NMR (300 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 9.49 (br s, 1H), 7.10 
(d, J = 8.0 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 4.38 (s, 1.4H), 3.72 (s, 3H), 3.32 – 3.24 (m, 2H), 
2.46 – 2.38 (m, 2H), 1.44 (s, 9H); Rotamer B; 4.30 (s, 0.6H) 
 
13
C NMR (75.5 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 157.9 (C), 155.5 
(C), 154.0 (C), 128.8 (C), 128.0 (CH), 114.0 (CH), 86.5 (C), 80.3 (C), 74.7 (C), 54.6 (CH3), 
50.1 (CH2), 43.7 (CH2), 28.0 (CH3), 17.3 (CH2); Rotamer B; 129.0 (C), 128.2 (CH), 53.7 
(CH3), 48.9 (CH2), 43.5 (CH2), 17.5 (CH2). 
 
HMRS (ESI) calculated for C18H23NO5Na [M+Na]
+
 356.1462, found 356.1462. 
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5-((4-methoxybenzyl)amino)pent-2-ynoic acid hydrochloride (2.41) 
 
 
 
To a stirred solution of carboxylic acid 2.40 (513 mg, 1.32 mmol) in dry CH2Cl2 (5 mL) at 0 
°C was added a 4M solution of HCl in dioxane (8 mL, 32.0 mmol). The reaction was allowed 
to warm to rt and left to stir for 16 hours, during which time the formation of white 
precipitates were observed. The solvent was removed in vacuo to afford a pale brown solid. 
This solid was triturated with diethyl ether to afford a white solid which was collected by 
filtration and washed well with diethyl ether, after drying under high vacuum the title product 
obtained was a white solid. The crude product 2.41 was used directly in the next step without 
further purification (275 mg, 82%). 
 
IR (neat) v (cm
-1
) 2924, 2854, 2246, 1692, 1460, 1143, 1253, 1178, 1032. 
 
1
H NMR (300 MHz, CDCl3, broadened signals were observed) δ 9.64 (br s, 1H), 7.50 (d, J = 
8.0 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 4.10 (s, 2H), 3.77 (s, 3H), 3.20 – 3.00 (m, 2H), 2.98 – 
2.80 (m, 2H). 
 
13
C NMR (75.5 MHz, DMSO-d6) δ 160.0 (C), 154.1 (C), 132.0 (C), 123.9 (CH), 114.3 (CH), 
83.7 (C), 75.9 (C), 55.5 (CH3), 49.6 (CH2), 43.9 (CH2), 15.7 (CH2). 
 
HMRS (ESI) calculated for C13H15NO3Na [M-HCl+Na]
+
 256.0950, found 256.0966. 
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5-(N-(4-methoxybenzyl)-1-(phenylsulfonyl)-1H-pyrrole-2-carboxamido)pent-2-ynoic 
acid: (2.10) 
 
 
 
To a stirred solution of salt 2.41 (187 mg, 0.69 mmol) and triethylamine (147 mg, 0.20 mL, 
1.45 mmol) in dry THF (5 mL) at 0 °C was added acid chloride 2.24 (186 mg, 0.66 mmol) in 
dry THF (5 mL). The reaction was allowed to warm to rt and left to stir for 16 hours. The 
reaction was then quenched with water, the aqueous layer was acidified and extracted three 
times with CH2Cl2. The organic layers were combined, washed once with brine, dried over 
anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a pale 
yellow oil. The crude product 2.10 was purified by flash chromatography on a silica gel 
column eluting with 1% methanol in CH2Cl2 to give the title compound 2.10 (135 mg, 44%) 
as a yellow oil. 
 
IR (neat) v (cm
-1
) 3065, 2932, 2239, 1712, 1612, 1514, 1369, 1249, 1176, 1154. 
 
1
H NMR (300 MHz, CDCl3, resolved signals of rotamers) δ Rotamer A; 8.04 (d, J = 7.0 Hz, 
2H), 7.66 – 7.49 (m, 3H), 7.27 – 7.22 (m, 1H), 7.16 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 8.0 Hz, 
2H), 6.34 (br s, 0.7H), 6.23 (br s, 0.7H), 4.55 (s, 1.4H), 3.80 (s, 3H), 3.60 (t, J = 7.0 Hz, 
1.4H), 2.72 (t, J = 7.0 Hz, 1.4H); Rotamer B; 6.40 (br s, 0.3H), 6.28 (br s, 0.3H), 4.78 (s, 
0.6H), 3.48 (br s, 0.6H), 2.52 (br s, 0.6H). 
 
13
C NMR (75.5 MHz, CDCl3) δ
 
164.5 (C), 159.8 (C), 156.4 (C), 138.7 (C), 134.7 (CH), 129.6 
(CH), 129.2 (CH), 128.3 (CH), 127.9 (C), 123.4 (CH), 114.6 (CH), 114.5 (CH), 112.7 (CH), 
86.8 (C), 74.6 (C), 55.7 (CH3), 53.5 (CH2), 43.0 (CH2), 17.3 (CH2). 
 
HMRS (ESI) calculated for C24H22N2O6SNa [M+Na]
+
 489.1091, found 489.1092. 
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1.1.  Metal-Free Methods of Generating Diradicals  
 
1.1.1. Natural Enediyne Anticancer Antibiotics 
 
The enediyne antibiotics are amongst the world’s most powerful antitumor agents, due to 
their intense activity against a multitude of murine tumour models.
1
 These compounds exhibit 
a new class of antibiotic with an exclusive chemical architecture, in which all members 
comprise a unit with two acetylenic groups adjoined to a double bond or incipient double 
bond with a nine or ten-membered ring.
2
 In the presence of DNA, enediyne antibiotic 
undergoes a prominent reaction, yielding sp
2
 carbon centred diradicals as the biologically 
active species.
3
 Nevertheless, the enediyne natural products are not discerning in their activity 
and will cleave DNA in both healthy and cancerous cells. This unselective behaviour has 
incited a concentration of experimental
4
 and computational
5
 research aimed at rational drug 
design.  
To date, there are three distinct families within the enedyine antibiotic class. These are 
defined as the following types; 1-) calicheamicin/esperamicin, 2-) dynemicin and 3-) 
chromoprotein. The original members identified of this new class were calicheamicin and 
esperamicin. These two antibiotics occur as complexes of several closely related components. 
The family of enediynes represented by chromoproteins used to be designated as 
neocarzinostatin. 
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Figure 1.1: The Key Enediyne Antitumor Antibiotics 
 
The enediyne antibiotics were originally produced from the fermentation of microorganisms. 
The organisms found to render the various enediyne complexes include different species 
Micromonospora, Actinomadura and Steptomyces. In account of their capacity to cleave 
DNA via the proposed Bergman cyclisation, much attention has been given to the enediyne 
compounds as potential sources for anticancer therapeutics.
6
  
To date, there have been many natural enediynes isolated from various marine and terrestrial 
plant sources. These represent highly potent clinically established classes of antitumor, 
antimicrobial and cytotoxic agents. Neocarzinostatin chromophores (1.1 and 1.2),
 
esperamicins (1.3 and 1.4), calicheamicin (1.5), dynemicins (1.6 and 1.7), kedarcidin (1.8), 
N1999-A2 (1.26), maduropeptin (1.27), shishijimicins (1.30A-C), namenamicin (1.31), 
lidamicins (C-1027) (1.32) and recently found uncialamycin (1.28 and 1.29) are the 
commonly known natural enediynes. Total syntheses of natural enediynes brought solutions 
for many challenging molecular architectures and made a distinct contribution to the progress 
of synthetic methodologies.
7
 Apart from their biological activity, enediynes are key building 
blocks in the synthesis of helical polycyclic aromatic hydrocarbons and of particular interest 
on account of their optical and electronic properties.
8
 In addition to this, it was suggested that 
enediynes are potentially useful mechanophores; that is, stress-sensitive units applied to the 
synthesis of polymers whose properties can be altered by mechanical energy.
9
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1.1.1.1. Calicheamicin and Esperamicin  
 
The cyclic ten-membered enediyne esperamicins (1.3 and 1.4) were isolated from a 
fermentation broth of Actinomadura Verrucosospora in 1985.
10 Subsequently, their structures 
were reported two years later;
11 
the precise mechanism for esperamicin A1’s antitumor 
activity is not entirely understood. In a recent paper by Capitani et al.,
12
 a number of 
explanations are brought to light. In the most widely acknowledged mechanism for 
esperamicin’s activity, a bioreductive cleavage of the trisulfide tail, is conducted by a 
reducing agent formulating a thiol.
13
 The thiol is then subjected to an intramolecular 
accumulation to the ten-membered ring comprising of the enediyne moiety. This in turn 
decreases differential strain between the reactant and intermediate state and increases 
flexibility in the enediyne ring, which considerably drops the activation barrier for Bergman 
cyclisation.  
 
 Esperamicin n R
1
 R
2
 R
3
 
 
 Esperamicin A1 
 
3 
 
H 
 
Ar 
 
i-Pr 
 Esperamicin A1b 3 Ar H i-Pr 
 Esperamicin A1c 3 H Ar Me 
 Esperamicin P 4 H Ar i-Pr 
 Esperamicin A2 3 H Ar i-Pr 
 Esperamicin A2b 3 Ar H Et 
 Esperamicin A2c 3 Ar H Me 
 
Table 1.1: Enediyne Esperamicins 
 
The cyclic ten-membered enediyne calicheamicins 1.5 were isolated from the soil bacterium 
Micromonospora echinospora spp. calichensis in 1986.
14
 Initially, the structure was put 
forward by Lee et al.
14
 in 1987. Subsequently, a revision of the configuration at one of the 
stereogenic centres took place. The total synthesis was then accomplished by Nicolaou and 
Dai.
15
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 Calicheamicin X R
1
 R
2
 R
3
 
     
 Calicheamicin β1
Br
 Br 3-O-MeRha Ami Me2CH 
 Calicheamicin γ1
Br
 Br 3-O-MeRha Ami Et 
 Calicheamicin α1
I
 I H Ami Et 
 Calicheamicin α3
I
 I 3-O-MeRha H - 
 Calicheamicin β1
I
 I 3-O-MeRha Ami Me2CH 
 Calicheamicin γ1
I
 I 3-O-MeRha Ami Et 
 Calicheamicin δ1
I
 I 3-O-MeRha Ami Me 
 
Table 1.2: Enediyne Calicheamicins 1.5 
 
Calicheamicin γ1 is one of the most prominent components of the calicheamicin complex. 
The enediynes Calicheamicin γ1 and esperamicin A1 share the same amino sugars, thio sugar 
and enediyne chromophore with a methyl trisulfide group. However, there is a difference in 
substitution alongside the keto group of the chromophore, the substitution of the aromatic 
groups, the composition of substituent sugar and aromatic units of the chromophore. Despite 
differences in structure between both molecules, they cleave DNA via the equivalent free 
radical mechanism (Scheme 1.1). 
 
 
 
Scheme 1.1: The Mechanism of DNA Cleavage by Calicheamicin γ1 
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1.1.1.2. Dynemicin  
 
The prominent component of the complex was named dynemicin A 1.6, discovered in 1989 
when it was isolated from a fermentation broth of Micromonospora chersina.
16,17
 This highly 
effective antitumor antibiotic has a ten-membered enediyne unit linked with the 
hydroxyanthraquinone chromophore of the classical anthracycline antibiotics. The existence 
of the anthraquinone moiety in the molecule is in disparity to the other members of the family 
such as calicheamicin γ1 and esperamicin A1, which have oligosaccharide tails.
5
 It is this 
contrast which makes 1.6 a particularly interesting contender for quantum chemical studies as 
its structure is both relatively inflexible and condensed. Furthermore, it has been the subject 
of extensive investigation by synthetic chemists. Investigations have been predominantly 
focused on the active centre, such as the pentacyclic framework and enediyne core.
18
 
Following this, Myers et al.
19
 accomplished a highly-convergent enantioselective synthesis of 
dynemicin A 1.6 in 1995. 
More recently, an additional member of this family, bioactive deoxydynemicin A 1.7, was 
isolated from Micromonospora globosa MG331-hF6.
20
 Similar to the activity of dynemicin A 
1.6, this member cleaves DNA duplex causing both single- and double-stranded cuts. Several 
dynemicin A model systems were designed, synthesised and investigated by Nicolaou et al.
21
 
 
As a
 
response to these investigations, the cascade through a hetero atom mediated epoxide 
ring opening was hypothesised. More specifically, two mechanisms were put forward 
(Scheme 1.2). Intercalation of the anthracycline like aromatic backbone followed by 
bioreduction, renders the dihydroanthroquinone 1.13.
22 
Heteroatom-mediated epoxide ring 
opening
21,23,24 
initiated by either the hydroquinone (path b)
22,25 
or the secondary amine (path 
a)
21,26,27
 yields the quinone 1.17 or imine 1.14 respectively. Nucleophilic attack on either 
intermediate renders the same re-aromatised product 1.15 with a greatly reduced cd distance 
(3.17 Å [Nu=OH, MMX], 3.18 Å [Nu=SCH2CO2Me. MMX]).
 28
 A spontaneous Bergman 
cyclisation then occurs in the aromatised precursor 1.15 to produce the bi-radical species 
1.18. This is comparable to that previously seen in the esperamicins (esperamicin A1) and 
calicheamicins (calicheamicin γ1) and leads to the duplex cleavage of DNA. The formulation 
of 1.19 via the process of DNA cleavage is subsequently oxidised and produces the 
anthroquinone product 1.20.  
132 
 
 
Scheme 1.2: The Mechanism of DNA Cleavage by Dynemicin 
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1.1.1.3. Neocarzinostatin Chromophore 
 
Chromoproteins are a category of potent antitumor antibiotics that comprise of a non-peptidic 
chromophore complexed with an apoprotein. These antibiotics commonly contain broad-
spectrum antitumor activity against solid-tumor cell lines. The intensely acidic protein 
provides stability to the chromophore from the generating organism and most likely, acts to 
protect the organism from DNA deterioration. Therefore, there has been substantial interest in 
establishing the tertiary structure of the apoproteins. This effort has acquired encouragement 
from the observation that the apoproteins of auromomycin (macromomycin) and 
actinoxanthin exhibit considerable resemblance to the apoprotein of neocarzinostatin.
29
  
Neocarzinostatin (NCS) was the first naturally occurring enediyne chromoprotein studied
30
 
and displays an interesting feature; its carrier protein is able to divert the enediyne 
cycloaromatisation into a distinct pathway. It has a unique double role in that it intercalates 
into DNA and imposes radical-mediated damage after thiol activation.
31
 
 
 
 
Scheme 1.3: The Mechanism of DNA Cleavage by Neocarzinostatin 
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The mechanism of action for neocarzinostatin chromophore appeared similar to that of 
calicheamicin and esperamicin and it consisted of two acetylenic units in a nine-membered 
ring. Therefore, the neocarzinostatin chromophore was subsequently acknowledged as an 
additional member of the new enediyne class of antibiotics. 
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Figure 1.2: The Key Enediyne Antitumor Antibiotics 
 
 
1.1.1.4. Namenamicin and Shishijimicins 
 
The cyclic nine-membered enediyne namenamicin 1.28 is one of two enediyne natural 
products of marine origin. Isolated from the Fijian tunicate Polysyncraton lithostrotum, this 
enediyne was extracted in very low yield (less than 1 mg from 1 kg of frozen tissue, 0.0001% 
yield).
32
 Strikingly, it has much in common with its nearby terrestrial equivalents, the 
calicheamicins 1.4 and esperamicins 1.3. Similarities can be detected between its 
trisaccharide domain and esperamicin A1, in particular the presence of isopropyl aminosugar 
(C ring) and two unusual 6-deoxysugars (A and B rings). However, namenamicin’s most 
unusual feature is the novel linkage between the A and B rings in which C4 of the A ring is 
disubstituted with a methyl thioether and a two carbon moiety to which the B ring is adjoined 
at the C7 oxygen. As a result of its capacity to cleave DNA and its limited availability, 
Nicolaou et al.
33
 reported progress towards the total synthesis of this natural product. 
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The on-going search for bioactive metabolites from Japanese marine invertebrates, led 
Fusetani et al.
34
  to discover a lipophilic extract of ascidian Didemnum proliferum which 
showed cytotoxicity. Four active compounds were furnished as a result of Bioassay-guided 
isolation; the first was identified as namenamicin 1.28 by spectral data. The remaining three 
were novel compounds of the enediyne class named shishijimicins 1.25A-C and these 
exhibited highly potent cytotoxicity. Additionally, Shishijimicins 1.25A-C and namenamicin 
1.28 are the only members of the enediyne class to derive from marine sources.  
Each of the shishijimicins contains the equivalent enediyne core to the one detected in 
namenamicin 1.28 and calicheamicin γ1 (known as calicheamicinone) 1.4. There is a distinct 
difference however, in the unique carboline structural motif of the shishijimicins. 
Respectively, β-carboline is reported to intercalate into double-stranded DNA35 and 
numerous β-carbolines have been able to cleave DNA under photoirradiation conditions.36 
Also, Shishijimicin 1.25A is the most potent of the shishijimicin family, in account of these 
findings and the extreme rarity of shishijimicin 1.25A, Nicolaou et al.
37
 recently reported the 
chemical synthesis of the carboline disaccharide domain of shishijimicin 1.25A. 
 
 
1.1.1.5. Kedarcidin 
 
The structure of the cyclic nine-membered kedarcidin, an antitumor enediyne, was first 
reported in 1991 as fermentation product of Actinomycete strain (L585–6).38 The enediyne 
antitumor antibiotic kedarcidin carries an intricate ansamacrocyclic bridge and two unique 2-
deoxysugar components. This complex chemical architecture and high level of reactivity 
accounts for several revisions on the reported structure of kedarcidin.
39,40
 Its structure was 
initially proposed by Leet et al. in 1992,
41
  the α-azatyrosyl fragment of the ansa-bridge was 
then revised to the interrelated β-amino acid derivative. In addition, the definitive structure of 
the entire molecule was amended by Hirama et al.
 42
 as 1.26 in 1997 and the total synthesis of 
1.26 was accomplished by Myers and coworkers in 2007.
43
 As a result of the total synthesis 
of 1.26, 
1
H NMR data enabled a further revision of the C10 stereochemistry as illustrated in 
structure 1.27 (Figure 1.2).
43
 
The work of Leet’s group proposed that kedarcidin 1.26 functions differently compared with 
the enediyne triggers reported to date.
41
 The identified cd distance in the stable enediyne has 
been determined at just 2.85 Å, 
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 which is considerably lower than necessary for spontaneous cyclisation.
87,88 
In light of this 
observation and the marginal decrease in the cd distance 2.82 Å upon epoxide opening, the 
role of the  epoxide  chemical protecting  group  is  not  to  inhibit  Bergman  cyclisation  by  
increasing the cd distance. Alternatively, it  is  understood  that  the  role  of  the  epoxide  
chemical  protecting group is to increase the ring strain engaged with the transition states of 
the Bergman cyclisation and therefore, to counteract its  occurrence. Deuterium labelled 
epoxide opening, afforded evidence for the theorised epoxide chemical protecting group 
(Scheme 1.6).
 
 
 
 
Reagents and Conditions: (a) NaBD4, CD3OD. 
 
Scheme 1.6: Original Reaction Pathway Suggested by Leet et al.
41
 (containing debated 
stereochemistry) 
 
 
1.1.1.6. C-1027 Chromophores 
 
In 1988, the cyclic nine-membered enediyne C-1027 chromophore 1.29 was isolated from 
culture filtrates of Streptomyces globisporus.
44
  The C-1027 is a representative of potent 
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antitumor antibiotic chromoproteins and consists of a nonprotein chromophore and its carrier 
apoprotein.
45
 The chromophore is very labile, but is considerably stabilised through specific 
binding to the apoprotein. If separated from the binding protein, the C-1027 chromophore 
1.29 has very limited stability in solution and has been demonstrated to undergo spontaneous 
cycloaromatisation via Masamune–Bergman rearrangement. The nine-membered enediyne 
moiety of 1.29 is unlike all the other enediyne natural products reported, which depend on 
external activators such as nucleophiles to instigate the electronic rearrangement. Uniquely, 
the nine-membered enediyne moiety of 1.29 spontaneously aromatises at room temperature 
without the presence of an activator.
46
 This high level of reactivity, alongside distinct 
structural features such as the chlorocatechol-containing ansa-bridge with atropisomerism, 
the highly strained bicyclo[7.3.0]trienediyne, the appended benzooxazine and the aminosugar 
present the inherent difficulty in achieving the total synthesis of 1.29.
47
 
 
 
 
Scheme 1.5: The Mechanism of DNA Cleavage by C-1027 Chromophore 
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1.1.1.7. N1999-A2 (NA2)  
 
The novel antibiotic N1999-A2 (NA2) 1.30, isolated from a culture supernatant of 
Streptomyces sp. AJ9493,
48
 contains a naphthoate moiety and a nine-membered ring enediyne 
chromophore (Figure 1.2). The molecular structure of NA2 1.30 is strikingly similar to that 
of neocarzinostatin chromophore (NCS-chr) 1.1 with the exception that neocarzinostatin 
chromophore consists of an aminoglycoside residue. NA2 1.30 is adequately stable during the 
isolation process despite the non-protein chromophores and this is of particular interest and 
differs significantly from the other nine-membered ring enediyne chromophore.  
To further investigate the stability of NA2 1.30 in solution, Miyagawa et al.
49
 scrutinised the 
DNA cleavage activity of NA2 1.30. The results indicated that NA2 1.30 was substantially 
stable at 37 °C and the decomposition rate of NA2 1.30 was considerably slower compared 
with NCS-chr 1.1. The intense DNA damage by NA2 1.30 was noticeably observed at 
thymidine and adenine base sites. The prevalence of the attacked bases was very similar to 
NCS-chr but different from C-1027 1.29, esperamycin A1 1.3, and calichemicin γ1 1.4. 
Nevertheless, a more random DNA cleavage profile of NA2 1.30 was observed when 
compared with NCS-chr 1.1. Miyagawa and co-workers
49
 suggested that the methylamino 
group of the NCS-chr 1.1 aminoglycoside moiety engages in the specific recognition of the 
thymine base by generating a hydrogen bond with the C2 carbonyl of the thymine base. 
Furthermore, the authors proposed that the naphthoate ring undergoes stacking interaction 
with DNA bases. 
Interestingly, NA2 1.30 can cleave DNA even in the absence of thiol agents whereas the 
activation of NCS-chr 1.1 relies on thiol agents such as dithiothreitol, methyl thioglycolate 
and glutathione.
50
 Alternatively, the presence of thiol agents increases the activation of NA2 
1.30 further.
50
 
 
 
1.1.1.8. Maduropeptin 
 
In 1991, a complex of macromolecular antibiotics known as Maduropeptin was isolated from 
the broth filtrate of Actinomadura madurae.
51
 According to reports, maduropeptin comprises 
of a 1:1 complex of an acidic, water soluble 32 kDa carrier protein. In addition, the 
maduropeptin possesses a nine-membered ring enediyne chromophore that carries remarkable 
antibacterial and antitumor properties (Figure 1.2).
52
 Schroeder et al.
52
 documented the 
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structure of the maduropeptin chromophore 1.31 and described the nine-membered ring diyne 
as the methanol adduct of a structurally unknown labile chromophore. Maduropeptin 
chromophore 1.31 demonstrates intense antitumor and antibacterial activities.
53
 However, the 
mechanism which accounts for these activities differs from similar enediyne natural 
products.
53
 The highly strained system 1.41, cycloaromatises spontaneously to the p-benzyne 
bi-radical which can effectively cleave DNA. In conclusion, 1.31 exhibits a stable, pro-drug 
version of the reactive nine-membered enediyne structure. Remarkably, the total synthesis of 
maduropeptin has recently been accomplished by Khan et al.
54
 
 
 
Scheme 1.4: The Mechanism of DNA Cleavage by Maduropeptin 
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1.1.1.9. Uncialamycin 
 
Only recently, the cyclic ten-membered enediyne uncialamycin 1.32 was collected in British 
Columbia, isolated from the surface of lichen Cladonia uncialis.
55
 Similar to dynemicin A 
1.6,
16,17
 the structure of uncialamycin 1.32, amalgamates a ten-membered enediyne with an 
anthraquinone substructure. Initial biological analyses demonstrated that 1.32 possesses 
potent in vitro antibacterial activity against to Staphylococcus aureus, Escherichia coli and 
Burkholderia apia.
55
 Although there was a small amount of product available (∼300 μg were 
isolated) the structure of 1.32 was resolved but attributing the absolute configuration of C26 
was not possible. Recently, research by Nicolaou et al.
56
 demonstrated unequivocal evidence 
for the structure of 1.32 in its entirety. Furthermore, the findings identified the absolute 
stereochemistry at C26 following total synthesis of the racemic mixture and reported the first 
asymmetric synthesis.
57
 Able to access sufficient quantities of 1.32 and its C26-epimer 1.33, 
Nicolaou and co-workers examined its biological properties in DNA-cleavage, antibacterial 
and cytotoxic activities. These studies indicated promising, high potent antitumor activities 
and broad-spectrum antibacterial properties.
57
  
 
 
1.1.2. The Bergman Cyclisation  
 
1.1.2.1. Pre-Bergman Cyclisation 
 
1.1.2.1.1. Work by Sondheimer 
 
Originally defined by Sondheimer in the early 1960s,
58
 an [n]annulene is a monocyclic 
hydrocarbon comprised of alternating single and double bonds. The annulenes have been 
studied extensively due to their potentially aromatic character.
59
 The synthesis of [6]-
annulene (benzene), and [8]-annulene (cyclooctatetraene) were reported in the early 20
th
 
century.
60
 The synthesis of the following compounds in the series was highly sought after, 
with particular interest given to the aromatic annulenes. According to Hückel’s rule,61 the 
following aromatic compounds of the series were the [10]-annulene and [14]-annulene, 1.45 
and 1.46 respectively. However, as it was previously pointed out, these two molecules cannot 
be planar in view of the steric interactions of the internal hydrogen atoms in the planar 
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molecules. Consequently, the [18]-annulene 1.47 appeared to be the first compound of the 
series to be genuinely planer. 
 
 
Figure 1.3: [10]-, [14]- and [18]-annulenes 
 
The major breakthrough in annulene chemistry was the synthesis of the fully conjugated 
macrocyclic polyenes; [18]-annulene (cyclooctadecanonaene) 1.47, [24]-annulene 
(cyclotetracosadodecaene) and [30]-annulene (cyclotriacontapentadecaene) by Sondheimer et 
al.
58
 This was then followed by work on the [14]-annulene 1.46 and it was intended that the 
[14]-annulene 1.46 could be synthesised by starting from base-induced elimination of 
cyclotetradeca-3,5,10,12-tetrayne-1,8-diyl dimethanesulfonate 1.48. However, when this 
compound was reacted with potassium hydroxide in methanol at room temperature, extensive 
transannular bond formation occurred and the reaction led to the unusual bicyclic compound 
1.50.
62 
 
 
 
Reagents and Conditions: (a) KOH, MeOH, rt, 1.49: 1%, 1.50: 15-20%. 
 
Scheme 1.7: Towards the Synthesis of [14]-Annulene  
 
When this reaction was carried out under more vigorous conditions (1.48 in a small volume  
of  dimethyl sulfoxide boiled  under  reflux with 7% potassium hydroxide in 95% aqueous 
methanol for 15 min.) neither of these substances were obtained, yet the three  tricyclic 5,6-
benzazulene derivatives 1.51, 1.52a-b and  1.53 were isolated.
63
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     Reagents and Conditions: (a) DMSO, 7% KOH, MeOH, H2O, reflux, 1.51: 25%,      
1.52a-b: 5%, 1.53: 9% 
 
Scheme 1.8: Cyclisation Reaction under more Vigorous Conditions 
 
Generally, Sondheimer et al.
62,63
 is regarded as the first group to synthesise the cyclisation 
product related to enediyne chemistry. The proposed mechanism of this cyclisation is that the 
eleven-membered ring of the bicyclic hydrocarbon 1.50 generates a fused ring-system by 
transferring hydride ion from methoxide under reflux. The product 1.53 is presumably 
formed via similar mechanism, the reactive intermediate 1.54 reacting with the formaldehyde 
prior to protonation. Similarly, the formation of compounds 152a and 1.52b is explained by 
the direct attack of methoxide onto bicyclic hydrocarbon 1.50. 
 
 
Scheme 1.9: Sondheimer’s Proposed Mechanism 
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1.1.2.1.2. Work by Masamune 
 
Masamune and co-workers also carried out extensive work into the formation of annulenes, 
particularly focusing on the synthesis of the [10]-annulene.
64,65
 This organic compound is 
a conjugated 10-π electron cyclic system and according to Hückel's rule it should 
display aromaticity. However, it is not aromatic because of a combination of steric 
strain and angular strain. During the synthesis of [10]-annulene, Masamune and co-workers 
obtained surprising products which were 3,4-benzocyclodec-3-ene-1,5-diyne 1.57 and 
1,2,3,4-tetrahydroanthracene 1.58 instead of the desired dehydro annulene 1.56. 
 
 
Reagents and Conditions: (a) NaOMe, MeOH. 
 
Scheme 1.10: Towards the Synthesis of [10]-Annulene 
 
Treatment of the dimesylate 1.55 with sodium methoxide produced both the bicyclic and 
tricyclic compounds 3,4-benzocyclodec-3-ene-1,5-diyne 1.57 and 1,2,3,4-tetrahydro 
anthracene 1.58, as shown in Scheme 1.10. The authors did not give a mechanism for the 
formation of 1,2,3,4-tetrahydroanthracene 1.58 but did give a suggested mechanism for the 
formation of 3,4-benzocyclodec-3-ene-1,5-diyne 1.57. The suggested mechanism proceeds 
via a “Cope-like” rearrangement. The proposed mechanism of the formation of compound 
1.57 is shown in Scheme 1.11. 
 
 
Scheme 1.11: Masamune’s Proposed Mechanism 
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Further studies by Masamune using an aromatic dimesylate 1.60 for the formation of 1,5-
didehydro-3,4-benz[10]annulene 1.61 yielded only anthracene 1.62 (Scheme 1.12). Use of 
the deuteriated solvents in the reaction showed that the two additional hydrogen atoms were 
inserted at the C9 and C10 positions. No mechanism for this reaction was suggested at the 
time but it was suggested that 1,5-didehydro-3,4-benz[10]annulene 1.61 was formed. 
Subsequently, it decomposed by an unknown mechanism to form anthracene 1.62. 
 
 
Reagents and Conditions: (a) KOH, MeOH. 
 
Scheme 1.12: Formation of Anthracene 1.62 
 
 
1.1.2.2. Bergman Cyclisation 
 
In the early 1970s Bergman and co-workers postulated that upon thermolysis, the parent cis-
hex-3-ene-1,5-diyne 1.63 containing  deuterium  in  the  acetylenic positions underwent a 
symmetry-allowed rearrangement to the reactive intermediate 1,4-didehydrobenzene 1.64.
66
  
Subsequently, this could collapse to the starting material or the rearrangement product 1.65. 
 
 
 
Scheme 1.13: Original work by Bergman et al.
66 
 
In order to trap the bi-radical species 1.64, this reaction was performed in a range of solvents. 
When cis-1,5-hexadiyn-3-ene 1.66 was heated in 2,6,10,14-tetramethylpentadecane at 200 °C
 
in 0.01M concentration of the starting material (to avoid polymerisation), benzene 1.67 was 
generated.
66,67
 Likewise, 1,4-dichlorobenzene 1.68, diphenylmethane 1.69 and benzyl alcohol 
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1.70 were obtained when using either CCl4, toluene or methanol as the  respective  solvents.
67
 
All these reactions provided further evidence for the occurrence of Bergman’s bi-radical 
intermediate 1.64; the results are shown in Scheme 1.14. 
 
 
 
Scheme 1.14: Trapping of Bi-radical   
 
The radical nature of the intermediate was further demonstrated by Grissom and co-workers 
when the bi-radical, generated in-situ from benzodiyne 1.71, was trapped via a double 
intramolecular 5-exo cyclisation onto two α,β-unsaturated esters (Scheme 1.15).68 The bi-
radical intermediate was formed using the Bergman reaction of benzodiyne 1.71 in 
chlorobenzene at 230 °C and with 1,4-cyclohexadiene as hydrogen atom donor.  
 
 
 
Reagents and Conditions: (a) PhCl, 1,4-cyclohexadiene, 230 °C, 6h, 99%. 
 
Scheme 1.15: Trapping the Bi-radical 
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Bergman’s report was the first to elucidate the details of this unusual transformation, despite 
its disguised appearance in the literature the previous year.  
The account by Masamune et al.
64,65
 showed the conversion of a cyclic, benzannulated 
enediyne to anthracene. Furthermore, Masamune’s explanation incorporated two H-atoms at 
the 9,10-positions of the product without direct implication of the now signature 1,4-diradical 
intermediate. 
 
 
Scheme 1.16: Masamune’s Work Explained by the Bergman Reaction 
 
Similarly, Sondheimer’s observations could also be explained by the formation of a bi-
radical.
58,62,63 
Since its discovery, the Bergman cyclisation has advanced many fields of endeavour such as 
mechanistic organic chemistry,
69
 material science
70,71
 and drug discovery.
72
 It has also 
provided a unique opportunity for testing the accuracy of computational methods.
73
 
 
 
1.1.3. Myers-Saito Cyclisation 
 
1.1.3.1. The Chemistry of Myers et al. 
 
To develop the work carried out on the neocarzinostatin chromophore 1.1, Myers et al.
74,75
 
replicated the cumulene system in an open chain as (Z)-1,2,4-heptatrien-6-yne 1.74. This led 
to the finding that the cumulene system goes through a first-order thermal reaction to yield an 
intermediary α,3-dehydrotoluene  bi-radical  1.75 (Scheme 1.17). 
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Scheme 1.17: Myers-Saito Cyclisation 
 
Fascinated by this newly unearthed reaction, Myers and co-workers tested the thermal 
cyclisation on rudimentary enyne-allene system 1.74. An intriguing reaction was detected 
between the acetylene and allene portions with creation of products 1.76, 1.77 and 1.78 
(Scheme 1.18). Their isolation was accredited to the transitional nature of bi-radical 1.75 
(Scheme 1.17).
75,76 
 
 
Reagents and Conditions: (a) 1,4-Cyclohexadiene, reflux, 0.003M, 1.76: 60%, 1.77: 20%, 
1.78: 20%. 
 
Scheme 1.18: First Reported Myers Cyclisation 
 
In succession, the formation of a bi-radical system was evidenced by experimental work; 
thermolysis of 1.74 in methanol and carbon tetrachloride supplied trapped products 1.79, 
1.80, 1.81 and 1.82 (Scheme 1.19).
75 
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Reagent and Conditions: (a) MeOH, 0.003M, 100 °C, 30 min., 1.79: 35%, 1.80: 10%; (b) 
CCl4, 0.003M, 100 °C, 30 min., 1.81+1.82: 15-25%. 
 
Scheme 1.19: Trapping Studies by Myers et al.
75
 
 
 
1.1.3.2. The Chemistry of Saito et al. 
 
Concurrently, Saito and co-workers were investigating the Bergman cyclisation and the 
disparity suggested by studies of neocarzinostatin chromophore 1.1.
77
 The work of Saito and 
co-workers initiated with the theory that interchange of one of the alkyne groups in the 
Bergman cyclisation for an allene 1.84, would significantly decrease the cd distance in the 
designed system. The formation of the desired starting material 1.84 was unsuccessful, 
resulting in the products 1.86 and 1.87 (Scheme 1.20). However, classification of the two 
prominent products triggered the hypothesis that the desired compound 1.84 had been formed 
and unexpectedly cyclised to generate the aromatic products detected. 
 
150 
 
 
 
Reagents and Conditions: (a) CCl4, 45 °C, 1.5h. 
 
Scheme 1.20: Reaction Development by Saito et al.
77
 
 
To validate the existence of the bi-radical intermediate 1.85, the reaction was replicated under 
adjusted conditions with 1,4-cyclohexadiene as a radical trap (Scheme 1.21).  
 
 
 
Reagents and Conditions: (a) 1,4-cyclohexadiene, 37 °C, 5h. 
 
Scheme 1.21: Radical Quenching with 1,4-Cyclohexadiene 
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After five hours, the reaction furnished the cyclised products 1.88 and 1.89 by following the 
suggested bi-radical intermediate 1.85, maintained by provision of hydrogen in the 
anticipated positions (Scheme 1.21). 
The Myers-Saito (C
2
-C
7
) cyclisation of enyne-allenes has been a hot topic in recent years 
since α,3-didehydrotoluene bi-radicals play an important role in DNA-cleavage reactions78 
and subsequent reactions of synthetic interest.
79
 
It is likely that the most comprehensively studied area of the synthetic utility of a Myers-
Saito type reaction includes the use of eneyne ketenes. These have been investigated by 
Padwa et al.
80,81
 and Nakatani et al.
82
 but most prominently by Moore et al.
83
 in a synthetic 
framework. The work by Moore et al.
83,84
 included the in-situ generation of an eneyne ketene 
from a substituted cyclobutene which then underwent a reaction analogous to the Myers-Saito 
reaction (Scheme 1.22). 
 
 
 
Reagents and Conditions: (a) p-Xylene, 135 °C, 75-80%. 
 
Scheme 1.22: Initial Work by Moore et al.  
 
In light of subsequent developmental work by Moore et al.
85
 and the protocols for 
derivatisation of squaric acid derivatives in the literature,
86
 the Moore reaction established a 
highly useful entry into the substituted quinones. Evidence of this usability can be found in 
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the synthesis of allylquinone 1.96, spirocycle 1.98 and benzocyclobutene 1.100 (Scheme 
1.23) by Moore et al.
85  
 
 
 
Reagents and Conditions: (a) p-Xylene, reflux, 76%; (b) Toluene, reflux, 91%; (c) p-Xylene, 
reflux, 49-64%. 
 
 Scheme 1.23: Examples of Moore Reactions 
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1.1.4. Factors Determining the Reactivity of Enediynes in the Cyclisation Processes 
 
1.1.4.1. Theory of Distances 
 
Early work on the synthesis and examination of enediyne fragments reinforced a relationship 
between the critical internuclear distance of the forming carbon-carbon bond and the 
cyclisation barrier.
87,88
 The acetylenic substitution determines this distance, which can also be 
affected by ring size if the acetylenes are linked via a larger macrocycle. Nicolaou et al.
87 
proposed that compounds with distances of less than 3.20Å should undergo spontaneous 
cyclisation. Alternatively, when distances were higher than 3.31Å the enediyne was relatively 
stable at ambient temperature. In conclusion, it was regarded that the length of 3.20-3.31Å 
was critical for reactivity. 
 
 
 
Figure 1.4: Calculated cd Distance: Effect on the Bergman Cyclisation. 
 
Following the calculation of activation energies of monocyclic enediynes of varying size,
89
 
Schreiner proposed the extension of this critical reactivity range to encompass internuclear 
distances covering 2.90-3.40Å.
89
  In conclusion of the enediyne reactivity analysis, Alabugin 
and Manoharan demonstrated that the critical distance of 3.20Å is characteristic of 
spontaneous cyclisation. This is explained by the attractive two-electron interaction of the in-
plane π-π/ orbitals outweighing the repulsive contribution of the π-π interaction.90 
Similar to the arrival of aromatic systems from enediynes as a result of Bergman cyclisation, 
(Z)-hepta-1,2,4-trien-6-ynes are able to yield cyclised systems via α,3-didehydrotoluene 
diradicals. In contrast to Bergman cyclisation, acyclic enyne-allenes 1.101 and 1.103 react in 
accordance to Myers-Saito at ambient temperatures.
91,92  
Furthermore, the reaction of cyclic 
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enyne-allenes is similar to acyclic analogues and neocarzinostatin demonstrates biological 
activity through the instigation of such reaction.
93
 
 
 
 
Reagents and Conditions: (a) 24h, 37 °C or 30 min., 75 °C; (b) 70 min., 37 °C. 
 
Scheme 1.24: Myers-Saito Cyclisation 
 
Furthermore, metal coordination has been demonstrated as a potentially useful approach for 
enabling Bergman cyclisations under reasonably mild conditions.
 94
 
 
 
 
Scheme 1.25: Decreasing the cd Distance with Metal Coordination  
 
In the absence of metal-ion complexation, the bipyridyl unit in 1.105 occurs in the transoid 
conformation which drives the terminal acetylenic carbon atoms to be far apart. Once metal-
ion binding takes place, the 2,2’-bipyridyl unit alters into a cisoid conformation that allows 
the bidentate ligands to coordinate to the metal ion. During the process, the cd distance 
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decreases and an increase in thermal reactivity is expected, this was indeed the case. The 
thermal stability of compound 1.105 and its Hg
2+
 complex 1.106 exhibited significant 
difference. Although a temperature of approximately 237 °C is required to induce irreversible 
thermal cyclisation of 1.105, the Hg
2+
 complex 1.106 reacts at approximately 145 °C. 
Furthermore, there have been fewer studies carried out on derivatives with increased 
cyclisation barriers; the large activation energy necessary for even unconstrained enediynes
95
 
may account for this. For example, the presence of the two propyl groups on enediyne 1.108 
significantly increases the temperature necessary for cyclisation relative to 1.107. To date, 
one of the most impeded systems investigated is (Z)-1,6-diphenylhex-3-ene-1,5-diyne 1.109 
which reacts at 280 °C.
96
  
 
 
 
Figure 1.5: Examples of Enediyens that Undergo the Bergman Cyclisation 
 
Unexpectedly, Lewis et al.
97
 discovered that specific enediynes induce products that are not 
simply the results of cycloaromatisation but most probably derive from an initially formed 
1,4-didehydroarene and involve one or more phenyl shifts. An example of this can be found 
in the reaction of 1,2-bis(phenylethynyl)benzene 1.110, which yielded the expected isomer 
2,3-diphenylnaphthalene 1.112 as a minor product (<3% yield) under all conditions studied.
97
 
The dominant species formed were 1,3-diphenylnaphthalene 1.113 (16%) and 1,4-
diphenylnaphthalene 1.114 (11%), resulting from single and double phenyl shifts, 
accordingly. 
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Scheme 1.26: Reaction of Diphenyl-Substituted Diethynylbenzene and Observed Phenyl-
Shifted Products 
 
 
1.1.4.2. Effect of Strain in the Chromophore of Cyclic Enediyne 
 
The increase in the number of species characterised, prompted the task of finding an adequate 
explanation for the lowering of the cyclisation activation barrier.
98
 This resulted in the 
proponent theory of strain release across the reaction coordinate. It was proposed that 
difference in molecular strains between the ground and transition states serves as the 
mainspring for cyclisation.
99,100
 Furthermore, the use of fused ring systems, decreasing the 
ring strain in moving from the reactant to product became just as significant a factor in 
rationalising lower activation barriers.
101
 
Basak et al.
102
 presented the outcome of a distant double bond in a pyridazine system 
assimilated into the enediyne ring on the kinetics of Bergman cyclisation. Basak and co-
workers discovered that saturation of the distant double bond quickens the process of 
cycloaromatisation and impacts on the instigating mechanism of this reaction. For this reason, 
14-oxa-1,19-diazatricyclo[13.3.1.0]nonadeca-5(10)6,8,15(19),16-pentaene-3,11-diyn-18-one 
1.115 and its dihydro analogue, 14-oxa-1,19-diazatricyclo[13.3.1.0]nonadeca-5(10),6,8,15 
(19)-tetraene-3,11-diyn-18-one 1.119 were synthesised and their capacity to go through 
cycloaromatisation in the solid phase was examined.  
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Scheme 1.27: Cycloaromatisation of Compound 1.115 
 
 
 
Scheme 1.28: Cycloaromatisation of Compound 1.119 
 
The previously mentioned solid-phase reaction was observed by differential scanning 
calorimetry. Both enediynes exhibited an intense exothermic peak at 228 °C and 196 °C for 
compounds 1.115 and 1.119, correspondingly. Although the cd distances in the molecules of 
both enediynes are equivalent (3.79Å), saturation of the C4=C5 bond in the heteroring alters 
the activation barrier to Bergman cyclisation. These findings signify a significantly higher 
reactivity of enediyne 1.119 in comparison to 1.115 and reveal the value of hybridization of 
carbon atoms in the heterocyclic chromophore.  
Work by Magnus and Snyder also showed that the cycloaromatisation was not always due to 
a short cd distance.
103
 Compounds 1.123 and 1.126 were synthesised and X-ray analysis of 
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compounds 1.123 and 1.126 showed that the cd distance of bicycle[7.2.1]-enediyne 1.126 
was shorter than that of compound 1.123. However, although enediyne 1.126 had the shortest 
cd distance, its cycloaromatisation reaction proved to be the most difficult (see rate constants 
on Scheme 1.29).  
 
 
Scheme 1.29: Rate of Cyclisation of Bicylo[7.3.1] and [7.2.1]-Enediynes 
 
In a series of photochemically activated molecules, increased reactivity for designed 
enediynes with high strain was noted.
104
 In this particular research, the internuclear distance 
spanned from 3.89-4.94Å. In contrast to the critical distance hypothesis, the per cent 
conversion at the longest distance was 100%, while at the shortest was only 66%. 
Undoubtedly, both strain release and the distance between cycloaromatising carbons play a 
part in influencing the reactivity of enediynes.  
 
 
1.1.4.3. Effect of Electronic Factors  
 
Kim and Russell developed a program for studying the effects of aromaticity and electronic 
factors on the rate of cycloaromatisation and showed that the distance between the acetylenic 
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branches (cd), the strain energy of cyclic enediynes and electronic factors considerably affect 
the formation of diradicals.
105
 Systematic studies on 1,2-dialkynylbenzenes 1.129a-f revealed 
a linear free energy relationship between the Bergman cyclisation rate and the Hammett δm 
substituent coefficient (Table 1.3).
106
 
 
 
 
Reagents and Conditions: (a) PhCl, 1,4-cyclohexadiene. 170 °C, yields, see Table 1.3. 
 
Scheme 1.30: Thermolysis of Enediynes 1.129a-f 
 
Compound k x 10
-2
, s
-1
 J1/2, min Yield (%) 
 
1.129a 
 
2.54 
 
11.8 
 
- 
1.129b 1.93 15.6 63 
1.129c 4.66 6.5 65 
1.129d 5.08 5.9 78 
1.129e 5.78 5.2 60 
1.129f 7.03 4.3 59 
 
Table 1.3: Kinetic Parameters of the Bergman Cyclisations of Compounds 1.129a-f 
 
Weak interactions induce appreciable change in the activation profile of well-known 
medically important enediynes.
107
 Strong electron-withdrawing groups increase the barrier to 
Bergman cyclisation,
108
 while δ-donor groups reduce its height. The effect of π-conjugation is 
weak. Alabugin et al.
109
 estimated stereoelectronic effects in cyclohexane-, 1,3-dioxane-, 1,3-
oxathiane- and 1,3-dithiane-substituted enediynes. Rawat and Zaleski demonstrated steric 
effect of functional groups in terminal acyclic enediynes on their cycloaromatisation 
according to Bergman cyclisation.
110
 Basak et al.
111
 were the first to report on the synthesis 
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and donor-acceptor properties of a series of 1,2-dialkynylbenzenes 1.131-1.133 and on the 
effect of charge transfer and π-π interactions on the kinetics of Bergman cyclisation. 
 
 
R
1
, R
2
 = H, 2-NO2, 4-NO2, 4-CN, 3-CF3, R
3
 = H, 4-OMe 
 
Scheme 1.31: Series of 1,2-Dialkynylbenzenes 1.131-1.133 Synthesised by Basak et al.
111
 
 
Using differential scanning calorimetry, the thermal reactivity of donor-acceptor and donor-
donor pairs was shown to be higher than that of acceptor-acceptor couples.
111
 The difference 
was attributed to intramolecular charge transfer and π-stacking between the two branches, 
which shorten the cd distance. 
Additionally, stabilisation of either the enediyne or the bi-radical by conjugation and/or 
substitution by heteroatoms can play a role.
112
 
 
 
1.1.5. Thermal C1-C5 Diradical Cyclisation of Enediynes 
 
Schreiner et al.
113
 employed computational studies for the parent enediyne 1.134a, which 
demonstrated a significantly higher barrier for the C
1
-C
5
 diradical cyclisation than for the C
1
-
C
6
 pathway. Nevertheless, this partiality can be reversed and the thermal C
1
-C
5
 diradical 
cyclisation is a significant and sometimes primary reaction in diaryl-substituted enediynes.  
In sterically challenging systems, theoretical calculations suggest that the difference in energy 
between five- and six-membered ring formation is considerably reduced.
113
 To assess the 
feasibility of C
1
-C
5
 cyclisation, Pascal et al.
114
 computationally screened a number of 
benzannulated enediynes substituted with an aryl group at one alkyne terminus; the results 
are displayed in Table 1.4. 
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Scheme 1.32: Thermolysis of Enediynes 1.134a-f 
 
Entry Compound R Ea (C
1
-C
6
) Ea (C
1
-C
5
) 
     
1 1.134a H 24.6 37.2 
2 1.134b phenyl 28.7 31.4 
3 1.134c 2,6-dichlorophenyl 30.8 31.6 
4 1.134d 2,6-dichloro-4-nitrophenyl 31.8 31.6 
5 1.134e 2,6-dichloro-4-aminophenyl 30.7 30.4 
6 1.134f 2,6-dimethylphenyl 30.5 30.9 
 
Table 1.4: Activation Energies (kcal/mol) for the Cyclisations of Monosubstituted 1,2-
Diethynylbenzenes 
 
The examination of entries 1 and 2 indicates that the activation energy for Bergman 
cyclisation increases by 4 kcal/mol when the hydrogen atom is replaced by a phenyl group 
(likely a steric effect). However, this is not the case for the C
1
-C
5
 pathway which decreases 
by 6 kcal/mol; this effect is explained by stabilisation of the emerging vinyl radical centre in 
the C
1
-C
5 
pathway and is apparent in the short phenyl-C6 bond (bond b) in the transition 
state. These particular effects do not occur in the Bergman pathway but the C
1
-C
6
 cyclisation 
maintains strong partiality for 1.134b. Nonetheless, when a 2,6-dichlorophenyl group is 
substituted for phenyl (1.134c), increased steric effects continue to slow the Bergman 
reaction and the contending transition states’ are brought to within 1 kcal/mol. The addition 
of either a nitro (1.134d) or an amino group (1.134e) to the aryl ring causes the activation 
energies of the C
1
-C
6
 and C
1
-C
5
 cyclisations to equalise at this level of theory. 
Remarkably, thermolysis of 1.135 in toluene at 260 °C in the presence of 1,4-cyclohexadiene 
gave indene derivatives 1.136 and 1.137 (Scheme 1.33) in 19% and 50% isolated yield, 
accordingly. The observed products 1.136 and 1.137 reportedly arise from the C
1
-C
5
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cyclisation of enediyne 1.135. Intriguingly, no Bergman cyclisation product was observed in 
these reaction mixtures. 
 
 
 
Reagents and Conditions: (a) Toluene, 260 °C, 1,4-cyclohexadiene, 1.136: 19%, 1.137: 50%. 
 
Scheme 1.33: Thermolysis of Enediyne 1.135 
 
 
1.1.6. The Schmittel Reaction 
 
Whilst carrying out an investigation into increasing the activation energy of the Myers-Saito 
reaction, Schmittel discovered a novel reaction route. This led to an alternative bi-radical 
intermediate 1.139 to that reported by Myers and Saito.
115
 As a consequence of the 
introduction of bulky groups onto the allene and alkyne units, Schmittel was aiming to 
cultivate a more stable allene intermediate 1.138 that would advance the investigation into the 
Myers-Saito.
116
 On the contrary, Schmittel reported a 63% yield of product 1.140 formed via 
a C
2
-C
6
 cyclisation over the Myers-Saito (C
2
-C
7
). 
 
 
Reagents and Conditions: (a) 1,4-cyclohexadiene (excess), benzene, reflux, 63%. 
 
Scheme 1.34: Thermolysis of Enyne-Allene 1.138 
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Investigations which employ experimental and computational mechanistic methods indicated 
that these transformations progress via diradical intermediates.
117
 The enyne-allene systems 
(Scheme 1.35) have been accounted for by two alternative cyclisation paths: C
2
-C
7
 and C
2
-C
6
 
cyclisations. 
 
Scheme 1.35: The Myers-Saito and the Schmittel Cyclisations 
 
For the enyne-allene system, the formation of aromaticity is the mainspring for the Myers-
Saito (C
2
-C
7
) cyclisation. The Schmittel (C
2
-C
6
) route is also energetically preferred in 
account of the carbon hybridization conversion from sp to sp
2
. Nevertheless, the C
2
-C
7 
cyclisation is normally favoured and relevant substitutions on alkyne termini are commonly 
required for adjusting the regioselectivity to C
2
-C
6 
cyclisation. However, the capability to 
construct a 5-membered ring secures the Schmittel cyclisation as an original strategy for 
complex poly aromatic structure construction. 
A system which would select Schmittel’s (C2-C6) cyclisation over Myers-Saito (C2-C7) was 
opportunely
 
developed by Rodriguez.
118
 More specifically, the steric hindrance supplied by a 
trimethylsilyl group on alkyne 1.144 favoured Schmittel’s C2-C6 cyclisation to yield tricycle 
1.145. However, at the withdrawal of the TMS group to yield the terminal alkyne 1.146, 
Myers-Saito C
2
-C
7
 cyclisation was favoured to give 1.148 and 1.149 as visualised by 
Schmittel. Respectively, the more hindered trimethylsilyl protected alkyne depended on a 
higher reaction temperature for the cyclisation to actualise. 
Also, the regioselectivity of the cyclisation is used in the synthesis of the kinamycin
119
 and 
the neocryptolepine
120
 families in addition to the preparation of large hydrocarbons.
121
 
Furthermore, it becomes relevant in studying the DNA cleavage.
122
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     Reagents and Conditions: (a) Toluene, 110 °C; (b) K2CO3, MeOH; (c) Toluene, MeOH,       
70 °C; (d) Toluene, 1,4-cyclohexadiene, 70 °C. 
 
Scheme 1.36: Mode Change due to Sterics 
 
Photochemical analogues of the Bergman cyclisation of acyclic
 123,124 
and cyclic
125
 enediynes, 
as well as of natural antibiotic Dynemicin A
126 
and other photochemically activated enediyne 
processes have spurred a number of research studies, in account of their potential application 
to photodynamic therapy (PDT).
127
  On the contrary, photochemical analogues of the Myers-
Saito or the C
2
-C
6
 cyclisation of enyne-allenes have endured obscurity. 
Schmittel disclosed photochemical reactions of enyne-heteroallenes,
128
 these cyclisations 
emerged very effectively along the C
2
-C
6
 but intriguingly, not via the C
2
-C
7
 (Myers-Saito) 
pathway. Subsequent theoretical studies by Engels accounted for the preference for the C
2
-C
6
 
route, illustrating that the process is triggered by triplet sensitisation.
129
 Furthermore, for a 
photochemical enyne-allene cyclisation to be effective, the study advised the avoidance of 
benzannulated derivatives as a result of their high excitation energy. Schimittel et al.
130
 
demonstrated that photochemical C
2
-C
7
 and C
2
-C
6
 cyclisations of enyne-allenes can be 
activated when specially designed systems are employed. 
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Reagents and Conditions: (a) Toluene, hv, 1,4-cyclohexadiene, 1.153: 15%, 1.154: 15%. 
 
Scheme 1.37: Enyne-Allene Cascade Cyclisation (Photo condition reported by Schmittel) 
 
The cyclisation products 1.153 and 1.154 were produced in relatively small yields (15%) with 
limited selectivity (1:1). It was predicted that the diradical conformers 1.151 and 1.152 were 
in equilibrium. To acquire the sequential cyclisation product 1.154, Wang suggested a 
different thermal strategy which utilised a bulky tert-butyl group to drive the diradical 
equilibrium towards the 1.152 conformer.
131
 Compound 1.157 was then effectively acquired 
with improved yields. Following this, Wang et al.
132
 demonstrated the synthetic utility of this 
method for the foundation of heteroaromatic and polyaromatic structures. 
 
Reagents and Conditions: (a) Toluene, KO-t-Bu, reflux, 12h, 90%. 
 
Scheme 1.38: Enyne-Allene Cascade Cyclisation (Thermal condition reported by Wang
132
) 
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Although the C
2
-C
6
 cyclisation was mechanistically intriguing and synthetically encouraging, 
there were limitations. To begin with, the reaction conditions demanded high temperature and 
the total efficiency was low. Following this, the sterically hindered group was needed to drive 
the equilibrium to conformer 1.152 for successful aromatic cyclisation, hence limiting the 
reaction capacity. Recently, Wang et al.
133
 disclosed the triazole-gold (TA-Au, 3 mol%) 
catalysed propargyl vinyl ether cascade rearrangement and cyclisation, to produce the 
preferred benzannulated indenes at room temperature. 
 
 
 
Reagents and Conditions: (a) TA-Au (3%), CH2Cl2, rt; (b) NaBH4, MeOH, 1.161: 33%. 
 
Scheme 1.39: The Schmittel Cyclisation at Room Temperature  
 
The 1,3-rearragnement of propargyl ether 1.158 would produce the trisubstituted allene 
1.159. In the presence of the photocyclisation condition (Scheme 1.37), the diradical 
intermediates proceeded via two alternative reaction paths which should induce the formation 
of 1.161 and 1.160. Notably, the TA-Au catalysed conditions produced 1.161 exclusively as 
the cyclisation product. One possible explanation for this might be the mild reaction 
conditions that preferred the aromatic cyclisation instead of the elimination (formation of 
1.160), emphasising the greatly improved selectivity of this method when compared with 
thermal and photo conditions. Altering the alkyne termini substituents from Ph to TMS 
enabled the successful isolation of the suggested allene intermediate 1.163, which supplied 
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additional concrete evidence for the proposed mechanism and the rare reactivity of TA-Au 
(activation of the alkyne over the allene). 
 
 
 
Reagents and Conditions: (a) TA-Au (3%), rt, CH2Cl2; (b) NaBH4, MeOH, 1.163: 23%. 
 
Scheme 1.40: Confirmed Allene Intermediate 
 
 
1.1.7. A Novel Cyclisation by Parsons et al. 
 
1.1.7.1. Studies Towards the Total Synthesis of Lactonamycin 
 
Matsumoto et al.
134
 were the first to report the propitious antibiotic Lactonamycin 1.164 from 
Streptomyces rishiniensis cultures.  
 
 
 
 
Figure 1.6: Lactonamycin 
 
Lactonamycin 1.164 exhibits a plethora of biological activities with potential medicinal use. 
Most prominent of these, is the potent activity demonstrated against methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
135
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Additionally, the antibiotic displays antitumor activity against a number of malignant 
cancerous cell lines. 
As a result of its complex chemical structure and conspicuous biological activity, many 
research groups have worked on the synthesis of lactonamycin in the laboratory.
136
 However, 
achievements of this kind are rare and only one total synthesis has been accomplished to 
date.
137
 The Parsons et al. has been concerned with the total synthesis of lactonamycin for 
several years and initially aimed to acquire the construction of the core CDEF fused ring 
structure.
138,139
 The selected retrosynthetic approach is illustrated in Scheme 1.41 below. 
 
 
 
Scheme 1.41: Retrosynthetic Analysis of Lactonamycin by Parsons et al.
138,139
 
 
Advanced intermediate 1.165 could be accessed by a single synthetic manipulation of 1.166 
or 1.167. In order to test the feasibility of the above cascade sequence, a model system 1.168 
was synthesised (Scheme 1.42) The amide 1.168 was constructed with the aim of conducting 
either a palladium
140
 or radical
141
  cascade sequence
142
 to form the structurally complex core 
CDEF fused ring structure of lactonamycin 1.164.
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Reagents and Conditions: (a) Benzene, radical initiator, reflux, time, yield, see Table 1.5. 
 
Scheme 1.42: Thermal Cyclisation of Precursor 1.168 
 
Entry Radical initiator Time (h) Yield (%) 
 
1 
 
n-BuSnH/AIBN 
 
11 
 
14 
2 (Me3Si)3SiH 72 22 
 
Table 1.5: Radical Cyclisations of 1.168 
 
Two contrasting cyclisation conditions were administered to the material, resulting in a 
higher yield in tris(trimethylsilyl)silane than tri-n-butyltin hydride. However, both reactions 
were notably effected by excessive decomposition. A further study on thermal stability 
employed the technique of boiling 1.168 alone in benzene for 40 hours.
143
 Most interestingly, 
this procedure gave a higher yield (26%) than any of the radical initiators previously used. 
This process revealed that the reagents used in the palladium or radical mediated cyclisations 
accounted for the decomposition. Subsequently, it was concluded that the reaction was 
thermally activated which led to the testing of a variety of solvents and temperatures. The 
model alkyne 1.168 was heated under reflux in toluene for 24 hours which afforded the 
desired tetracyclic compound 1.169 in 50% yield. Furthermore, in the presence of an acid 
trap (1-epoxyhexene) the yield of the reaction was advanced to 76%.  
Originally, it was proposed that the cyclisation may have occurred via an acid-catalysed 
pathway. This was explained by the possible formation of hydrogen bromide under the 
reaction conditions. 
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Scheme 1.43: Proposed Acid-Catalysed Mechanism for the Formation of Compound 1.169 
 
However, as mentioned previously when 1-epoxyhexene was added to the reaction mixture, 
the yield of the product was increased. As a result, an acid catalysed pathway was likely to be 
discounted. In order to substantiate this hypothesis, the cyclisation reaction of compound 
1.172 was examined.
144
 In this particular test, the generation of acid was not possible during 
the reaction. Consequently, if the reaction was acid catalysed then it would yield no product. 
On the contrary, in the absence of acid scavengers thermolysis of 1.172 in toluene furnished 
two new products. 
 
 
 
Reagents and Conditions: (a) Toluene, reflux, 0.1M, 6h, 1.173: 76%, 1.174: 9%. 
 
Scheme 1.44: Thermal Cyclisation of Precursor 1.172 
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The isolation of compound 1.173 disproved the previous acid-catalysed theory, as bromine 
was not present in the molecule to produce catalytic quantities of hydrogen bromide in 
solution. Of particular interest, was the unexpected formation of product 1.174.  Its structure 
disclosed that the lower alkynyl portion in 1.172 failed to participate in the cyclisation and 
that two extra hydrogen atoms were incorporated during the course of the reaction. As a 
result of these observations, the mechanism in Scheme 1.45 was put forward. 
 
 
 
Scheme 1.45: Postulated Mechanism for the Formation of Compounds 1.173 and 1.174 
 
In the proposed mechanism, alkyne 1.172 cyclises to produce a concentration of bi-radical 
1.175 which in succession could give bi-radical 1.176 by intramolecular 1,5-hydrogen atom 
abstraction and tautomerism. The bi-radical 1.176 reacted intramolecularly, yielding 
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tetracycle 1.177 followed by isomerisation to phenol 1.173. On the other hand, the bi-radical 
1.176 could hydrogen-abstract from the solvent to generate enol 1.178 which is in 
equilibrium with the observed product 1.174. 
 
 
1.2. Ene Reactions Involving Triple Bonds 
 
1.2.1. The Propargylic Ene Reaction 
 
The ene reaction is mechanically linked to the well-known and more commonly applied 
Diels-Alder reaction, proceeding via a cyclic transition state comprising of six electrons. The 
intramolecular ene reaction is a well-known procedure,
145
 however, there are just a few cases 
in the literature where the “ene” component is an alkyne with propargyl hydrogen instead of 
an alkene with an allylic hydrogen. The propargylic ene reaction generates an allene, which 
may engage in supplementary reaction in a tandem mode.  
In 1973, Oppolzer identified the first propargylic ene reaction.
146
 The reaction illustrated 
below occurred at a significantly reduced temperature than the equivalent 1,6-dialkene ene-
cyclisations. 
 
 
 
Reagents and Conditions: (a) Neat, 210 °C, 2h, 43%. 
 
Scheme 1.46: First Example of Propargylic-Ene Reaction by Oppolzer et al.
146
 
 
A mechanistic explanation was not put forward for the above reaction. However, it was 
suggested that the reaction occurs via an ene-mechanism.  
In 1988, Shea et al.
147
 identified an unfamiliar by-product from the attempted intramolecular 
Diels-Alder reaction of dienyne 1.181. The authors reported 1,2-cyclooctadiene 1.182 as the 
intermediate in this reaction, in account of a propargylic ene transformation of dienyne 1.181.  
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Reagents and Conditions: (a) Neat, 420 °C, 12%. 
 
Scheme 1.47: Work by Shea et al.
147
 
 
This mechanism for the conversion of 1.181 to 1.183 is supported by deuterium labelling 
experiments.
147 
 
 
 
 
Scheme 1.48: Deuterium-labelling Studies by Shea et al.
147
 
 
A concerted propargylic-ene reaction with attendant 1,6-hydrogen abstraction produces cyclic 
allene 1.185. The second step of the rearrangement was assumed to proceed through a retro-
hetero ene fragmentation consisting of a 1,5-hydrogen abstraction step.
147
 
In 2003, Pérez proposed a propargylic ene reaction as the decomposition route for a 1,6-diyne 
substrate that was being examined in Pd-catalysed [2+2+2] cycloadditions with benzene.
148
 
After standing at room temperature, 1.187 was converted into a compound with the assigned 
structure of 1.188. Pérez and co-workers did not identify any spectral data for 1.188, claiming 
that it “finally evolved into a mixture of dimers.” 
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Reagents and Conditions: (a) Neat, rt. 
 
Scheme 1.49: Work by Pérez et al.
148
 
 
Allene 1.188 is a highly reactive s-cis vinylallene, which accounts for the difficulty in it 
being isolated. In addition, vinylallenes are reactive dienes in Diels-Alder reactions.  
In 2006, Altable and co-workers proposed an intramolecular ene reaction of 1,6-
fullerenynes.
149
 The authors were aiming to extend the [2+2] cycloaddition of 1,6-
fullerenynes to produce cyclobutene derivatives to contain non-terminal alkynes. Instead, 
they discovered efficient formation of allene derivatives (Scheme 1.50). 
 
 
 
Reagents and Conditions: (a) PhCl, reflux, 3h, 99%. 
 
Scheme 1.50: Work by Altable et al.
149 
 
In 2010, Roglans and co-workers reported a domino process combining an ene reaction 
between two alkynes and a Diels-Alder cycloaddition of the vinylallene formed. The process 
accounts for the thermally induced cycloisomerisation of cyclic enediyne 1.191 to give fused 
tetracycle 1.192.
150
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Reagents and Conditions: (a) Toluene, reflux, 30h, 32%. 
 
Scheme 1.51: Work by Roglans et al.
150
  
 
The addition of a excess of 1,4-cyclohexadiene to the reaction mixture was found to increase 
the yield of the above reaction to 77% yield.
150 
Initially, this discovery led the authors to 
propose that a bi-radical mechanism is in operation, comparable to that suggested by Parsons 
et al.
138,139
 for their reaction. Nonetheless, EPR studies carried in the presence of radical traps 
were unsuccessful in confirming the presence of radical intermediates and alternatively, a 
propargylic-ene mechanism was proposed.
150
 
Recently, Danheiser et al.
151
 reported the use of an intramolecular cyclotrimerisation between 
two alkynes and a cyano group for the synthesis of substituted pyridines. A selected example 
is illustrated below (Scheme 1.52). 
 
 
 
Reagents and Conditions: (a) Toluene, 0.1M, 160 °C, 21h, 71%. 
 
Scheme 1.52: Work by Danheiser et al.
151 
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The proposed mechanism involves a intramolecular propargylic-ene reaction between the 
1,6-diyne with consequent Diels-Alder cycloaddition of the resulting vinylallene with the 
cyano group (Scheme 1.53).
151 
 
 
 
Scheme 1.53: Proposed Mechanism Postulated by Danheiser et al.
151
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Chapter 2. 
Results & Discussion 
 
 
The development of novel strategies equips the synthetic chemist with techniques to 
synthesise interesting drug-like molecules. However, due to the complexity of many 
pharmaceutical drug molecules, long multi-step syntheses are necessary to construct the final 
compound. As a result, large amounts of reagents, solvents and energy are required, leading 
to a substantial quantity of waste production at each stage of synthesis. This has instigated 
growth in the research and development of greener tandem reactions, which conjoin multiple 
steps in a one-pot process, for the synthesis of complex organic molecules. The Parsons et al. 
recently developed a novel thermal cyclisation reaction as described in Chapter 1. This 
reaction could generate a bi-radical species and after being trapped with a suitable alkene or 
alkyne, could lead to the formation of tetracyclic molecules comprising heterocyclic cores. 
Therefore, we wish to further investigate this novel reaction and develop tandem reaction 
methodology around it.  
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2.1. Novel Cyclisation of 1,6-Diyne 2.1 for the Generation of Tricycle 2.2 
 
2.1.1. Outline of Investigation  
 
The aim of this DPhil research project was to devise and execute a series of experiments with 
the intention of gaining a better mechanistic understanding of the novel thermal cyclisation 
discovered by Parsons et al.
138,139
 (Scheme 2.1). 
 
 
 
Reagents and Conditions: (a) Toluene, reflux, 76%. 
 
Scheme 2.1: Original Cyclisation Discovered by Parsons et al.
138,139
 
 
To further investigate the mechanism and scope of the cyclisation, the model system 2.1 was 
proposed (Scheme 2.2). Removal of the aromatic portion of the precursor and conversion of 
the alcohol to an ether linker was used to increase the versatility of the cyclisation model. 
These structural modifications would enable greater diversifications and more widely 
applicable methodology for the construction of polycyclic systems. 
 
 
 
Reagents and Conditions: (a) Toluene, reflux. 
 
Scheme 2.2: Aim within this Thesis. 
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An overview of our retrosynthetic plan is depicted in Scheme 2.3. In this analysis, cyclisation 
precursor 2.1 was disconnected at the amide linkage. This process revealed the carbamate 
fragment 2.3 and the carboxylic acid fragment 2.4 as the first target of our synthesis. 
 
 
 
Scheme 2.3: Retrosynthetic Analysis of Cyclisation Precursor 2.1 
 
The retrosynthetic approach for the coupling precursor 2.3 is depicted in Scheme 2.4 below. 
 
 
Scheme 2.4: Retrosynthetic Analysis of the Carbamate Fragment 2.3  
 
Deprotonation of the N-Boc amine 2.6 and subsequent quenching with paraformaldehyde 
should afford the propargylic alcohol 2.5. This can be manipulated to form the methyl ether 
2.3, ready for coupling with carboxylic acid fragment 2.4 to form the cyclisation precursor 
2.1. 
In addition, the carboxylic acid fragment 2.4 can be readily synthesised by oxidation of the 
deprotected alcohol 2.8. The protected alcohol 2.9 can be generated by reaction of alkyl 
chloride 2.10 and the Grignard reagent derived from allyl bromide. Alkyl chloride 2.10 can 
be easily synthesised by deprotonation of the alkyne 2.11 and subsequent quenching with 
chloro(chloromethyl) dimethylsilane. Furthermore, compound 2.11 can be obtained from 
commercially available propargyl alcohol 2.12 (Scheme 2.5). 
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Scheme 2.5: Retrosynthetic Analysis of Carboxylic Acid Fragment 2.4 
 
 
2.1.2. Synthesis of Cyclisation Precursor 2.1 
 
2.1.2.1. Investigation of Nitrogen Protection/Deprotection Sequence 
 
It was necessary to protect N-methylpropargyl amine 2.7 at the nitrogen atom, in order to 
selectively deprotonate the terminal alkyne position (pKa ~ 25 in H2O
152,153
). An additional 
factor to consider was that deprotonation by strong bases of the propargylic protons α to the 
nitrogen atom can be a contending possibility, as indicated in Scheme 2.6 for a selected 
example.
154
  
 
 
 
Reagents and Conditions: (a) t-BuOK, THF, 0 °C, 10 min., 88%. 
 
Scheme 2.6: Work by Maddaluno et al.
154 
 
Therefore, the optimal protecting group for N-methylpropargyl amine 2.7 should replace the 
proton on the nitrogen atom whilst sterically hindering the propargylic position. One of the 
most frequently used groups for amine protection in organic synthesis is tert-butyl 
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carbamate.
155
 This group is stable to nucleophilic, strong bases and is also moderately bulky. 
The adaptation of the Boc protecting group for the synthesis of amine fragment 2.3 is 
illustrated in Scheme 2.7 below. 
 
 
 
Reagents and Conditions: (a) Di-tert-butyl dicarbonate, pyridine, CH2Cl2, 0 °C to rt, 16h, 
96%; (b) n-BuLi, THF then paraformaldehyde, -78 °C to rt, 16h, 78%; (c) MeI, KOH, 
DMSO, rt, 16h, 90%. 
 
Scheme 2.7: The Use of Boc Protecting Group for the Synthesis of Amine Fragment 2.3 
 
Protection of N-methylpropargyl amine 2.7 with di-tert-butyl dicarbonate in the presence of 
pyridine afforded the N-Boc-N-methyl propargylamine 2.6 in near quantitative yield 
(96%).
139 
The treatment of the N-Boc-N-methyl propargylamine 2.6 with n-butyllithium in 
THF, followed by subsequent addition of paraformaldehyde at -78 °C afforded the desired 
alcohol 2.5 in 78% yield.
139 
Deprotonation of the alcohol 2.5 with sodium hydride and 
treatment with methyl iodide afforded the required methyl ether 2.3 in 67% yield.
156
 More 
encouraging results were obtained when propargylic alcohol 2.5 was treated with potassium 
hydroxide in DMSO, followed by subsequent addition of methyl iodide (90%).
157
  
The next step in the synthetic sequence was the removal of the N-Boc protecting group. 
Various methods were employed for the removal of the N-Boc protecting group and these are 
shown in Table 2.1. 
 
 
182 
 
 
 
Reagents and Conditions: (a) Reagent, solvent, temperature, yield, see Table 2.1 
 
Scheme 2.8: Attempted Boc-Deprotection 
 
Entry Reagent Solvent Temperature (°C) Yield (%)
a
 
 
1 
2 
 
TFA 
2M HCl 
 
CH2Cl2 
Et2O 
 
0-rt 
0-rt 
 
DM
b
 
48 
3 2M HCl EtOAc 0-rt 51 
4 4M HCl Dioxane 0-rt 71 
5 
6 
7 
BF3·OEt2 
MgBr2 
TMSCl 
CH2Cl2 
CH2Cl2 
CH2Cl2 
 
0-rt 
0-rt 
0-rt 
- 
- 
- 
a
 Yields of isolated products. DM
b
 = decomposition of material 
 
Table 2.1: Reagents Tested for Boc-Deprotection  
 
Initial attempts at N-Boc deprotection utilised trifluoroacetic acid in dichloromethane.
158,159
 
Unfortunately, addition at 0 °C followed by stirring at room temperature for one hour led to 
complete decomposition of the reaction mixture. More promising results were obtained when 
a solution of hydrogen chloride in ethyl acetate was employed.
160
 Treatment of the methyl 
ether 2.3 with a 2M solution of hydrochloric acid in ethyl acetate, followed by collection by 
vacuum filtration of the hydrogen chloride salt afforded a clean deprotection (51%). This 
result however was deemed unsatisfactory due to the high cost of N-methylpropargyl amine 
2.7 which is needed at the start of the synthesis of precursor 2.3. It was suggested that using 
BF3·OEt2 and 4Å molecular sieves in dichloromethane followed by oxalic acid addition 
might increase the yield.
161
 However, entries 5, 6 and 7 suffered from a slow rate of reaction 
and the isolated products were contaminated with significant amount of impurities.
162,163
 The 
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best results were obtained with a 4M solution of hydrogen chloride in dioxane which gave the 
hydrogen chloride salt of 2.15 in 71% yield. This material required no further purification.
164
 
 
 
2.1.2.2. Synthesis of Carboxylic Acid Fragment 2.4 
 
It was necessary to protect propargyl alcohol 2.12 at the oxygen atom, in order to selectively 
deprotonate the terminal alkyne position (pKa ~ 25 in H2O
152,153
). Silyl ethers are often used 
as protecting groups for alcohols.
165
 The reason for the wide popularity of silicon protecting 
groups is easily explained; they are readily formed and cleaved under mild conditions and 
their relative stability can be finely tuned by varying the substituents on silicon.
 
 
The commercially available tert-butyldimethylsilyl (TBS) chloride is often used as a 
silylating agent.
165 
The derivatisation of alcohols as their tert-butyldimethylsilyl ethers has 
been recognised as one of the most useful protection methods since its introduction by Corey 
and Venkateswarlu in 1972.
166
 This is in account of its easy installation and general stability 
to basic and mildly acidic conditions. tert-Butyldimethylsilyl ethers are also stable to column 
chromatography and they are stable below 0 °C to strong non-protic bases such as n-
alkyllithiums.  
The adaptation of the TBS protecting group for the synthesis of alkyl chloride 2.17 is 
illustrated in Scheme 2.9 below. 
 
 
 
Reagents and Conditions: (a) tert-Butyldimethylsilyl chloride, imidazole, CH2Cl2, 0 °C  to rt, 
1h, 98%; (b) n-BuLi, THF then chloro(chloromethyl)dimethylsilane, -78 °C to rt, 16h, 85%. 
 
Scheme 2.9: Synthesis of Alkyl Chloride 2.17 
 
The use of imidazole as an acid scavenger with tert-butyldimethylsilyl chloride in 
dichloromethane proved to be effective, and resulted in the mild conversion of propargyl 
alcohol 2.12 to tert-butyldimethylsilyl ether 2.16 in excellent yield (98%).
167
 Treatment of 
silyl ether 2.16 with n-butyllithium in THF, followed by subsequent addition of 
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chloro(chloromethyl)dimthylsilane at -78 °C gave the desired alkyl chloride 2.17 in 85% 
yield.
139
 
An attempted coupling of allylmagnesium chloride with alkyl chloride 2.17 was carried out. 
Unfortunately, none of the desired product was observed so the reaction was repeated using 
an alternative procedure. A reverse addition was attempted with the addition of the alkyl 
chloride 2.17 to allylmagnesium chloride. None of the desired product was observed and only 
starting material was recovered in these reactions.  
 
 
 
Reagents and Conditions: (a) Allylmagnesium chloride, THF, 0 °C to rt, 16h. 
 
Scheme 2.10: Coupling Reaction of Alkyl Chloride 2.17 with Allylmagnesium Chloride  
 
Having failed to find suitable conditions for the coupling of allylmagnesium chloride with 
alkyl chloride, our attention was directed towards exchange of the halogen atom for another. 
The equilibrium exchange of the halogen atom in alkyl halides for another halogen atom is 
known as the Finkelstein reaction.
168
 Halide exchange is an equilibrium reaction yet the 
reaction can be driven to completion by taking advantage of differential solubility of halide 
salts, or by using a large excess of the halide salt. The classic Finkelstein reaction involves 
the conversion of an alkyl chloride or an alkyl bromide to an alkyl iodide by the addition of 
sodium iodide in acetone.
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Reagents and Conditions: (a) NaI, acetone, rt, 16h, 91%. 
 
Scheme 2.11: Conversion of Alkyl Chloride 2.17 to an Alkyl Iodide 2.19 
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The coupling of alkyl iodide 2.19 with a 2M solution of allylmagnesium chloride in THF was 
used as the test reaction (Scheme 2.12). In the absence of a catalyst, the reaction yielded only 
5% of the required product 2.18. 
 
 
 
Reagents and Conditions: (a) Allylmagnesium chloride, THF, 0 °C to rt, 16h, 5%. 
 
Scheme 2.12: Coupling Reaction between Alkyl Iodide 2.19 and Allylmagnesium Chloride  
 
Considering that efficient alkyl–alkyl coupling reactions had been difficult to achieve, the 
judicious choice of catalyst and reaction conditions were employed to circumvent this 
problem. Kambe et al.
170,171,172
 demonstrated that non-activated alkyl halides could be 
coupled to alkyl Grignard reagents in high yields in the presence of various copper salts. 
Following these reported conditions, coupling reactions were repeated in the presence of 
CuCl, however no coupling product was formed. The addition of CuI (used by Fuchikami et 
al.
173
) to couple alkyl iodide 2.19 with Grignard reagent also failed to yield the desired 
compound. Furthermore, Baeckvall et al.
174
 demonstrated that Grignard reagents could 
efficiently undergo CuCN catalysed coupling reactions with alkyl halides.  Following these 
reported conditions, one equivalent of cuprous cyanide was used to attempt to afford the 
corresponding lower-order cyanocuprate. The cuprate was then reacted with alkyl iodide 2.19 
to yield the desired compound 2.18. Nevertheless, these conditions also afforded none of the 
desired compound. The soluble copper reagent Li2CuCl4 which is known to couple terminal 
alkyl halides with long chain terminal unsaturated Grignard reagents was also used as a 
catalyst.
175
 After having little success with this catalyst (Entry 6, Table 2.2), the Grignard 
addition was tried again under various conditions and the results are shown in Table 2.2 
below. The yields were over 75% for reactions in THF at 0 °C but lower for reactions in 
diethyl ether (Entries 7 and 8 respectively, Table 2.2). A catalyst loading of 50 mol% was 
sufficient to give a yield of 77%.  
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Reagents and Conditions: (a) Allylmagnesium chloride, catalyst, solvent, temperature, yield, 
see Table 2.2. 
 
Scheme 2.13: Coupling Reaction between Alkyl Iodide 2.19 and Allylmagnesium Chloride 
 
Entry Catalyst Solvent Temperature (°C) Yield (%)
a
 
     
1 - THF 0-rt 5 
2 CuCl THF -78-rt/-30-rt/0-rt 0 
3 CuI THF -78-rt/-30-rt/0-rt 0 
4 CuCN THF -78-rt/-30-rt/0-rt 0 
5 Li2CuCl4 (5-100 mol%) THF -78-rt 0 
6 Li2CuCl4 (5 mol%) THF 0-rt 16 
7 Li2CuCl4 (50 mol%) THF 0-rt 77 
8 Li2CuCl4 (50 mol%) Et2O 0-rt 71 
 
a
 Yields of isolated products 
 
Table 2.2: Catalysts Tested for the Coupling Reaction  
 
The next step in the synthetic sequence was the removal of the TBS protecting group. A wide 
variety of acidic reagents were used for the cleavage of tert-butyldimethylsilyl, including 
HOAc/THF/H2O,
176
 mineral acids such as HCl
177
 and H2SO4,
178
 TsOH,
179
  HF/CH3CN
180
 and 
TFA.
181
 These reactions proceeded to completion within 1 hour. The reaction mixture was 
monitored by thin layer chromatography. The isolated product indicated that removal of the 
but-3-en-1-yl dimethylsilane group had predominantly occurred instead of the desired 
selective deprotection of the silyl motif. Deprotection with a less acidic reagent was then 
pursued. However, stirring 2.18 in MeOH in the presence of PPTS (pKa = 5.21 in H2O
182
) 
furnished the same product 2.16 in 28% yield (Table 2.3).
183
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Reagents and Conditions: (a) Reagent, solvent, temperature, yields, see Table 2.3. 
 
Scheme 2.14: Attempted TBS-Deprotection  
 
Entry Reagent Solvent Temperature (°C) 2.20 (yield)
a
 2.16 (yield)
a 
 
1 
 
HCl 
 
MeOH 
 
0-rt 
 
trace 
 
37 
2 H2SO4 MeOH 0-rt trace 32 
3 TsOH MeOH 0-rt trace 32 
4 TFA THF 0-rt trace 35 
5 HF CH3CN 0-rt trace 30 
6 HF THF 0-rt trace 40 
7 AcOH THF/H2O 0-rt trace 38 
8 PPTS MeOH 0-rt trace 28 
 
a
 Yields of isolated products 
 
Table 2.3: Attempts to remove the tert-Butyldimethylsilyl Group  
 
A possible cause for the undesired cleavage of the silyl group could be its ability to stabilise a 
β-cation (β-silicon effect184,185) which would be generated from the protonation of the alkyne 
in 2.18 as depicted in Scheme 2.15. Subsequent attack by the conjugate base on the silicon 
group would then furnish 2.16. 
 
 
Scheme 2.15: Possible Mechanism for the Elimination of the Silyl Group 
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Deprotection of TBS ethers is not limited to acidic reagents: fluoride is also effective and the 
most popular reagent is tetrabutylammonium fluoride (TBAF).
186
 The same result was also 
obtained when TBAF was employed in THF (41% yield of 2.16). 
Having observed the probable stability of the silyl ether, the propargyl alcohol 2.12 was 
protected with TES group. The TES group can be readily introduced and is facile to 
remove.
165 
Furthermore, it is sufficiently stable to endure column chromatography and many 
organometallic reactions. The TES ethers are relatively less stable towards acid and base 
catalysed hydrolysis compared to TBS ethers.
165
 The adaptation of the TES protecting group 
for the synthesis of silyl ether 2.25 is shown in Scheme 2.16 below. 
 
 
 
 Reagents and Conditions: (a) Chlorotriethylsilane, imidazol, DMF, 0 °C to rt, 1h, 86%; (b)     
n-BuLi, THF then chloro(chloromethyl)dimethylsilane, -78 °C to rt, 16h, 85%; (c) NaI, 
acetone, rt, 16h, 88%; (d) Allylmagnesium chloride, Li2CuCl4, THF, 0 °C to rt, 16h, 80%. 
 
Scheme 2.16: Synthesis of Silyl Ether 2.25 
 
The use of imidazole with chlorotriethylsilane in dimethylformamide proved to be effective 
and resulted in the mild conversion of propargyl alcohol 2.12 to triethylsilyl ether 2.22 in 
high yield (86%).
187
 The but-3-en-1-yldimethyl(3-((triethylsilyl)oxy)prop-1-yn-1-yl)silane 
2.25 was prepared from compound 2.22 by using an identical procedure to the preparation of 
but-3-en-1-yl(3-((tert-butyldimethylsilyl)oxy)prop-1-yn-1-l) dimethylsilane 2.18. 
The removal of triethylsilyl group was subsequently attempted with HCl in methanol.
188
 The 
isolated product indicated that removal of the but-3-en-1-yldimethylsilane group had 
predominantly occurred instead of the desired deprotection. Attempts to prevent this 
unwanted product were unsuccessful and results are shown in Table 2.4 below. 
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Reagents and Conditions: (a) Reagent, solvent, temperature, yields, see Table 2.4. 
 
Scheme 2.17: Attempted TES-Deprotection 
 
Entry Reagent Solvent Temperature (°C) 2.20 (yield)
a
 2.22 (yield)
a
 
 
1 
 
HCl 
 
MeOH 
 
0-rt 
 
trace 
 
33 
2 PPTS MeOH 0-rt trace 43 
3 TBAF THF 0-rt trace 46 
4 K2CO3 i-PrOH 0-rt 0 0 
5 K2CO3 MeOH 0-rt 0 0 
 
a
 Yields of isolated products 
 
Table 2.4: Attempts to Remove the Triethylsilyl Group 
 
Carefully chosen oxidative conditions allow for the selective removal of a silyl group from 
primary alcohol with the resulting free carbinol undergoing oxidation. Swern conditions have 
been employed for the conversion of primary TES ethers into aldehydes via the in-situ 
desilylation-oxidation of protected alcohol.
189
 Unfortunately this procedure suffered from a 
slow rate of reaction (72 hours) and produced aldehyde 2.26 in poor yield (22%).  
 
 
 
Reagents and Conditions: (a) (COCl)2, DMSO, Et3N, 72h, 22%. 
 
Scheme 2.18: Oxidative Deprotection of TES-Ether 
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A more efficient method had to be sought and to this end a THP protecting group was 
suggested. Tetrahydropyranyl ethers were one of the first generally useful protecting groups 
for alcohols and they are still widely used today.
190
 The particular merits of the THP group 
are its ease of introduction, the low cost of 3,4-dihydro-2H-pyran, its stability (in the absence 
of protic and Lewis acids) under a wide range of reaction conditions and its ease of removal. 
THP protection has disadvantages such as the complexity of the NMR spectra and the fact 
that diastereoisomers are formed on reaction with chiral alcohols.  
The adaptation of the THP protecting group for the synthesis of THP ether 2.30 is shown in 
Scheme 2.19 below. 
 
 
 
Reagents and Conditions: (a) 3,4-dihydro-2H-pyran, para-toluenesulfonic acid monohydrate, 
CH2Cl2, 0 °C to rt, 4h, 95%; (b) n-BuLi, THF then chloro(chloromethyl)dimethylsilane, -78 
°C to rt, 16h, 89%; (c) NaI, Acetone, rt, 16h, 82%; (d) Allylmagnesium chloride, Li2CuCl4, 
THF, 0 °C to rt, 16h, 76%. 
 
Scheme 2.19: The Use of THP Protecting Group for the Synthesis of THP Ether 2.30 
 
The use of para-toluenesulfonic acid as a catalyst with 3,4-Dihydro-2H-pyran in 
dichloromethane proved to be effective and resulted in the mild conversion of propargyl 
alcohol 2.12 to tetrahydropyranyl ether 2.27 in excellent yield (95%).
191
 The but-3-en-1-
yldimethyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl) silane 2.30 was prepared from 
compound 2.27 by using an identical procedure to the preparation of but-3-en-1-yl(3-((tert-
butyldimethylsilyl)oxy)prop-1-yn-1-yl)dimethylsilane 2.18. 
Most Lewis acids cleave THP ethers and conditions are mild enough to allow retention of 
protecting groups that are otherwise labile in aqueous or alcoholic acid solutions. For 
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example, three equivalent of magnesium bromide in diethyl ether have been used to cleave 
THP ethers of primary alcohols.
192
 Unfortunately, addition at 0 °C followed by stirring at 
room temperature for one hour led to complete decomposition of the reaction mixture. The 
attempted removal of THP group with PPTS in MeOH was tried and the required alcohol 
2.20 was obtained in low yield (39%).
193
 The alcohol 2.20 was oxidised with Jones’ reagent 
to give the carboxylic acid 2.4 in 85% yield. 
 
 
 
Reagents and Conditions: (a) PPTS, MeOH, rt, 3h, then sat. aq. NaHCO3, 39%; (b) CrO3, 
H2SO4, H2O, acetone, 0 °C to rt, 3h, 85%. 
 
Scheme 2.20: Synthesis of Carboxylic Acid 2.4 
 
Regeneration of the protected group to the original functional group or its oxidized form is a 
useful transformation. The latter has been the focus of attention and a variety of methods 
have been reported.
194 Attempted oxidative deprotection of tetrahydropyranyl ether 2.30 with 
Jones’ reagent was tried and desired carboxylic acid 2.4 was obtained in excellent yield 
(96%).  
 
 
Reagents and Conditions: (a) CrO3, H2SO4, H2O, acetone, 0 °C to rt, 3h, 96%. 
 
Scheme 2.21: Oxidative Deprotection of Tetrahydropyranyl Ether 2.30 
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The reaction went to completion within 3 hours and the crude product was pure enough to be 
used directly in the next step. This method did not only reduce the required time for the 
synthesis but it also avoided column chromatography. 
 
 
2.1.2.3. Investigation of Amide Coupling 
 
The formation of amide 2.1 was subsequently investigated and to this ends various coupling 
reagents and additives
195
 were tested as shown in Table 2.5 below. 
 
 
 
Reagent and Conditions: (a) Et3N, CH2Cl2, activating agent, yield, see Table 2.5. 
 
Scheme 2.22 Synthesis of Cyclisation Precursor 2.1 
 
Entry Activating agent Yield (%)
a 
   
1 Oxalyl Chloride / DMF 48 
2 Oxalyl Chloride / DMAP 0 
3 DCC 38 
4 CDI 18 
5 HBTU 38 
6 DCC / HOBt 21 
7 EDCl 33 
 
a
 Yields of isolated products 
 
Table 2.5: Different Activating Agents Tested for Amide Coupling 
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The -++best results were obtained with oxalyl chloride in the presence of a catalytic amount 
of DMF which gave amide 2.1 in 48% yield.
196
 However, this result was deemed 
unsatisfactory due to the high cost of N-methylpropargylamine 2.7 which is required at the 
start of the synthesis of coupling precursor 2.15. Therefore attention was directed to other 
reagents involved in the reaction, and different bases were screened for the amide coupling 
(Scheme 2.23). 
 
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), CH2Cl2, base, yield, see Table 2.6. 
 
Scheme 2.23: Synthesis of Cyclisation Precursor 2.1 
 
Entry Base Yield 
   
1 Et3N 46 
2 Pyridine 38 
3 DIPEA 55 
4 2,6-Lutidine 71 
 
Table 2.6: Different Bases Tested for Amide Coupling 
 
The use of pyridine as a base afforded the required product in 38% yield, while N,N-
diisopropylethylamine delivered a slight improvement over triethylamine. The highest yield 
was obtained with 2,6-lutidine (Entry 4, Table 2.6) which afforded the required amide 2.1 in 
71% yield. A tendency is notable in Table 2.6 suggesting that more sterically hindered bases 
give higher yields of desired amide 2.1. At the beginning of this stage during the synthesis of 
coupling precursor 2.4 the but-3-en-1-yldimethylsilane group in 2.18 was removed by action 
of various reagents; a similar effect could be induced by unhindered nitrogen bases during the 
formation of amide 2.1. 
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2.1.3. Thermal Cyclisation  
 
Once cyclisation precursor 2.1 had been obtained, attempts at the cyclisation could proceed. 
Although there was experimental evidence to suggest the cascade would work, considering 
the amount of work that had already been required it was expected that this would necessitate 
a significant effort. To our delight the cascade was successful with the first attempt.  
 
 
 
Reagent and Conditions: (a) Toluene, 0.1M, reflux, 12h, 30%. 
 
Scheme 2.24: Thermal Cyclisation of Precursor 2.1 at 0.1M concentration  
 
Unfortunately, the above thermolysis failed to give any isolable products in high yield. In 
order to test if the concentration of the starting material was a problem, heating of 2.1 in 
toluene was repeated at 0.01M. 
 
 
 
Reagent and Conditions: (a) Toluene, 0.01M, reflux, 16h, 38%. 
 
Scheme 2.25: Thermal Cyclisation of Precursor 2.1 at 0.01M Concentration 
 
After amide 2.1 was heated in toluene at reflux
 
in 0.01M concentration of the starting 
material (to avoid polymerisation), tricycle 2.2 was generated in 38% yield. Although the 
reaction took a longer time to reach completion, the yield of cyclisation product increased up 
to 38%. 
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The reaction to form tricycle 2.2 was encouraging. The formation of a complex tricycle ring 
from a simple starting material, using no reagent other than solvent was remarkable. Indeed, 
extensive searching of the literature indicated that the reaction was unique; this was a new 
way of forming polycyclic structures as reported previously in our group. 
As in the example shown in Section 1.45, the isolation of lactam 2.2 ruled out the previously 
proposed acid-catalysed mechanism as no bromine is present in the molecule to generate 
catalytic amounts of hydrogen bromide in solution.
144
 Following these observations the 
mechanism in Scheme 2.26 was proposed. 
 
 
Scheme 2.26: Proposed Mechanism for the Formation of Tricycle 2.2 
 
In Scheme 2.26 concerted path A would proceed by an intramolecular ene reaction to give 
the allene intermediate 2.34, which could also result from the radical pathway B. Either a 
Diels-Alder reaction from allene 2.34 to lactam 2.2 could occur, or alternatively, the 
cycloaddition pathway from the bi-radical 2.33 would also result in the formation of the 
lactam 2.2.
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The difficulties associated with the amine and alcohol protection/deprotection and amide 
coupling for the synthesis of the cyclisation precursor 2.1 had been successfully solved. The 
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newly developed method has proven highly popular in the Parsons group and is currently 
employed in studies towards the total synthesis of the antibiotic Lactonamycin 1.164. 
Furthermore, this method can potentially be used in the synthesis of other natural products 
(see Chapter 3). 
 
 
2.2. Investigation through Modification of the Amide Linker 
 
2.2.1. Outline of Investigation  
 
To enable us to further understand the importance of the amide linker in the cyclisation 
mechanism, we opted to exchange the amide for an ester linker (Figure 2.1). 
 
 
 
Figure 2.1: Novel Cyclisation Precursor Consisting of an Ester Linker 
 
An overview of our retrosynthetic plan is depicted in Scheme 2.27. In this analysis, 
cyclisation precursor 2.35 was disconnected at the ester linkage. This process leads to the 
previously synthesised (3-(but-3-en-1-yldimethylsilyl)propiolic acid) 2.4 and alcohol 2.38.  
 
 
 
Scheme 2.27: Retrosynthetic Analysis of Cyclisation Precursor 2.35 
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2.2.2. Synthesis of Cyclisation Precursor 2.35 
 
In conjunction with the efforts to form acid 2.4 and amine 2.3, a synthesis of 4-methoxybut-
2-yn-1-ol 2.38 was developed. Two routes to this intermediate were considered, these routes 
are illustrated in Scheme 2.28 and Scheme 2.29. 
Scheme 2.28 below illustrates the synthesis of desired material 2.38. 
 
 
 
Reagent and Conditions: (a) tert-Butyldimethylsilyl chloride, imidazole, CH2Cl2, 0 °C  to rt, 
1h. 98%; (b) n-BuLi, THF then paraformaldehyde, -78 °C to rt, 16h, 82%; (c) KOH, MeI, 
DMSO, rt, 16h, 79%; (d) TBAF, THF, 0 °C to rt, 3h, 88%. 
 
Scheme 2.28: Synthesis of 4-methoxybut-2-yn-1-ol 2.38 
 
The use of imidazole with tert-butyldimethylsilyl chloride in dichloromethane proved to be 
effective and resulted in the mild conversion of propargyl alcohol 2.12 to tert-
butyldimethylsilyl ether 2.16 in excellent yield (98%).
166
 The treatment of the silyl ether 2.16 
with n-butyllithium in THF and the subsequent addition of parafomaldehyde at -78 °C 
afforded the desired alcohol 2.36 in 82% yield.
139
 The treatment of the propargylic alcohol 
2.36 with potassium hydroxide and subsequent reaction with methyl iodide in DMSO 
produced the required methyl ether in 70% yield.
157
 The removal of the silyl protecting group 
with tetrabutylammonium fluoride (TBAF) in THF afforded the required alcohol 2.38 in 88% 
yield.
186
 
A review of the literature revealed that although 4-methoxybut-2-yn-1-ol 2.38 was known, 
the syntheses that were developed were not ideal. Evidently, there was room for 
improvement; techniques to avoid a lengthy synthesis and to gain good reproducible yields 
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were necessary. In response to these issues, a useful process was quickly developed from 
standard chemistry (Scheme 2.29). 
 
 
 
Reagents and Conditions: (a) NaOH, H2O, Me2SO4, 2h, 80%; (b) n-BuLi, THF then 
paraformaldehyde, -78 °C to rt, 16h, 86%. 
 
Scheme 2.29: Synthesis of 4-methoxybut-2-yn-1-ol 2.38 
 
Treatment of a solution of propargyl alcohol 2.12 with aqueous sodium hydroxide followed 
by the addition of dimethyl sulfate afforded the methyl ether 2.37 in 80% yield.
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It was 
observed that the yield was much lower than expected for a simple O-methylation, the 
volatility of the product was considered as a probable explanation. The treatment of the 
methyl ether 2.37 with n-butyllithium in THF and the subsequent addition of 
parafomaldehyde at -78 °C gave the desired alcohol 2.38 in 86% yield.
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 As the synthetic 
sequence was easier to perform and afforded a higher yield than the sequential route 
previously used, this was selected as the method of choice for making 4-methoxybut-2-yn-1-
ol 2.38. 
The reaction of newly formed alcohol 2.38 with the acyl chloride derived from 3-(but-3-en-1-
yldimethylsilyl)propiolic acid 2.4 in the presence of 2,6-lutidine as a base, yielded desired 
cyclisation precursor 2.35.  
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 0 °C  to rt, 16h, 
74%. 
 
Scheme 2.30: Synthesis of Cyclisation Precursor 2.35 
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2.2.3. Thermal Cyclisation  
  
The newly formed cyclisation precursor 2.35 was heated in toluene, resulting in the clean 
cyclisation of 1,6-diyne 2.35 to form the tricycle 2.39. 
 
 
Reagent and Conditions: (a) Toluene, reflux, 0.01M, 20h, 40% 
 
Scheme 2.31: Thermal Cyclisation of Precursor 2.39 
 
Interestingly, the ester linkage caused the rate of reaction to significantly decrease. A similar 
observation had previously been described by Parker et al.
199
 during studies on the 
intramolecular Diels-Alder reaction of amides and esters. Parker and co-workers have 
demonstrated that some facile Diels-Alder reactions of tertiary amides 2.40 fail with the 
corresponding esters or secondary amides 2.42a-b in place (Scheme 2.32). The author 
proposed that this was in account of a transoid relationship of the diene and dienophile across 
the ester moiety. 
 
 
Reagents and Conditions: (a) Benzene, 80 °C, 6 days; (b) Benzene, 80 °C, 6 days. 
 
Scheme 2.32: Amide/Ester Cyclisation Comparison 
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Our system could endure the same constraints, as illustrated in Scheme 2.33. The ester linker 
predominantly adopts a transoid relationship 2.45b over the reactive cisoid diyne 2.45a. 
During the process, the distance between the two alkynic bonds increases and a decrease in 
thermal reactivity is expected, this was indeed the case. The thermal cyclisation of compound 
2.1 and 2.35 exhibited significant difference. 
 
 
 
Scheme 2.33: Relationships of Resonance Forms 
 
Following the assumption that the cyclisation was favoured by the cisoid conformation, it 
was anticipated that the attachment of a sterically demanding group on the nitrogen would 
enhance the cisoid geometry, displace the equilibrium to the left, decrease the distance 
between the two alkynic bonds and hence increase the rate of reaction. Therefore, the chosen 
course of action was to synthesise a novel cyclisation precursor consisting of a bulky N-
substituted 1,6-diyne system.  
 
 
2.3. Synthesise of a Novel Cyclisation Precursor Consisting of a Bulky N-Substituted 
1,6-Diyne System 
 
2.3.1. Outline of Investigation  
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Due to the immediate availability of isopropylamine in the laboratory, amide 2.46 (Figure 
2.2) was selected as a new synthetic target. 
 
 
 
Figure 2.2: Novel Cyclisation Precursor 2.46 
 
The retrosynthetic approach for the cyclisation precursor 2.46 is depicted in Scheme 2.34 
below. 
 
 
 
Scheme 2.34: Retrosynthetic Analysis of Cyclisation Precursor 2.46 
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A disconnection at the amide moiety leads to the previously synthesised (3-(but-3-en-1-
yldimethylsilyl)propiolic acid) 2.4 and secondary amine 2.53. The latter can be generated 
from protected amine 2.52. In addition, compound 2.52 can be easily synthesised by 
deprotonation of the terminal alkyne in the N-Boc amine 2.50 and subsequent quenching with 
paraformaldehyde followed by Williamson ether synthesis. Reaction of secondary amine 2.48 
and the propargyl bromide 2.49 can provide N-Boc amine 2.50. Furthermore, amine 2.48 can 
be obtained from commercially available isopropylamine 2.47. 
 
 
2.3.2. Synthesis of the Cyclisation Precursor 2.46 
 
Scheme 2.35 below illustrates the synthesis of desired material 2.53. 
 
 
Reagents and Conditions: (a) Di-tert-butyl dicarbonate, DMAP, THF, 0 °C to rt, 16h, 71%; 
(b) NaH, propargyl bromide, DMF, 0 °C to rt, 16h, 66%. (c) n-BuLi, THF then 
paraformaldehyde, -78 °C to rt, 16h, 81%; (d) MeI, KOH, DMSO, rt, 16h, 86%; (e) 4M HCl, 
dioxane, 0 °C to rt, 4h, 74%. 
 
Scheme 2.35: Synthesis of Amine 2.53 
 
Protection of commercially available isopropylamine 2.47 with di-tert-butyl dicarbonate in 
the presence of DMAP afforded the tert-butyl isopropylcarbamate 2.48 in 71% yield.
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Propargylation of the protected amine 2.48 was carried out by using NaH, followed by 
propargyl bromide 2.49 addition (66%). The treatment of the tert-butyl-isopropyl(prop-2-yn-
203 
 
1-yl)carbamate 2.50 with n-butyllithium in THF, followed by subsequent addition of 
paraformaldehyde at -78 °C afforded the desired alcohol 2.51 in 81% yield.
139
 Treatment of 
the alcohol 2.51 with potassium hydroxide, followed by reaction with methyl iodide in 
DMSO, afforded the required methyl ether 2.52 in 86% yield.
157
 The Boc group was cleanly 
removed from the compound 2.52 with 4M solution of hydrogen chloride in dioxane and the 
amine salt of the compound formed was used without further purification for the subsequent 
coupling reaction.
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The reaction of newly formed amine 2.53 with the acyl chloride derived from 3-(but-3-en-1-
yldimethylsilyl) propiolic acid 2.4 in the presence of 2,6-lutidine as a base, yielded desired 
cyclisation precursor 2.46.  
 
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 16h, 70%. 
2,6-lutidine 
 
Scheme 2.36: Synthesis of Cyclisation Precurs`or 2.46 
 
 
2.3.3. Thermolysis of  1,6-Diyne 2.46 
 
The 1,6-diyne 2.46 was heated in toluene for 24 hours, yet it failed to give the tricyclic 
product 2.54 and the starting material was the only identifiable product isolated from the 
reaction mixture.  
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Reagent and Conditions: (a) Toluene, reflux, 0.01M, 24h. 
 
Scheme 2.37: Thermolysis of 2.46 at 0.01M Concentration 
 
In contrast to the N-methyl amide equivalent 2.1, it was observed that cyclisation precursor 
2.46 did not cyclise to form the tricyclic compound 2.54. This replicated Oluwakemi’s result 
as indicated in Scheme 2.38 for a selected example.
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Reagents and Conditions: (a) Toluene, reflux, maleic anhydride, 0.1M, 32h. 
 
Scheme 2.38: Work by Oluwakemi
201
 
 
It can be concluded that the attachment of an isopropyl group on the nitrogen displaces the 
equilibrium to the right. It is safe to conclude that the sterically demanding isopropyl group 
on nitrogen have increased the distance between the two alkynic bonds and thereby decreased 
the rate of cyclisation reaction.  
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Scheme 2.39: Relationships of Resonance Forms 
 
 
2.4. Effects of Substituents on the Rate of Cyclisation  
 
The rate enhancement resulting from the replacement of hydrogen atoms on the carbon 
tethering two reacting centres with alkyl substituents has been widely used in organic 
synthesis
202
 and several of these examples will be discussed in this thesis.  
The following work aimed to devise and execute a series of experiments with the intention of 
gaining a better understanding of the rate of the novel thermal cyclisation discovered by 
Parsons et al.
138,139
 (Scheme 2.40). 
 
 
 
Reagents and Conditions: (a) Toluene, 0.1M, 13h, reflux, 85% 
 
Scheme 2.40: Thermal Cyclisation of Precursor 2.58 
 
 
2.4.1. Replacement of the C3 Methylene Hydrogens with a gem-Dimethyl Group 
 
2.4.1.1. Outline of Investigation  
 
The introduction of a C-3 gem-dimethyl motif was introduced on 2.58 to favour the Thorpe-
Ingold acceleration of the rate of cyclisation. 
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Figure 2.3: Novel Cyclisation Precursor 2.60  
 
The retrosynthetic approach for the cyclisation precursor 2.60 is depicted in Scheme 2.41 
below. 
 
 
Scheme 2.41: Retrosynthetic Analysis of Cyclisation Precursor 2.60     
 
A disconnection at the ester moiety leads to the commercially available (3-(trimethylsilyl)-2- 
propynoic acid) 2.65 and alcohol 2.63. The latter can be easily synthesised by deprotonation 
of the terminal alkyne in the compound 2.62, followed by subsequent quenching with 
paraformaldehyde. In addition, ether 2.62 could be accessed from alcohol 2.61 and propargyl 
bromide 2.49, by employing Williamson’s ether synthesis conditions. 
 
 
2.4.1.2. Synthesis of Cyclisation Precursor 2.60 
 
The construction of desired material 2.63 is detailed below in Scheme 2.42. 
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        Reagents and Conditions: (a) NaH, THF, propargyl bromide, 0 °C to rt, 16h, 65%; (b)          
n-BuLi, THF then paraformaldehyde, -78 °C to rt, 16h, 81%. 
 
Scheme 2.42: Synthesis of Alcohol 2.63 
 
Deprotonation of the alcohol 2.61 with sodium hydride in THF, followed by the subsequent 
addition of propargyl bromide 2.49 at 0 °C afforded the desired ether 2.62 in 65% yield. 
Treatment of the 3-methyl-3-(prop-2-yn-1-yloxy)but-1-ene 2.62 with n-butyllithium in THF 
with the subsequent addition of paraformaldehyde at -78 °C afforded the desired alcohol 2.63 
in 81% yield.
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The alkynic acid 2.65 could be prepared by deprotonation of trimethylsilyl acetylene 2.64 and 
quenching with CO2, either as a gas
203
 or a solid.
204
 Deprotonation of trimethylsilyl acetylene 
was at first conducted using n-butyllithium. The use of this base generated pentanoic acid 
(also known as valeric acid). The preferred purification method for the reaction was 
distillation and the pentanoic acid impurity had a boiling point similar to that of the desired 
alkynoic acid 2.65. A switch of base to methyllithium solved this problem and allowed 
synthesis of the desired acid in a typical yield of 78% from cheap starting materials and with 
no difference in yield when moving to large scale (typically performed on 0.1 to 0.2 mol).  
 
 
 
Reagents and Conditions: (a) MeLi, THF, -78 °C to -50 °C then CO2(s) then 1 M HCl(aq), 
78%. 
 
Scheme 2.43: Synthesis of (3-(trimethylsilyl)-2-propynoic acid) 2.65 
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The reaction of alcohol 2.63 with the acyl chloride derived from 3-(trimethylsilyl)-2-
propynoic acid 2.65 in the presence of 2,6-lutidine as a base, yielded desired cyclisation 
precursor 2.60. 
 
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 16h, 74%. 
 
Scheme 2.44: Synthesis of Cyclisation Precursor 2.60 
 
 
2.4.1.3. Thermal Cyclisation   
 
The newly formed cyclisation precursor 2.60 was heated in toluene, resulting in the clean 
cyclisation of 1,6-diyne 2.60 to form the tricycle 2.66.  
 
 
 
Reagents and Conditions: (a) Toluene, 0.1M, reflux, 2h, 96%. 
 
Scheme 2.45: Thermal Cyclisation of Precursor 2.60 
 
As predicted by the gem-dimethyl effect, replacement of the C3 methylene hydrogens of ester 
2.58 with a dimethyl group produced an increase in the rate of cyclisation. As a result, the 
strain of the five-membered ring intermediate (and of the transition state leading to it) is 
relieved and the rate increased.  
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2.4.2. Replacement of the C7 Methylene Hydrogen with a Bulky Unit 
 
2.4.2.1. Outline of Investigation    
   
Replacement of the C7 methylene hydrogen in the ester 2.58 with a bulky unit should also 
produce an increase in the rate of cyclisation. It is noteworthy that the simultaneous 
replacement of the C3 methylene hydrogens with a gem-dimethyl group and C7 methylene 
hydrogen with sterically demanding isopropyl group of ester 2.58 should afford an 
accelerated increase in the rate of cyclisation. 
 
 
 
Figure 2.4: Novel Cyclisation Precursor 2.67 
 
The retrosynthetic approach for cyclisation precursor 2.67 is depicted in Scheme 2.46 below. 
 
 
 
Scheme 2.46: Retrosynthetic Analysis of Cyclisation Precursor 2.67 
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A disconnection at the ester moiety leads to the previously synthesised (3-(trimethylsilyl)-2- 
propynoic acid) 2.65 and secondary alcohol 2.69. The latter could be generated from the 
alkylation of isobutyraldehyde 2.68 by the lithium salt of alkyne 2.62, which could be 
accessed from alcohol 2.61 and propargyl bromide 2.49 by employing Williamson’s ether 
synthesis conditions. 
 
 
2.4.2.2. Synthesis of Cyclisation Precursor 2.67 
 
Scheme 2.47 below illustrates the synthesis of desired material 2.67. 
 
 
 
Reagents and Conditions: (a) n-BuLi, THF then isobutyraldehyde 2.68, -78 °C to rt, 16h, 
96%; (b) Oxalyl chloride, 3-(trimethylsilyl)-2-propynoic acid 2.65, DMF(cat.), 2,6-lutidine, 
CH2Cl2, 0 °C to rt, 16h, 74%. 
 
Scheme 2.47: Synthesis of Cyclisation Precursor 2.67 
 
Deprotonation at the terminal acetylene of compound 2.62 and alkylation with a slight excess 
of isobutyraldehyde proceeded in 96% yield. After quenching with saturated aqueous 
ammonium chloride solution and washing with saturated aqueous sodium bisulfate to remove 
excess aldehyde via its bisulfate adduct, the product 2.69 was found to be adequately pure.
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The reaction of alcohol 2.69 with the acyl chloride derived from 3-(trimethylsilyl)-2-
propynoic acid 2.65 in the presence of 2,6-lutidine as a base, yielded desired cyclisation 
precursor 2.67.  
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2.4.2.3.  Thermal Cyclisation  
 
The newly formed cyclisation precursor 2.67 was heated in toluene, resulting in the clean 
cyclisation of 1,6-diyne 2.67 to form the tricycle 2.70. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.1M, reflux, 30 min., 95%. 
 
Scheme 2.48: Thermal Cyclisation of Precursor 2.70 
 
The cyclisation of ester 2.60 has been studied previously in order to assess the effect of 
methyl groups on rates. The study was extended to include isopropyl group and the reaction 
studied appeared to show a direct conversion into the corresponding cyclisation product (TLC 
analysis and visualization under the UV light indicated the completion of the cyclisation 
reaction after 30 min.). In this case, the relatively short time taken for the completion of the 
cyclisation reaction is an indication of the positive effect of the sterically demanding group 
on the geometry of the molecule. In principle, this could have resulted from the sterically 
demanding isopropyl group favouring the cisoid geometry, bringing the two alkynic bonds 
into closer proximity thereby increasing the rate of cyclisation reaction. This may have been 
aided by the methyl group on C3 and it is assumed that the mechanism would be identical to 
that of compound 2.1 (Scheme 2.26). 
 
 
2.5. Synthesis of a New Cyclisation Precursor 
 
2.5.1. Outline of Investigation  
 
In order to further investigate the cyclisation, the ester 2.77 was chosen as a new synthetic 
target. 
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Figure 2.5: Novel Cyclisation Precursor 2.77 
 
The retrosynthetic approach for cyclisation precursor 2.77 is depicted in Scheme 2.49. 
 
 
Scheme 2.49: Retrosynthetic Analysis of Cyclisation Precursor 2.77 
 
A disconnection at the ester moiety leads to the previously synthesised (3-(trimethylsilyl)-2- 
propynoic acid) 2.65 and alcohol 2.76. The latter can be generated from protected alcohol 
2.75, which can be obtained from the alkylation of aldehyde 2.74 by the lithium salt of silyl-
protected propargyl alcohol 2.16. In addition, aldehyde 2.74 can be generated by simply 
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refluxing the vinyl ether 2.73, which can be accessed from alcohol 2.71 and ethyl vinyl ether 
2.72. 
 
 
2.5.2. Synthesis of Cyclisation Precursor 2.77 
 
Scheme 2.50 below illustrates the synthesis of desired material 2.76 
 
 
 
Reagents and Conditions: (a) Hg(OAc)2, ethyl vinyl ether, 2 days, 66%; (b) Reflux, 24h, 
97%; (c) tert-butyldimethyl(prop-2-yn-1-yloxy)silane 2.16, n-BuLi, THF, -78 °C to rt, 93%; 
(d) TBAF, THF, 2h, 95%  
 
Scheme 2.50: Synthesis of Desired Alcohol 2.76 
 
The synthesis commenced with the formation of vinyl ether 2.73 from 3-methyl-2-buten-ol 
2.71. This reaction was carried out using mercuric acetate and ethyl vinyl ether 2.72 and 
desired vinyl ether 2.73 was obtained in 66% yield.
206
 The 3-methyl-1-(vinyloxy)but-2-ene 
2.73 was then heated at reflux for 24 hours and cooled to room temperature to obtain the title 
aldehyde 2.74 in excellent yield (97%).
219
 Deprotonation at the terminal acetylene of silyl-
protected alcohol 2.16 and alkylation with a slight excess of 3,3-dimethylpent-4-enal 2.74 
proceeded in 93% yield.
205
 Silyl deprotection of 2.75 was achieved using TBAF in THF.
186
 A 
basic work-up provided desired alcohol 2.76 as a yellow, pure oil in 95% yield.  
The reaction of alcohol 2.76 with the acyl chloride derived from 3-(trimethylsilyl)-2 
propynoic acid 2.65 in the presence of 2,6-lutidine as a base, yielded desired cyclisation 
precursor 2.77.  
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Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 16h, 70%. 
 
Scheme 2.51: Synthesis of Cyclisation Precursor 2.77 
 
 
2.5.3. Thermal Cyclisation  
 
The 1,6-diyne 2.77 was heated in toluene for 12 hours, resulting in total consumption of the 
starting material to give the tricyclic product 2.78 as the only identifiable product in a 82% 
yield. NMR, IR and mass analysis of the solid obtained revealed its structure to be ketone 
2.78 below. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux, 12h, 82%. 
 
Scheme 2.52: Thermal Cyclisation of Precursor 2.77 
 
Tricycle 2.78 proved to be a solid only marginally soluble in diethyl ether; therefore the 
reaction solution only needed to be cooled, the precipitate collected through vacuum filtration 
and washed with a cold diethyl ether to produce the reasonable yield (82%). 
 
 
 
 
 
215 
 
2.6. Ketone Modification - Novel Synthesis of Furan-2(5H)-one 
 
2.6.1. Outline of Investigation  
 
Deuterium-labelling studies have previously confirmed that during the cyclisation discovered 
by Parsons et al.,
138,139
 a hydrogen atom is abstracted intramolecularly (Scheme 2.53). 
 
 
 
Reagents and Conditions: (a) Toluene, reflux, 16h, 90%. 
 
Scheme 2.53: Cyclisation of Deuterated Compound 2.79  
 
A way to drastically alter the reactivity of compound 2.77 is to completely remove this 
hydrogen atom by oxidising the secondary alcohol moiety to a ketone (Figure 2.6). 
 
 
 
Figure 2.6: Position of the Abstracted Hydrogen Atom in 2.77 
 
 
2.6.2. Oxidation of Secondary Alcohol to Ketone  
 
There are countless procedures available in the literature to oxidise secondary alcohols to 
ketones.
207
 Inspiration came from the work of Jones et al.
208
 on the oxidation of acetylenic 
alcohols employing chromic acid, generated from chromium(VI) trioxide and concentrated 
sulfuric acid. Preparation of Jones’ reagent was achieved using a published procedure.209 
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Reagents and Conditions: (a) 3.0M Jones’ reagent, acetone, rt, 96%. 
 
Scheme 2.54: Jones’ Oxidation of 2.77 
 
Oxidation of alcohol 2.77 with this solution proceeded in 96% yield (Scheme 2.54). Further 
advantages to the use of this procedure include short reaction times and straight forward 
work-up conditions. Frequently, it was observed that only a simple filtration via a short 
column of silica was all that was required to acquire pure 2.81. 
 
 
2.6.3. Thermal Cyclisation  
 
The next step was to test the thermolysis of 2.81 in refluxing anhydrous, degassed toluene. 
Identical to previous cyclisations a 0.01M concentration of the starting material was chosen. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux, 6h, 30%. 
 
Scheme 2.55: Thermal Cyclisation of Precursor 2.81 
 
When the ketone 2.81 was heated in toluene solution for 6 hours under reflux a remarkable 
transformation was observed; the alkyne 2.82 was isolated in 30% isolated yield (Scheme 
2.55).  
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The formation of the alkyne 2.82 was totally unexpected and the mechanism outlined in 
Scheme 2.56 was proposed to account for this transformation. 
 
 
 
Scheme 2.56: Proposed Mechanism for the Formation of 2.82 
 
The bi-radical 2.83 could be formed as described in Scheme 2.26 and instead of hydrogen 
atom abstraction, the alkenyl radical could add to the carbonyl group as illustrated in 
structure 2.83 to form the new bi-radical 2.84. The fragmentation of 2.84 would give the acyl 
silane 285, which on loss of carbon monoxide and benzyltrimethylsilane would give the 
observed product 2.82.  
A second mechanism based on the reported intramolecular [4+2] cycloaddition of conjugated 
ynones
210
 was also proposed (Scheme 2.57). 
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Scheme 2.57: Postulated ynone [4+2] Mechanism for the Formation of 2.82 
 
A concerted [4+2] cycloaddition between the ynone functionality and the silyl acetylene in 
2.81 would yield highly strained heterocyclic allene 2.86. Electrocyclic ring opening in 2.86 
would yield the acyl silane 2.85 which on loss of carbon monoxide and benzyltrimethylsilane 
would give the observed product 2.82. 
Unfortunately, no definitive empirical evidence for either mechanism is available and the 
question of which of these mechanisms is involved in the generation of compound 2.82 
remains unanswered.  
Since it was now obvious that the terminal alkene was not necessary for the cyclisation to 
occur (Scheme 2.56 and Scheme 2.57), the chosen course of action was to synthesise a novel 
cyclisation precursor consisting solely of a diynone system. 
 
 
2.7. Synthesis of a Novel Cyclisation Precursor Consisting Solely of a Diynone System 
 
2.7.1. Outline of Investigation  
 
The novel cyclisation precursor 2.87 was selected in order to test the repeatability of the 
devised transformation (Scheme 2.55). 
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Figure 2.7: Novel Cyclisation Precursor 2.87 
 
The retrosynthetic approach envisaged for the cyclisation precursor 2.87 is shown in Scheme 
2.58 below. 
 
 
Scheme 2.58: Retrosynthetic Analysis of Cyclisation Precursor 2.87 
 
Ketone 2.87 can be generated from oxidation of the secondary alcohol 2.92, which can be 
obtained from the elaboration of protected alcohol 2.91. A disconnection at the ester moiety 
in 2.91 leads to the previously synthesised (3-(trimethylsilyl)-2-propynoic acid) 2.65 and 
alcohol 2.90. The latter can be easily synthesised by deprotonation of the terminal alkyne in 
2.89 and subsequent quenching with paraformaldehyde. Furthermore, compound 2.89 can be 
obtained from commercially available but-3-yn-2-ol 2.88. 
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2.7.2. Synthesis of Cyclisation Precursor 2.87 
 
Scheme 2.59 below illustrates the synthesis of desired material 2.90 
 
 
 
Reagents and Conditions: (a) 3,4-dihydro-2H-pyran, para-toluenesulphonic acid, CH2Cl2, 
0 °C to rt, 4h, 97%; (b) n-BuLi, THF then paraformaldehyde, -78 °C to rt, 16h, 83%. 
 
Scheme 2.59: Synthesis of Alcohol 2.90 
 
But-3-yn-2-ol 2.88 was protected in near quantitative yield as its tetrahydropyranyl ether 
using 3,4-dihydro-2H-pyran in the presence of catalytic amount of para-toluenesulphonic 
acid.
211
 Deprotonation of 2.89 was performed by the addition of one equivalent of n-
butyllithium solution at -78 °C. Warming to -20 °C to ensure complete proton abstraction and 
reaction of the resulting lithium salt with excess paraformaldehyde followed by quenching 
with saturated aqueous NH4Cl afforded desired alcohol 2.90.
139
 
The reaction of alcohol 2.90 with the acyl chloride derived from 3-(trimethylsilyl)-2-
propynoic acid 2.65 in the presence of 2,6-lutidine as a base, yielded desired ester 2.91 in 
82% yield.  
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 16h, 82%. 
 
Scheme 2.60: Synthesis of Ester 2.91 
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Once the protection was no longer needed, the THP group was removed with catalytic 
amount of PPTS in MeOH (78%).
193
 The oxidation of the secondary alcohol was performed 
in CH2Cl2 using DMP at room temperature and reached completion within 2 hours.
212
 
 
 
(a) PPTS, MeOH, 45 °C to rt, 6h, 78%; (b) DMP, CH2Cl2, 0 °C to rt, 2h, 83%. 
 
Scheme 2.61: Synthesis of Cyclisation Precursor 2.87 
  
The THP ether can be converted directly to an aldehyde or ketone using a variety of oxidative 
methods.
213
 In most of the examples, the reagent cleaves the THP ether and then oxidises the 
alcohol to the carbonyl derivatives. There are countless procedures available in the literature 
to oxidise THP protected alcohols to ketones.
213 
Inspiration came from our previous work on 
the oxidation of THP protected acetylenic alcohol employing chromic acid, generated from 
chromium(VI) trioxide and concentrated sulfuric acid.
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Reagents and Conditions: (a) 3.0M Jones’ reagent, acetone, rt, 3h, 92%. 
 
Scheme 2.62: Jones’ Oxidation of 2.91 
 
Oxidative deprotection of THP ether 2.91 with this solution proceeded in very high yield. 
Added advantages to the use of this procedure are short reaction times and easy work-up 
conditions. Often it was found that only a simple filtration through a short column of silica 
was all that was required to obtain pure ketone 2.87. 
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2.7.3. Thermolysis of Diynone 2.87  
 
Heating the newly formed cyclisation precursor 2.87 in anhydrous, degassed toluene at 
0.01M concentration for 24 hours resulted in the quantitative recovery of starting material 
2.87, with no sign of conversion to the cyclised product 2.93 or decomposition to any by-
products. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux, 24h. 
 
Scheme 2.63: Attempted Cyclisation of 2.87 in Refluxing Toluene 
 
The presence of 2,2-dimethylbut-3-en-1-yl group in the molecule appears to be of 
fundamental importance for the cyclisation to proceed. Early work on the synthesis and 
examination of enediyne fragments reinforced a relationship between the critical inter-nuclear 
distance of the forming carbon-carbon bond and the cyclisation barrier.
77,78
  
 
 
 
Scheme 2.64: Calculated cd Distance: Effect on the Bergman Cyclisation. 
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It could be then postulated that in cyclisation precursors containing a 2,2-dimethylbut-3-en-1-
yl group, the approach of the two acetylene moieties is facilitated by resonance an effect 
which would not be observed for the methyl analogue (Scheme 2.63). 
Moreover, there have been studies carried out on derivatives with increased cyclisation 
barriers; the large activation energy necessary for even unconstrained enediynes.
95
 For 
example, the presence of the two propyl groups on enediyne 1.120 significantly increases the 
temperature necessary for cyclisation relative to 1.119.  
 
 
 
Scheme 2.65: Examples of Enediyens that Undergo the Bergman Cyclisation 
 
As it appeared that the rate of reaction is directly proportional to the temperature as 
demonstrated in the examples by Nicolaou and co-workers,
95
 it should then be possible to 
cyclise the ketone analogue 2.87 by increasing the temperature. This would increase the 
statistical chance of the two acetylene moieties to encounter each other in space. To test this 
hypothesis, different solvents and temperatures were used for the newly discovered 
transformation; unfortunately no reaction took place (Table 2.7). 
 
 
 
Reagents and Conditions: (a) Solvent, time, yield, see Table 2.7. 
 
Scheme 2.66: Thermolysis of 2.87 
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Entry Solvents Boiling Temperatures (°C) Time Yield (%) 
 
1 
 
DMSO 
 
189 
 
30 min 
 
DM
a
 
2 DMF 153 30 min DM
a
 
3 p-Xylene 138 30 min DM
a
 
 
DM
a
 = decomposition of material 
 
Table 2.7: Different Conditions Tested for the Thermolysis of 2.87 
 
It was thought that the reaction temperature in the higher boiling solvents was so hot that 
thermal decomposition was a likely pathway. 
The only obvious difference between this substrate and the successfully cyclised 2.81 is the 
size of the substituent at the carbonyl centre. It could then be postulated that there is a 
fundamental necessity for a large substituent to aid the locking of the molecule in a 
favourable conformation as shown in Scheme 2.67 below. 
 
 
 
Scheme 2.67: Possible Substituent Effect during Cyclisation of 2.81  
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Steric interactions in the precursor 2.87 would be greatly diminished thus limiting the 
statistical chance of participation of the carbonyl group in the reaction. This may have been 
aided by the ester linkage which predominantly adopts transoid geometry over the reactive 
cisoid geometry.  
 
 
2.8. Investigation through Modification of the Ester Linker 
 
2.8.1. Outline of Investigation  
 
Following the assumption that the cyclisation was disfavoured by the transoid geometry, it 
was anticipated that exchange of the ester for an amide linker would enhance the cisoid 
geometry and increase the rate of reaction. Therefore, the chosen course of action was to 
synthesise a novel cyclisation precursor consisting of a N-substituted diyne system with a 
sterically demanding group attached to carbonyl centre. Due to the immediate availability of 
benzaldehyde in the laboratory, amide 2.94 was selected as a new synthetic target. 
 
 
 
Figure 2.8: Novel Cyclisation Precursor 2.94 
 
The retrosynthetic approach for cyclisation precursor 2.94 is depicted in Scheme 2.68 below. 
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Scheme 2.68: Retrosynthetic Analysis of Cyclisation Precursor 2.94 
 
Ketone 2.94 can be generated from oxidation of the secondary alcohol 2.99. A disconnection 
at the amide moiety in 2.99 leads to the previously synthesised (3-(trimethylsilyl)-2-
propynoic acid) 2.65 and secondary amine 2.98. The latter can be generated from protected 
amine 2.97 which can be obtained from the alkylation of benzaldehyde 2.95 by the lithium 
salt of alkyne 2.96. Furthermore, amine 2.96 can be obtained from commercially available N-
methylpropargylamine 2.7. 
 
 
2.8.2. Synthesis of Cyclisation Precursor 2.94 
 
The difficulties encountered in finding suitable conditions for the Boc-deprotection in 2.3, led 
us to identify a different protecting group for the secondary amino-group. Silyl amines are 
not frequently encountered in organic synthesis due to their sensitivity to moisture, which 
makes their handling a delicate task.
155
 However, they have been successfully employed in 
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the synthesis of some complex molecules. For example, Wang et al.
214
 have reported the use 
of the tri-isopropylsilyl protection in the synthesis of 2.103 (Scheme 2.69). 
 
 
 
 Reagents and Conditions: (a) n-BuLi, THF, -78 °C then TIPS-OTf, -78 °C to rt; (b) n-BuLi,  
-78 °C then TsCN, -78 °C to rt 72%; (c) 5 mol% Rh(OAc)2, dimethyl diazomalonate, DCE, 
reflux; (d) 5M HF in MeCN, rt, 60%. 
 
Scheme 2.69: Work by Wang et al.
214 
 
The silyl amine is stable to n-butyllithium and remarkably resilient to a metal carbenoid 
generated from diazomalonate and rhodium acetate. Silyl removal in this study was 
performed by action of a solution of hydrofluoric acid in acetonitrile.
214 
 
All the positive points described above prompted the study of silyl protection for the 
secondary amino group and due to its availability in the  laboratory the tri-isopropylsilyl 
group was chosen for the investigation.
104
 
The adaptation of the silyl protecting group for the synthesis of amine 2.98 is illustrated in 
Scheme 2.70 below. 
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Reagents and Conditions: (a) TIPS-OTf, Et3N, CH2Cl2, 0 °C to rt, 16h, 96%; (b) n-BuLi, 
THF, benzaldehyde, - 78 °C to rt, 16h, then sat. aq. NH4Cl, 96%; (c) 40% aq. HF, MeCN, rt, 
30 min., then 10% aq. K2CO3, 95%. 
 
Scheme 2.70:Silyl-Protection of N-Methylpropargylamine, Alkylation and Silyl-Deprotection 
 
Protection of N-methylpropargylamine 2.7 was achieved in quantitative yield with tri-
isopropylsilyl trifluoromethanesulfonate in the presence of triethylamine as an acid scavenger 
(96%). Deprotonation at the terminal acetylene of silyl-protected amine 2.104 and alkylation 
with a slight excess of benzaldehyde proceeded in 96% yield. After quenching with saturated 
aqueous ammonium chloride and washing with saturated aqueous sodium bisulfate to remove 
excess aldehyde via its bisulfate adduct,
205
 the product 2.105 was found to be adequately pure 
so further purification was not performed. This also reduces the required time for the 
synthesis and avoids the potentially problematic column chromatography of the silyl amine. 
Silyl deprotection of 2.105 was achieved using 40% aqueous hydrofluoric acid in acetonitrile 
inside a plastic container. A basic work-up furnished desired amine 2.98 as a white, pure 
solid in 87% yield. This material required no further purification.  
Once the amine 2.98 was in hand, formation of amide 2.99 could then be attempted through 
an amide coupling reaction. The reaction of amine 2.98 with the acyl chloride derived from 
3-(trimethylsilyl)-2-propynoic acid 2.65 in the presence of 2,6-lutidine as a base, yielded 
desired amide 2.99.  
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Reagents and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 0 °C to rt, 
80%. 
 
Scheme 2.71: Synthesis of Amide 2.99 
 
The next step in the synthetic sequence was the oxidation of the secondary alcohol in newly 
formed amide 2.99. Our previous work on the oxidation of acetylenic alcohols prompted our 
decision to employ chromic acid, generated from chromium(VI) trioxide and concentrated 
sulfuric acid. 
 
 
 
Reagents and Conditions: (a) 3.0M Jones’ reagent, acetone, rt, 96%. 
 
Scheme 2.72: Jones’ Oxidation of 2.99 
 
 
2.8.3. Thermolysis of 1,6-Diynone 2.94 
 
The next step was to test the thermolysis of 2.94 in refluxing anhydrous, degassed toluene. 
Identical to previous cyclisations a 0.01M concentration of the starting material was chosen. 
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Reagents and Conditions: (a) Toluene, 0.01M, reflux, 24h. 
 
Scheme 2.73: Attempted Cyclisation of 2.94 in Refluxing Toluene 
 
Unfortunately the above thermolysis failed to give any isolable products. A single product 
was produced which was found to be unstable to moisture, light, prolonged heating in various 
solvents and mild acidic conditions. 
 
 
2.9. Investigation through Modification of the Ether Linker 
 
2.9.1. Outline of Investigation  
 
To further investigate the mechanism and scope of the cyclisation, the model system 2.111 
was proposed. 
 
 
 
Figure 2.9: Novel Cyclisation Precursor 2.111 
 
Conversion of the ether linker to a carbon scaffold was used to assess the versatility of the 
cyclisation model. Template 2.112 contains indene-2,2-dicarboxylate, lactone functionality 
and allyl silane, all of which would enable greater diversifications and widely applicable 
methodology for the construction of polycyclic systems.  
231 
 
The retrosynthetic approach for cyclisation precursor 2.111 is depicted in Scheme 2.74 
below. 
 
 
 
Scheme 2.74: Retrosynthetic Analysis of Cyclisation Precursor 2.111 
 
A disconnection at the ester moiety leads to the previously synthesised (3-(trimethylsilyl)-2-
propynoic acid) 2.65 and alcohol 2.110. The latter can be easily synthesised by deprotonation 
of the terminal alkyne in 2.109 and subsequent quenching with acetaldehyde. Alkyne 2.109 
can be generated by the reaction of compound 2.108 and the propargyl bromide 2.49. 
Furthermore, compound 2.108 can be obtained from commercially available dimethyl 
malonate 2.107. 
 
 
2.9.2. Synthesis of Cyclisation Precursor 2.111 
 
Scheme 2.75 below illustrates the synthesis of desired material 2.111. 
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Reagents and Conditions: (a) NaH, 2,3-dibromopropene, THF, 0 °C to rt, 16h, 67%; (b) NaH, 
propargyl bromide, THF, 0 °C to rt, 16h, 96%; (c) n-BuLi, THF then acetaldehyde, -78 °C to 
rt, 16h, 96%. 
 
Scheme 2.75: Synthesis of Alcohol 2.110 
 
Deprotonation of the dimethyl malonate 2.107 with sodium hydride and treatment with 2,3-
dibromopropene afforded the desired compound 2.108 in 67% yield.
215
 Propargylation of the 
compound 2.108 was carried out by using NaH, followed by the addition of propargyl 
bromide 2.49. Treatment of the dimethyl 2-(2-bromoallyl)malonate 2.109 with n-butyllithium 
in THF, followed by subsequent addition of acetaldehyde at -78 °C afforded the desired 
alcohol 2.110.
139 
The reaction of alcohol 2.110 with the acyl chloride derived from 3-
(trimethylsilyl)-2-propynoic acid 2.65 in the presence of 2,6-lutidine, as a base yielded 
desired cyclisation precursor 2.111. 
 
 
 
Reagent and Conditions: (a) Oxalyl chloride, DMF(cat.), 2,6-lutidine, CH2Cl2, 16h,  69%. 
 
Scheme 2.76: Synthesis of Cyclisation Precursor 2.111 
 
Advanced intermediate 2.111 was synthesised, however the investigations could not be 
completed due to time constraints. 
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Chapter 3. 
Conclusion & Future Work 
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The development of a route for the synthesis of cyclisation precursor 2.111 has been 
developed and the synthesis of cyclisation precursor 2.111 has successfully achieved. Once 
cyclisation precursors 2.111 in hand, the standard cyclisation conditions should provide the 
tricycles 2.112. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, 1,2-epoxyhexene, reflux. 
 
Scheme 3.1: Thermal Cyclisation of Precursors 2.111 
 
The overall findings from this DPhil project will enable the rapid construction of complex 
ring systems as templates for drug design. This evidence gives support to the theory that a 
range of structures, richly substituted with functional groups could be synthesised using the 
thermal cyclisation reaction developed within the Parsons’ research group.  
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, 1,2-epoxyhexene, reflux. 
 
Scheme 3.2: Construction of Complex Ring Systems 
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Template 3.2 contains pyrrole and lactone/lactam functionality and allyl silane, all of which 
can be used to create structural diversity. Boracycles 3.4 can be prepared and their chemistry 
investigated. The novel chemistry of these compounds will be very exciting as bridge boranes 
3.5 can be readily made as well as cyclopentadieneones 3.6. 
 
 
 
Reagents and Conditions: (a) Diels-Alder; (b) KCN (or CO), H2O2. 
 
Scheme 3.3: The Novel Chemistry of Boracycles 
 
Seco-prezizaane-type sesquiterpene Jiadifenin
216
 3.9 is a biologically and structurally 
interesting molecule that provides the organic chemist with a rewarding synthetic challenge. 
For example, the tricyclic core of Jiadifenin can be synthesised using the thermal cyclisation 
reaction discovered within the Parsons’ research group. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux. 
 
Scheme 3.4: Proposed Route to Synthesise Tricyclic Core of Jiadifenin 
 
Alternatively the tricyclic core of Jiadifenin can be synthesised using cyclisation precursor 
3.10.  
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Reagents and Conditions: (a) Toluene, 0.01M, reflux. 
 
Scheme 3.5: Proposed Route to Synthesise Tricyclic Core of Jiadifenin 
 
The biodiversity associated with the drimane-type sesquiterpeniods makes these compounds 
attractive targets. In addition, the analogues of these structures shown herein allows for 
diversity in an array of new structures and the synthesis of natural products. The tricyclic core 
of drimane-type sesquiterpeniods can also be synthesised using the thermal cyclisation 
reaction developed within the Parsons’ research group. 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux. 
 
Scheme 3.6: Proposed Route to Synthesise Tricyclic Core of Drimane-type Sesquiterpeniods 
 
237 
 
Furthermore, the 1,6-diynone analogue 2.81 cyclised to give alkyne 2.82. In order to further 
investigate this transformation the esters 3.16a-b can be selected as new synthetic targets. 
 
 
 
Reagents and Conditions: (a) Toluene, 0.01M, reflux. 
 
Scheme 2.7: Thermolysis of Cyclisation Precursors 3.16a-b 
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Section 
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4.1.General Procedure 
 
Reactions were carried out under a nitrogen atmosphere in oven-dried glassware at room 
temperature (rt) unless otherwise stated. Standard inert atmosphere techniques were used in 
handling all air and moisture sensitive reagents. Flash column chromatography was carried 
out on Merck Kieselgel (230-400 mesh). All reactions were followed by thin-layer 
chromatography (TLC) where possible; using Merck aluminium backed sheets coated with 
Merck Kieselgel 60 F254 (230-400 mesh) fluorescent treated silica. These were visualised 
under UV light (λmax= 254 or 365 nm) and developed using potassium permanganate or 
vanillin stains. 
Reaction solvents were purified and dried according to literature methods; tetrahydrofuran 
and diethyl ether were distilled from sodium with benzophenone as an indicator. CH2Cl2, 
toluene, methanol and acetonitrile were distilled from CaH2 under a positive pressure of dry 
nitrogen. Et3N, 2,6-lutidine and pyridine were also distilled from CaH2 and stored over KOH 
under nitrogen. Petroleum ether refers to the fraction boiling at 40-60 °C. Bulk solutions were 
evaporated under reduced pressure using a rotary evaporator. Other solvents and reagents 
were used as supplied. Brine refers to a saturated aqueous solution of NaCl. Salicylaldehyde 
phenylhydrazone was used as an indicator for the titration of organometallic species, 
including Grignard reagents.  
1
H NMR spectra were recorded on a Varian 500 MHz machine (operating at ambient probe 
temperature using an internal deuterium lock). Chemical shifts (δ) are given in parts per 
million (ppm), and coupling constants (J) are given in Hertz (Hz). The 
1
H NMR spectra are 
reported as follows: δ/ppm (multiplicity, coupling constant J/Hz (where appropriate), number 
of protons). Multiplicity is abbreviated as follows: s = singlet, br s = broad singlet, d = 
doublet, br d = broad doublet, app br d = apparent broad doublet, dd = doublet of doublets, t 
= triplet, dt = doublet of triplet, q = quartet, dq = doublet of quartet, quint = quintet, m = 
multiplet, app s = apparent singlet, app d = apparent doublet, app t = apparent triplet, app q = 
apparent quartet. 
13
C NMR spectra were recorded at 126 MHz. The 
13
C NMR spectra are 
reported in δ/ppm. Two-dimensional (COSY, HSQC, H2BC, HMBC) NMR spectroscopy 
were used to assist the assignment of signals in the 
1
H and 
13
C NMR spectra.  
ESI Mass spectra were recorded on a Bruker Daltonics Apex III spectrometer with methanol 
or diethyl ether as solvents. EI mass spectra were recorded on a Fisons VG Autospec 
spectrometer by the internal service at the Department of Chemistry, University of Sussex.   
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IR spectra were recorded neat on a Perkin Elmer Spectrum One FT-IR spectrometer with a 
diamond ATR module and only selected maximum absorbances (νmax) of the most intense 
peaks are reported (cm
-1
).   
Melting points were recorded using a Leica Galen III hot-stage microscope apparatus and are 
reported uncorrected in degrees Celsius (°C). 
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4.2. Compounds 
 
tert-Butyldimethyl(prop-2-yn-1-yloxy)silane: (2.16) 
 
 
 
To a stirred solution of 2-propynol 2.12 (10.0 g, 178 mmol) in dry CH2Cl2 (200 mL) at 0 ºC 
was added tert-butyldimethylsilyl chloride (32.3 g, 214 mmol) and imidazole (30.4 g, 446 
mmol). After 1 hour, the reaction mixture was quenched with water. The phases were 
separated and the aqueous phase was extracted twice with CH2Cl2. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous sodium 
sulfate and concentrated under reduced pressure to give a colourless liquid. Distillation under 
reduced pressure afforded 29.74 g (98%) of clear colourless liquid. 
Spectroscopic data are in agreement with the literature values
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b.p.: 52 
o
C (14 Torr) 
 
IR (neat) v (cm
-1
) 3312, 2956, 2887, 2859, 2121, 1256, 1098, 838, 779. 
 
1
H NMR (500 MHz, CDCl3) δ 4.29 (d, J = 2.4 Hz, 2H), 2.38 (t, J = 2.4 Hz, 1H), 0.92 (s, 9H), 
0.13 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 82.4 (C), 72.7 (CH), 51.4 (CH2), 25.6 (CH3), 18.1 (C), -5.2 
(CH3). 
 
HRMS (ESI+) calculated for C9H18OSi [M]
+
: 170.1127, found: 170.1131. 
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tert-Butyl((3-((chloromethyl)dimethylsilyl)prop-2-yn-1-yl)oxy)dimethylsilane: (2.17) 
 
 
 
To a stirred solution of alkyne 2.16 (24.0 g, 141 mmol) in dry THF (250 mL) at -78 ºC was 
added n-BuLi (2.3 M solution in hexanes, 64.4 mL, 148 mmol). The reaction was stirred 10 
minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of chloro(chloromethyl) dimethylsilane (21.18 g, 19.50 mL, 148 mmol). 
The reaction mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was 
then quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a yellowish 
liquid. The crude product 2.17 was purified by flash chromatography on a silica gel column 
eluting with 15% diethyl ether in hexanes to give the title compound 2.17 (33 g, 85%) as a 
pale yellow oil. 
 
IR (neat) v (cm
-1
) 2930, 2858, 2177, 1470, 1362, 1252, 1092, 816, 777.  
 
1
H NMR (500 MHz, CDCl3) δ 4.30 (s, 2H), 2.83 (s, 2H), 0.90 (s, 9H), 0.29 (s, 6H), 0.13 (s, 
6H).  
 
13
C NMR (126 MHz, CDCl3) δ 106.5 (C), 85.9 (C), 52.1 (CH2), 29.7 (CH2), 25.7 (CH3), 18.1 
(C), -3.4 (CH3), -5.1 (CH3).  
 
HRMS (ESI+) calculated for C12H25ClOSi2Na [M+Na]
+
: 299.1025, found: 299.1024. 
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tert-Butyl((3-((iodomethyl)dimethylsilyl)prop-2-yn-1-yl)oxy)dimethylsilane: (2.19) 
 
 
 
To a stirred solution of sodium iodide (21.71 g, 144 mmol) in dry acetone (70 mL) was 
slowly added a solution of alkyl chloride 2.17 (20.0 g, 72 mmol) in dry acetone (210 mL). 
The reaction mixture was left to stir at rt for 16 hours. Subsequently, the precipitate was 
filtered off, washed once with acetone and the solvent was evaporated under reduced pressure 
to give a yellow oil. The crude product 2.19 was purified by flash chromatography on a silica 
gel column eluting with 5% diethyl ether in hexanes to give the title compound 2.19 (24.13 g, 
91%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 2955, 2929, 2857, 2177, 1468, 1363, 1252, 1092, 1001, 813, 776, 715, 674. 
 
1
H NMR (500 MHz, CDCl3) δ 4.31 (s, 2H), 2.07 (s, 2H), 0.91 (s, 9H), 0.30 (s, 6H), 0.13 (s, 
6H). 
 
13
C NMR (126 MHz, CDCl3) δ 106.2 (C), 86.4 (C), 52.2 (CH2), 25.8 (CH3), 18.2 (C), -1.7 
(CH3), -5.0 (CH3), -14.5 (CH2). 
 
HRMS (ESI+) calculated for C12H25lOSi2Na [M+Na]
+
: 391.0381, found: 391.0378. 
 
 
 
 
 
 
 
 
 
 
244 
 
But-3-en-1-yl(3-((tert-butyldimethylsilyl)oxy)prop-1-yn-1-yl)dimethylsilane: (2.18) 
 
 
 
Preparation of dilithium tetrachlorocuprate(II) solution (Li2CuCl4): 
To a stirred solution of LiCl (2.12 g, 50 mmol) in dry THF (250 mL) at 0 °C was added 
CuCl2 (3.36 g, 25 mmol). The approximate molarity of the resultant solution was 0.1M. 
 
Allylmagnesium chloride (2.0 M solution in THF, 40.72 mL, 81.44 mmol) was added to a 
stirred solution of alkyl iodide 2.19 (15.0 g, 40.72 mmol) in dry THF (75 mL) at 0 °C 
followed by the addition of a solution of Li2CuCl4 (0.1M solution in THF, 203.6 mL, 20.36 
mmol). The reaction was allowed to warm to rt and left to stir for 16 hours. Subsequently, the 
reaction mixture was quenched with saturated aqueous NH4Cl solution. The phases were 
separated and the aqueous phase was extracted twice with diethyl ether. The organic layers 
were combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give an dark yellow 
liquid. The crude product 2.18 was purified by flash chromatography on a silica gel column 
eluting with 5% diethyl ether in hexanes to give the title compound 2.18 (8.56 g, 77%) as a 
yellow oil. 
 
IR (neat) v (cm
-1
) 2956, 2926, 2905, 2857, 2177, 1640, 1472, 1467, 1362, 1252, 1093, 1000, 
833, 777, 722, 648, 663, 621. 
 
1
H NMR (500 MHz, CDCl3) δ 5.89 (ddt, J = 16.5, 10.1, 6.2 Hz, 1H), 5.01 (dd, J = 17.1, 1.7 
Hz, 1H), 4.90 (dd, J = 10.1, 1.4 Hz, 1H), 4.25 (s, 2H),  2.20 – 2.12 (m, 2H), 0.92 (s, 9H), 0.75 
– 0.70 (m, 2H), 0.17 (s, 3H), 0.16 (s, 3H), 0.13 (s, 6H). 
 
13
C NMR (125 MHz, CDCl3) δ 141.0 (CH), 112.9 (CH2), 105.2 (C), 88.5 (C),  52.2 (CH2), 
27.8 (CH2), 25.7 (CH3), 18.2 (C), 15.1 (CH2), -0.2 (CH3), -1.7 (CH3), -5.0 (CH3).  
 
HRMS (ESI+) calculated for C15H30OSi2Na [M+Na]
+
: 305.1727, found: 305.1723. 
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Triethyl(prop-2-yn-1-yloxy)silane: (2.22) 
 
 
 
To a stirred solution of 2-propynol 2.12 (10.0 g, 178 mmol) in DMF (200 mL) at 0 ºC was 
added chlorotriethylsilane (32.25 g, 214 mmol) and imidazole (30.4 g, 446 mmol). After 1 
hour, the reaction mixture was quenched with 1% aqueous Na2CO3 solution. The phases were 
separated and the aqueous phase was extracted twice with diethyl ether. The organic layers 
were combined, washed once with water, washed once with brine, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a pale yellow liquid. 
Distillation under reduced pressure afforded 26.07 g (86%) of clear colourless liquid. 
Spectroscopic data are in agreement with the literature values.
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b.p.: 74 – 75 °C (15 Torr). 
 
IR (neat) v (cm
-1
) 3313, 2955, 2911, 2875, 2122, 1459, 1413, 1371, 1238, 1068, 1003, 971, 
726, 664. 
 
1
H NMR (500 MHz, CDCl3) δ 4.31 (d, J = 2.4 Hz, 2H), 2.39 (t, J = 2.4 Hz, 1H), 0.99 (t, J = 
7.9 Hz, 9H), 0.66 (q, J = 7.8 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 82.3 (C), 72.7 (CH), 51.1 (CH2), 6.6 (CH3), 4.4 (CH2). 
 
HRMS (ESI+) calculated for C9H18OSiNa [M+Na]
+
: 193.1019, found: 193.1023. 
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(Chloromethyl)dimethyl(3-((triethylsilyl)oxy)prop-1-yn-1-yl)silane: (2.23) 
 
 
 
To a stirred solution of alkyne 2.22 (24.0 g, 141 mmol) in dry THF (250 mL) at -78 ºC was 
added n-BuLi (2.3 M solution in hexanes, 64.4 mL, 148 mmol). The reaction was stirred 10 
minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of chloro(chloromethyl) dimethylsilane (21.18 g, 19.50 mL, 148 mmol). 
The reaction mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was 
then quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a yellowish 
liquid. The crude product 2.23 was purified by flash chromatography on a silica gel column 
eluting with 15% diethyl ether in hexanes to give the title compound 2.23 (33 g, 85%) as a 
pale yellow oil. 
 
IR (neat) v (cm
-1
) 2956, 2929, 2901, 2857, 2181, 1472, 1362, 1252, 1095, 1003, 835, 722, 
648.  
 
1
H NMR (500 MHz, CDCl3) δ 4.31 (s, 2H), 2.84 (s, 2H), 0.98 (t, J = 7.9 Hz, 9H), 0.66 (q, J = 
7.9 Hz, 6H), 0.29 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 106.3 (C), 85.8 (C), 51.7 (CH2), 29.8 (CH2), 6.6 (CH3), 4.4 
(CH2), -3.4 (CH3). 
 
Ion not found 
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Triethyl((3-((iodomethyl)dimethylsilyl)prop-2-yn-1-yl)oxy)silane: (2.24) 
 
 
 
To a stirred solution of sodium iodide (21.71 g, 144 mmol) in dry acetone (70 mL) was added 
a solution of alkyl chloride 2.23 (20.0 g, 72 mmol) in dry acetone (210 mL). The reaction 
mixture was stirred at rt for 16 hours. Subsequently, the precipitate was filtered off, washed 
once with acetone and the solvent was evaporated under reduced pressure to give a yellow 
oil. The crude product 2.24 was purified by flash chromatography on a silica gel column 
eluting with 5% diethyl ether in hexanes to give the title compound 2.24 (23.41 g, 88%) as a 
yellow oil. 
 
IR (neat) v (cm
-1
) 2955, 2911, 2876, 2179, 1458, 1375, 1255, 1060, 836, 800, 726, 690.  
 
1
H NMR (500 MHz, CDCl3) δ 4.32 (s, 2H), 2.07 (s, 2H), 0.98 (t, J = 7.9 Hz, 9H), 0.66 (q, J = 
7.9 Hz, 6H), 0.30 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 106.0 (C), 86.3 (C), 51.8 (CH2), 6.6 (CH3), 4.4 (CH2), -1.7 
(CH3), -14.6 (CH2).  
 
HRMS (ESI+) calculated for C12H25IOSi2Na [M+Na]
+
: 391.0381, found: 391.0371. 
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But-3-en-1-yldimethyl(3-((triethylsilyl)oxy)prop-1-yn-1-yl)silane: (2.25) 
 
 
 
Allylmagnesium chloride (2.0 M solution in THF, 40.72 mL, 81.44 mmol) was added to a 
stirred solution of alkyl iodide 2.24 (15.0 g, 40.72 mmol) in dry THF (75 mL) at 0 °C 
followed by addition of a solution of Li2CuCl4 (0.1M solution in THF, 203.6 mL, 20.36 
mmol). The reaction was allowed to warm to rt and left to stir for 16 hours. Subsequently, the 
reaction mixture was quenched with saturated aqueous NH4Cl solution. The phases were 
separated and the aqueous phase was extracted twice with diethyl ether. The organic layers 
were combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give an orange liquid. 
The crude product 2.25 was purified by flash chromatography on a silica gel column eluting 
with 5% diethyl ether in hexanes to give the title compound 2.25 (9.20 g, 80%) as a yellow 
oil. 
 
IR (neat) v (cm
-1
) 2956, 2912, 2878, 2177, 1640, 1459, 1413, 1363, 1250, 1090, 1000, 840 
814, 776.  
 
1
H NMR (500 MHz, CDCl3) δ 5.90 (ddt, J = 16.6, 10.2, 6.3 Hz, 1H), 5.01 (dd, J = 17.0, 1.6 
Hz, 1H), 4.90 (dd, J = 10.1, 1.1 Hz, 1H),  4.32 (s, 2H), 2.19 – 2.11 (m, 2H), 0.99 (t, J = 7.9 
Hz, 9H), 0.75 – 0.71 (m, 2H), 0.66 (q, J = 7.9 Hz, 6H), 0.17 (s, 3H), 0.16 (s, 3H).  
 
13
C NMR (126 MHz, CDCl3) δ 141.1 (CH), 112.9 (CH2), 105.0 (C), 88.4 (C),  51.8 (CH2), 
27.8 (CH2), 15.1 (CH2), 6.6 (CH3), 4.5 (CH2), -0.3 (CH3), -1.9 (CH3). 
 
HRMS (ESI+) calculated for C15H30OSi2Na [M+Na]
+
: 305.1727, found: 305.1723. 
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2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran: (2.27) 
 
 
 
Propargyl alcohol 2.12 (8.41 g, 150 mmol) was added dropwise to a stirring solution of 3,4-
dihydro-2H-pyran (18.93 g, 225 mmol) and para-toluenesulphonic acid monohydrate (7.5 
mg) in CH2Cl2 (225 mL) at 0 °C. The reaction was allowed to warm to rt and left to stir for 4 
hours. Subsequently, the resultant solution was diluted with diethyl ether and washed once 
with half-saturated brine to remove the catalyst, dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure to give a pale yellow oil. The crude product 
2.27 was purified by flash chromatography on a silica gel column eluting with 30% diethyl 
ether in hexanes to give the title compound 2.27 (19.97 g, 95%) as a colourless oil. 
Spectroscopic data are in agreement with the literature values.
217
 
 
IR (neat) v (cm
-1
) 3291, 2942, 2879, 2122, 1442, 1350, 1261, 1202, 1118, 1023, 954, 874, 
816. 
  
1
H NMR (500 MHz, CDCl3) δ 4.77 (t, J = 3.1 Hz, 1H), 4.27 (dd, J = 15.7, 2.5 Hz, 1H), 4.22 
(dd, J = 15.7, 2.5 Hz, 1H), 3.84 – 3.78 (m, 1H), 3.53 – 3.44 (m, 1H), 2.38 (t, J = 2.4 Hz, 1H), 
1.85 – 1.42 (m, 6H). 
 
13
C NMR (125 MHz, CDCl3) δ 96.7 (CH), 79.7 (C), 73.9 (CH), 61.8 (CH2), 53.8 (CH2), 30.1 
(CH2), 25.2 (CH2), 18.1 (CH2). 
 
HRMS (ESI+) calculated for C8H12O2Na [M+Na]
+
: 163.0781, found: 163.0779. 
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(Chloromethyl)dimethyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)silane: (2.28) 
 
 
 
To a stirred solution of alkyne 2.27 (18.0 g, 128 mmol) in dry THF (200 mL) at -78 ºC was 
added n-BuLi (2.3 M solution in hexanes, 58.69 mL, 135 mmol). The reaction was stirred 10 
minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of chloro(chloromethyl) dimethylsilane (19.32 g, 17.79 mL, 135 mmol). 
The reaction mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was 
then quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a yellow liquid. 
The crude product 2.28 was purified by flash chromatography on a silica gel column eluting 
with 30% diethyl ether in hexanes to give the title compound 2.28 (29.25 g, 89%) as a yellow 
oil. 
 
IR (neat) v (cm
-1
) 2942, 2870, 2854, 2179, 1443, 1391, 1343, 1253, 1120, 1060, 1026, 802, 
815, 795.  
 
1
H NMR (500 MHz, CDCl3) δ 4.81 (t, J = 3.4 Hz, 1H), 4.32 – 4.22 (m, 2H), 3.87 – 3.80 (m, 
1H), 3.57 – 3.51 (m, 1H), 2.86 (s, 2H), 1.88 – 1.49 (m, 6H), 0.30 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 103.6 (C), 96.7 (CH), 87.0 (C), 61.8 (CH2), 54.7 (CH2), 30.1 
(CH2), 29.0 (CH2), 25.1 (CH2), 18.2 (CH2), -3.8 (CH3). 
 
HRMS (ESI+) calculated for C11H19ClO2SiNa [M+Na]
+
: 269.0729, found: 269.0735. 
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(Iodomethyl)dimethyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)silane: (2.29) 
 
 
 
To a stirred solution of sodium iodide (26.72 g, 178 mmol) in dry acetone (70 mL) was 
slowly added a solution of alkyl chloride 2.28 (22.0 g, 89 mmol) in dry acetone (210 mL). 
The reaction mixture was stirred at rt for 16 hours. After which time, the precipitate was 
filtered off, washed once with acetone and the solvent was evaporated under reduced pressure 
to give a yellow oil. The crude product 2.29 was purified by flash chromatography on a silica 
gel column eluting with 10% diethyl ether in hexanes to give the title compound 2.29 (24.69 
g, 82%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2941, 2875, 2854, 2183, 1440, 1343, 1252, 1120, 1025, 814, 713, 673, 652,   
 
1
H NMR (500 MHz, CDCl3) δ 4.81 (t, J = 3.3 Hz, 1H), 4.31 – 4.20 (m, 2H), 3.86 – 3.78 (m, 
1H), 3.55 – 3.48 (m, 1H), 2.07 (s, 2H), 1.88 – 1.47 (m, 6H), 0.30 (s, 6H).  
 
13
C NMR (126 MHz, CDCl3) δ 103.3 (C), 96.7 (CH), 87.6 (C), 61.9 (CH2), 54.6 (CH2), 30.2 
(CH2), 25.3 (CH2), 18.9 (CH2), -1.6 (CH3), -14.5 (CH2). 
 
HRMS (ESI+) calculated for C11H19IO2SiNa [M+Na]
+
: 361.0100, found: 361.0091. 
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But-3-en-1-yldimethyl(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)silane: (2.30) 
 
 
 
Allylmagnesium chloride (2.0 M solution in THF, 53.21 mL, 106.0 mmol) was added to a 
stirred solution of alkyl iodide 2.29 (18.0 g, 53.0 mmol) in dry THF (80 mL) at 0 °C followed 
by the addition of a solution of Li2CuCl4 (0.1M solution in THF, 265.0 mL, 26.5 mmol). The 
reaction was allowed to warm to rt and left to stir for 16 hours. Subsequently, the reaction 
mixture was quenched with saturated aqueous NH4Cl solution. The phases were separated 
and the aqueous phase was extracted twice with diethyl ether. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a pale orange 
liquid. The crude product 2.30 was purified by flash chromatography on a silica gel column 
eluting with 10% diethyl ether in hexanes to give the title compound 2.30 (10.16 g, 76%) as a 
yellow oil. 
 
IR (neat) v (cm
-1
) 2945, 2930, 2875, 2853, 2176, 1642, 1442, 1344, 1251, 1120, 1026, 992, 
900, 840, 817, 779, 696. 
 
1
H NMR (500 MHz, CDCl3) δ 5.88 (ddt, J = 16.6, 10.2, 6.3 Hz, 1H), 5.00 (dd, J = 17.1, 1.6 
Hz, 1H), 4.90 (dd, J = 10.1, 1.2 Hz, 1H), 4.81 (app. dd, J = 7.2, 3.6 Hz, 1H), 4.30 – 4.19 (m, 
2H), 3.86 – 3.80 (m, 1H), 3.55 – 3.49 (m, 1H), 2.16 – 2.10 (m, 2H), 1.87 – 1.49 (m, 6H), 0.75 
– 0.70 (m,  2H), 0.17 (s, 3H), 0.16 (s, 3H). 
 
13
C NMR (126 MHz, CDCl3) Anomer A: δ 140.8 (CH), 112.9 (CH2), 102.2 (C), 96.6 (CH), 
89.7 (C), 61.9 (CH2), 54.7 (CH2), 30.2 (CH2), 27.8 (CH2), 25.3 (CH2), 19.0 (CH2), 15.1 
(CH2), -0.2 (CH3), -1.7 (CH3); Anomer B: δ 101.5 (C), 96.7 (CH), 90.7 (C), 61.8 (CH2), 54.7 
(CH2), 30.2 (CH2), 19.9 (CH2). 
 
HRMS (ESI+) calculated for C14H24O2SiNa [M+Na]
+
: 275.1438, found 275.1435. 
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3-(But-3-en-1-yldimethylsilyl)prop-2-yn-1-ol: (2.20) 
 
 
 
To a stirred solution of tetrahydropyranyl ether 2.30 (3.80 g, 15.07 mmol) in methanol (30 
mL) was added pyridinium para-toluenesulfonate (PPTS; 3 mg). The reaction was stirred at 
rt for 3 hours and then quenched with saturated aqueous NaHCO3 solution. The phases were 
separated and the aqueous phase was extracted three times with ethyl acetate. The organic 
layers were combined, washed once with brine, dried over anhydrous sodium sulfate, filtered 
and concentrated under reduced pressure to give a yellow oil. The crude product 2.20 was 
purified by flash chromatography on a silica gel column eluting with 30% diethyl ether in 
hexanes to give the title compound 2.20 (0.98 g, 39%) as a yellow oil. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 5.84 (ddt, J = 16.5, 10.2, 6.2 
Hz, 1H), 4.97 (dd, J = 17.1, 1.6 Hz, 1H), 4.86 (dd, J = 10.1, 1.2 Hz, 1H), 4.20 (s, 2H), 3.05 
(br s, 1H), 2.12 – 2.06 (m, 2H), 0.71 – 0.65 (m, 2H), 0.12 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 140.9 (CH), 113.0 (CH2), 104.7 (C), 89.1 (C), 51.6 (CH2), 
27.7 (CH2), 15.0 (CH2), -0.2 (CH3), -1.8 (CH3). 
 
HRMS (ESI+) calculated for C9H16OSiNa [M+Na]
+
: 191.0981, found 191.0992. 
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3-(But-3-en-1-yldimethylsilyl)propiolic acid: (2.4) 
 
 
 
Preparation of Jones’ reagent:  
 
To a stirred solution of chromium(VI) trioxide (67 g, 670 mmol) in water (125 mL) at 0 °C 
was carefully added concentrated H2SO4 (110.2 g, 58 mL, 1.124 mol). Residual salts at the 
bottom of the flask were then dissolved using the minimum quantity of water necessary. The 
approximate molarity of the resultant solution was 3.0M. 
To a stirred solution of tetrahydropyranyl ether 2.30 (6.0 g, 35.65 mmol) in acetone (75 mL) 
at 0 °C was slowly added Jones’ reagent (3.0M solution, 35.65 mL, 106.95 mmol). The 
resultant mixture was stirred at 0 °C for 1 hour, it was then allowed to warm to rt and stirred 
for a further 3 hours. Subsequently, the reaction mixture was quenched with water, the phases 
were separated and the aqueous phase was extracted twice with diethyl ether. The organic 
layers were combined, dried over anhydrous sodium sulfate, filtered and concentrated under 
reduced pressure to give a pale brown liquid. The crude product 16 was used directly in the 
next step without future purifications (6.49, 96%). 
 
IR (neat) v (cm
-1
) 2964, 2930, 2176, 1690, 1406, 1252, 1054, 994, 908, 843, 822, 784,760, 
731. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 10.48 (br s, 1H), 5.87 (ddt, J 
= 16.5, 10.1, 6.3 Hz, 1H), 4.99 (dd, J = 17.1, 1.6 Hz, 1H), 4.89 (dd, J = 10.1, 1.4 Hz, 1H), 
2.19 – 2.12 (m, 2H), 0.83 – 0.78 (m, 2H), 0.24 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 156.9 (C), 140.2 (CH), 113.6 (CH2), 96.0 (C), 94.5 (C), 27.5 
(CH2), 14.2 (CH2), -2.5 (CH3). 
 
Ion not found 
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tert-Butyl methyl(prop-2-yn-1-yl)carbamate: (2.6) 
 
 
 
To a stirred solution of N-methylpropargylamine 2.7 (4.00 g, 57.9 mmol) and pyridine (5.49 
g, 5.59 mL 69.5 mmol) in dry diethyl ether (100 mL) at 0 °C was added di-tert-butyl 
dicarbonate (15.2 g, 69.5 mmol). The resultant solution was allowed to warm to rt and left to 
stir for 16 hours. Subsequently, the reaction mixture was quenched with water, the phases 
were separated and the aqueous phase was extracted three times with ethyl acetate. The 
organic layers were combined, washed once with brine, dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The crude 
product 2.6 was purified by flash chromatography on a silica gel column eluting with 10% 
diethyl ether in petroleum ether to give the title compound 2.6 (9.4 g, 96%) as a clear 
colourless oil. 
Spectroscopic data are in agreement with the literature values.
139
 
 
IR (neat) v (cm
-1
) 3308, 2978, 2933, 1699, 1482, 1454, 1421, 1392, 1368, 1249, 1152, 1050.  
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.00 (br s, 2H), 2.87 (s, 3H), 
2.17 (t, J = 2.5 Hz, 1H), 1.40 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 155.0 (C), 80.0 (C), 79.0 (C), 71.4 (CH), 37.8 (CH2), 33.2 
(CH3), 28.2 (CH3).  
 
HRMS (ESI+) calculated for C9H15NO2Na [M+Na]
+
: 192.0900, found: 192.0995. 
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tert-Butyl (4-hydroxybut-2-yn-1-yl)(methyl)carbamate: (2.5) 
 
 
 
To a stirred solution of alkyne 2.6 (4.0 g, 23.6 mmol) in dry THF (80 mL) at -78 ºC was 
added n-BuLi (2.3 M solution in hexanes, 11.3 mL, 26.0 mmol). The reaction was stirred 10 
minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of powdered paraformaldehyde (1.42 g, 47.3 mmol). The reaction mixture 
was allowed to warm to rt and left to stir for 16 hours. The reaction was then quenched at 0 
°C with saturated aqueous NH4Cl solution. The phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with water, washed once with brine, dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure to give a yellowish liquid. The crude product 2.5 was 
purified by flash chromatography on a silica gel column eluting with 30% diethyl ether in 
hexanes to give the title compound 2.5 (4.70 g, 78%) as a pale yellow oil. 
Spectroscopic data are in agreement with the literature values.
139
 
 
IR (neat) v (cm
-1
) 3411, 2975, 2932, 2870, 1681, 1480, 1451, 1398, 1366, 1349, 1248, 1230, 
1145, 1128, 1048, 1023, 869, 771, 666. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.22 (s, 2H), 4.02 (s, 2H), 
2.94 (br s, 1H), 2.85 (s, 3H), 1.42 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 155.7 (C), 82.0 (C), 80.5 (C), 80.1 (C), 50.7 (CH2), 38.0 
(CH2), 33.4 (CH3), 28.3(CH3). 
 
HRMS (ESI+) calculated for C10H17NO3Na [M+Na]
+
: 222.1101, found: 222.1107. 
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tert-Butyl (4-methoxybut-2-yn-1-yl)(methyl)carbamate: (2.3) 
 
 
 
To dimethyl sulfoxide (DMSO; 40 mL) was added powder potassium hydroxide (4.50 g, 
80.08 mmol). After stirring the suspension for 5 minutes the substrate 2.5 (4.0 g, 20.07 
mmol) was added, followed by immediate addition of methyl iodide (5.69 g, 2.49 ml, 40.14 
mmol). The reaction mixture was allowed to warm to rt and left to stir for 16 hours. The 
reaction was then quenched with water. The phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure to give a yellow oil. The crude product 2.3 was purified by flash chromatography on 
a silica gel column eluting with 20% diethyl ether in hexanes to give the title compound 2.3 
(3.85 g, 90%) as a yellow oil.   
 
IR (neat) v (cm
-1
) 2977, 2932, 2898, 2252, 1693, 1452, 1367, 1249, 1142, 1123.      
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.06 (s, 2H), 4.03 (br s, 2H), 
3.33 (s, 3H), 2.86 (s, 3H), 1.42 (s, 9H). 
  
13
C NMR (126 MHz, CDCl3) δ 154.9 (C), 81.8 (C), 79.9 (C), 79.1 (C), 59.8 (CH2), 57.1 
(CH3), 38.0 (CH2), 33.3 (CH3), 28.1 (CH3).   
 
HRMS (ESI+) calculated for C11H19NO3Na [M+Na]
+
: 236.1262, found: 236.1257. 
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4-Methoxy-N-methylbut-2-yn-1-amine hydrochloride: (2.15) 
 
 
 
To a stirred solution of N-Boc amine 2.3 (3.5 g, 16.42 mmol) in dry CH2Cl2 (40 mL) at 0 °C 
was added a 4.0 M solution of HCl in dioxane (98.52 mL, 394.08 mmol). The reaction 
mixture was allowed to warm to rt and left to stir for 4 hours, during which time the 
formation of brown precipitates were observed. The solvent was removed in vacuo to afford a 
brown solid. This solid was triturated with diethyl ether to afford a dark brown amorphous 
solid which was collected by filtration and washed well with diethyl ether, after drying under 
high vacuum the title product obtained was a brown amorphous solid. The crude product 2.15 
was used directly in the next step without future purifications (1.74, 71%). 
 
IR (neat) v (cm
-1
) 3377, 2940, 1633, 1465, 1360, 1123, 1188, 1087. 
 
1
H NMR (500 MHz, DMSO-d6) δ 4.14 (t, J = 1.9 Hz, 2H), 3.90 (s, 2H), 3.24 (s, 3H), 2.55 (s, 
3H). 
 
13
C NMR (126 MHz, DMSO-d6) δ 84.8 (C), 77.5 (C), 59.3 (CH2), 57.5 (CH3), 37.4 (CH2), 
31.9 (CH3). 
 
HRMS (ESI+) calculated for C6H13ClNO [M+H]
+
: 150.0700, found: 150.0680. 
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3-(But-3-en-1-yldimethylsilyl)-N-(4-methoxybut-2-yn-1-yl)-N-methylpropiolamide: (2.1) 
 
 
 
To a stirred solution of carboxylic acid 2.4 (1.0 g, 5.48 mmol) and 4 drops of DMF in dry 
CH2Cl2 (10 mL) at 0 °C was added oxalyl chloride (0.73 g, 0.49 mL, 5.75 mmol). The 
solution was allowed to warm to rt and left to stir for 2 hours. This was added to a solution of 
propargylic amine 2.15 (1.23 g, 8.22 mmol) and 2,6-lutidine (1.77 g, 1.91 mL, 16.44 mmol) 
in dry CH2Cl2 (20 mL) which had been stirring for 30 minutes. The resultant cloudy solution 
was allowed to warm to rt and left to stir for 16 hours. The reaction mixture was then 
quenched with water, the phases were separated and the aqueous phase was extracted three 
times with ethyl acetate. The organic layers were combined, washed once with 10% aqueous 
citric acid solution, washed once with 10% aqueous K2CO3 solution, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude product 2.1 was purified by flash chromatography on a silica gel column eluting with 
20% diethyl ether in hexanes to give the title compound 2.1 (0.98 g, 71%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2926, 2850, 1685, 1634, 1443, 1251, 1234, 1120, 1094, 843. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) Rotamer A: δ 5.86 (ddt, J = 16.6, 
10.1, 6.3 Hz, 1H), 5.02 – 4.98 (m, 1H), 4.93 – 4.87 (m, 1H), 4.26 (s, 1H), 4.07 (s, 1H), 3.34 
(s, 1.5H), 3.24 (s, 1.5H), 2.18 – 2.12 (m, 2H), 0.78 – 0.73 (m, 2H), 0.23 (s, 3H),  0.21 (s, 3H); 
Rotamer B: δ 4.41 (s, 1H). 4.09 (s, 1H), 3.35 (s, 1.5H), 2.99 (s, 1.5H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) Rotamer A: δ 153.4 (C), 140.4 
(CH), 113.4 (CH2), 97.0 (C), 96.2 (C), 80.1 (C), 80.0 (C), 59.8 (CH2), 57.6 (CH3), 35.4 
(CH3), 35.3 (CH2), 27.6 (CH2), 14.5 (CH2), -0.7 (CH3), -2.3 (CH3); Rotamer B: δ 97.0 (C), 
96.0 (C), 80.7 (C), 80.0 (C), 59.7 (CH2), 40.8 (CH2), 31.5 (CH3). 
 
HRMS (ESI+) calculated for C15H23NO2SiNa [M+Na]
+
: 300.1429, found: 300.1428. 
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5-(Methoxymethylene)-1,1,7-trimethyl-1,3,3a,4,5,6,7,8b-octahydrosilolo[2,3-e]isoindol-
8(2H)-one: (2.2) 
 
 
 
A solution of 3-(but-3-en-1-yldimethylsilyl)-N-(4-methoxybut-2-yn-1-yl)-N-methylpropiol 
amide 2.1 (0.5 g, 1.80 mmol) in de-gassed toluene (180 mL) was heated at reflux for 16 
hours. After cooling to rt the solvent was removed in vacuo and the crude product 2.2 was 
purified by flash chromatography on a silica gel column eluting with 20% diethyl ether in 
hexanes to give the title compound 2.2 (0.19 g, 38%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2960, 2923, 2854, 1678, 1456, 1400, 1379, 1252, 1177, 11261, 1048, 841, 
798.  
 
1
H NMR (500 MHz, CDCl3) δ 5.90 (s, 1H), 4.19 – 4.06 (m, 2H), 3.65 (s, 3H), 3.04 (s, 3H), 
2.35 – 2.27 (m, 1H), 2.07 – 0.82 (m, 5H), 0.75 – 0.69 (m, 2H), 0.33 (s, 3H), -0.05 (s, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 171.7 (C), 144.1 (CH), 138.5 (C), 133.3 (C), 109.3 (C), 60.1 
(CH3), 54.7 (CH2), 39.4 (CH), 36.0 (CH2), 29.6 (CH2), 29.0 (CH3), 28.3 (CH), 11.14 (CH2), -
1.2 (CH3), - 2.1 (CH3). 
 
HRMS (ESI+) calculated for C15H23NO2SiNa [M+Na]
+
: 300.1399, found: 300.1408. 
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3-Methoxyprop-1-yne: (2.37) 
 
 
To a mixture of 2-propynol 2.12 (6.0 g, 6.18 mL, 107.03 mmol) and water (4.65 mL) was 
added a 50% aqueous solution of NaOH (w/v; 12.85 g, 221.09 mmol). The reaction mixture 
was stirred for 30 minutes and dimethyl sulfate (8.03 g, 5.86 mL, 63.65 mmol) was added 
dropwise, the temperature was kept below 60 °C. After stirring at 50-60 °C for 2 hours, micro 
distillation gave a product that came over 61-62 °C, which was subsequently dried (CaCl2) 
overnight. Finally, re-distillation of the product at atmospheric pressure using a cooled 
receiver afforded 7.50 g of the title compound 2.37 (80%) as a colourless oil. 
Spectroscopic data are in agreement with the literature values.
198
 
 
b.p.: 60 °C (760 Torr). 
 
IR (neat) v (cm
-1
) 3284, 2945, 2843, 2129, 1453, 1338, 1306, 1105. 
 
1
H NMR (500 MHz, CDCl3) δ 4.01 (s, 2H), 3.30 (s, 3H), 2.40 (s, 1H). 
 
13
C NMR (126 MHz, CDCl3) δ 79.4 (C), 77.3 (CH), 59.4 (CH2), 57.2 (CH3). 
 
m/z (EI+) 31, 39, 69, 71. 
 
 
 
 
 
4-Methoxybut-2-yn-1-ol: (2.38) 
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To a stirred solution of methyl ether 2.37 (4.0 g, 57.10 mmol) in dry THF (60 mL) at -78 ºC 
was added n-BuLi (2.3 M solution in hexanes, 26.07 mL, 59.95 mmol). The reaction was 
stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -
78 °C before the addition of powdered paraformaldehyde (5.14 g, 171.30 mmol). The 
reaction mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a pale yellow 
liquid. Distillation under reduced pressure afforded 4.91 g (86%) of clear colourless liquid. 
Spectroscopic data are in agreement with the literature values.
218
 
 
b.p.: 96 – 97 °C (15 Torr). 
 
IR (neat) v (cm
-1
) 3374, 2938, 2828, 1450, 1356, 1119, 1087, 1011, 894. 
 
1
H NMR (500 MHz, CDCl3) δ 4.22 (s, 2H), 4.0 5 (s, 2H), 3.38 (s, 3H), 3.0 (br s, 1H). 
 
13
C NMR (126 MHz, CDCl3) δ 84.9 (C), 81.1 (C), 59.8 (CH2), 57.2 (CH3), 50.5 (CH2). 
 
HRMS (ESI+) calculated for C5H8O2Na [M+Na]
+
: 123.0422, found: 123.0409.  
 
 
 
 
 
4-Methoxybut-2-yn-1-yl 3-(but-3-en-1-yldimethylsilyl)propiolate: (2.35) 
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To a stirred solution of carboxylic acid 2.4 (2.0 g, 10.97 mmol) and 4 drops of DMF in dry 
CH2Cl2 (20 mL) at 0 °C was added oxalyl chloride (1.46 g, 0.98 mL, 11.52 mmol). The 
solution was allowed to warm to rt and left to stir for 2 hours. This was added to a solution of 
propargylic alcohol 2.38 (1.65 g, 16.45 mmol) and 2,6-lutidine (3.53 g, 3.81 mL, 32.91 
mmol) in dry CH2Cl2 (40 mL) which had been stirring for 30 minutes. The resultant cloudy 
solution was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched with water, the phases were separated and the aqueous phase was extracted three 
times with ethyl acetate. The organic layers were combined, washed once with 10% aqueous 
citric acid solution, washed once with 10% aqueous K2CO3 solution, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude product 2.35 was purified by flash chromatography on a silica gel column eluting with 
20% diethyl ether in hexanes to give the title compound 2.35 (2.15 g, 74%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2926, 2850, 1715, 1436, 1366, 1252, 1134, 1023, 1097.  
 
1
H NMR (500 MHz, CDCl3) δ 5.87 (ddt, J = 16.6, 10.1, 6.2 Hz, 1H), 5.03 (dd, J = 17.1, 1.6 
Hz, 1H), 4.94 (dd, J = 10.1, 1.2 Hz, 1H), 4.80 (s, 2H), 4.13 (s, 2H), 3.38 (s, 3H), 2.19 – 2.13 
(m, 2H), 0.83 – 0.78 (m, 2H), 0.25 (s, 3H), 0.23 (s, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.0 (C), 140.3 (CH), 113.5 (CH2), 94.5 (C), 94.3 (C), 83.5 
(C), 79.4 (C), 59.7 (CH2), 57.6 (CH3), 53.4 (CH2), 27.5 (CH2), 14.3 (CH2), -0.9 (CH3), -2.4 
(CH3). 
 
HRMS (ESI+) calculated for C14H20O3SiNa [M+Na]
+
: 287.1100, found: 287.1074.  
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5-(Methoxymethylene)-1,1-dimethyl-3,3a,4,5,6,8b-hexahydro-1H-silolo[2,3-
e]isobenzofuran-8(2H)-one: (2.39) 
 
 
 
A solution of 4-methoxybut-2-yn-1-yl 3-(but-3-en-1-yldimethylsilyl) propiolate 2.35 (0.5 g, 
1.89 mmol) in de-gassed toluene (189 mL) was heated at reflux for 20 hours. After cooling to 
rt the solvent was removed in vacuo and the crude product 2.39 was purified by flash 
chromatography on a silica gel column eluting with 20% diethyl ether in hexanes to give the 
title compound 2.39 (0.2 g, 40% isomer A+B, combined yield) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2931, 2859, 1738, 1644, 1449, 1339, 1246, 1215, 1133, 1067, 1017, 976, 
838, 796, 770, 752, 725, 618. 
 
1
H NMR (500 MHz, CDCl3) Isomer A; δ 6.05 (s, 1H), 5.06 – 4.92 (m, 2H), 3.68 (s, 3H), 2.37 
– 2.35 (m, 1H), 2.11 – 1.07 (m, 5H), 0.92 – 0.58 (m, 2H),  0.30 (s, 3H), -0.03 (s, 3H); Isomer 
B; δ 6.11 (s, 1H), 5.06 – 4.92 (m, 2H), 3.69 (s, 3H), 2.44 (app. dd, J = 14.0, 3.0 Hz, 1H), 2.11 
– 1.07 (m, 5H), 0.92 – 0.58 (m, 2H), 0.39 (s, 3H), 0.01 (s, 3H). 
 
13
C NMR (126 MHz, CDCl3) Isomer A; δ 174.6 (C), 148.9 (C), 147.1 (CH), 126.1 (C), 109.3 
(C), 71.9 (CH2), 60.5 (CH3), 39.3 (CH), 32.9 (CH2), 29.1 (CH2), 27.5 (CH), 11.0 (CH2), - 1.2 
(CH3), - 2.3 (CH3); Isomer B; δ 174.4 (C), 154.3 (C), 148.2 (CH), 125.3 (C), 107.8 (C), 72.2 
(CH2), 60.6 (CH3), 43.6 (CH), 30.5 (CH2), 30.3 (CH), 30.2 (CH2), 11.5 (CH2), - 1.4 (CH3), - 
3.3 (CH3). 
 
HRMS (ESI+) calculated for C14H21O3Si [M+H]
+
: 265.1200, found: 265.1249. 
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tert-Butyl isopropylcarbamate: (2.48) 
 
 
 
To a stirred solution of di-tert-butyl dicarbonate (24.0 g, 110 mmol) in dry THF (200 mL) at 
0 °C was added isopropylamine 2.47 (5.91 g, 8.59 mL, 100 mmol). A catalytic amount of 
N,N-dimethylpyridin-4-amine (DMAP; 122 mg, 1 mmol) was then added and the reaction 
was left to stir at rt for 16 hours. Subsequently, the solvent was evaporated off under reduced 
pressure to give a yellow solid which was redissolved in diethyl ether (100 mL). The resultant 
solution was washed once with water, washed once with saturated aqueous NaHCO3 solution, 
dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to 
give a yellow tinted solid. The crude product 2.48 was purified by flash chromatography on a 
silica gel column eluting with 20% ethyl acetate in hexanes to give the title compound 2.48 
(11.30 g, 71%) as a white solid. 
Spectroscopic data are in agreement with the literature values.
200
 
 
m.p.: 70 – 72 °C 
 
IR (neat) v (cm
-1
) 3342, 2974, 2932, 1679, 1528, 1455, 1363, 1248, 1168, 1076, 939, 886, 
839, 776, 754. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.34 (br s, 1H), 3.75 (br s, 
1H), 1.44 (s, 9H), 1.05 (d, J = 6.5 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 155.1 (C), 78.9 (C), 42.5 (CH), 28.4 (CH3), 23.0 (CH3). 
 
HRMS (ESI+) calculated for C8H17NO2Na [M+Na]
+
: 182.1151, found: 182.1152. 
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tert-Butyl isopropyl(prop-2-yn-1-yl)carbamate: (2.50) 
 
 
 
To a stirred suspension of sodium hydride (60% w/w in mineral oil; 2.49 g, 62.17 mmol) in 
dry DMF (50 mL) was added tert-butyl isopropylcarbamate 2.48 (9.0 g, 56.52 mmol) in dry 
DMF (25 mL). The resultant solution was cooled to 0 °C before the addition of propargyl 
bromide 2.49 (7.39 g, 5.52 mL, 62.17 mmol). The reaction mixture was then allowed to warm 
to rt and left to stir for 16 hours. Subsequently, it was added to a stirring biphasic mixture of 
10% aqueous K2CO3 solution and diethyl ether. The phases were separated and the aqueous 
phase was extracted twice with diethyl ether. The organic layers were combined, washed 
once with brine, dried over anhydrous sodium sulfate, filtered and concentrated under 
reduced pressure to give a yellow oil. The crude product 2.50 was purified by flash 
chromatography on a silica gel column eluting with 20% diethyl ether in hexanes to give the 
title compound 2.50 (8.09 g, 66%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 3309, 2978, 2934, 2195, 1688, 1443, 1402, 1365, 1329, 1271, 1250, 1214, 
1162, 1097, 1070, 943, 898, 861, 774, 748. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.20 (br s, 1H), 3.80 (s, 2H), 
2.09 (s, 1H), 1.43 (s, 9H), 1.15 (d, J = 6.8 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 146.6 (C), 85.0 (C), 79.8 (C), 68.9 (CH), 47.6 (CH), 31.1 
(CH2), 28.3 (CH3), 20.4 (CH3). 
 
HRMS (ESI+) calculated for C11H20NO2 [M+H]
+
: 198.1489, found: 198.1493. 
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tert-Butyl (4-hydroxybut-2-yn-1-yl)(isopropyl)carbamate: (2.51) 
 
 
 
To a stirred solution of alkyne 2.50 (6.0 g, 30.41 mmol) in dry THF (118 mL) at -78 ºC was 
added n-BuLi (2.5 M solution in hexanes, 12.77 mL, 31.93 mmol). The reaction was stirred 
10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of powdered paraformaldehyde (1.82 g, 60.82 mmol). The reaction 
mixture was allowed to warm to rt and left to stir for 16 hours. The reaction mixture was then 
quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a dark yellow 
liquid. The crude product 2.51 was purified by flash chromatography on a silica gel column 
eluting with 30% diethyl ether in hexanes to give the title compound 2.51 (5.59 g, 81%) as a 
yellow oil. 
 
IR (neat) v (cm
-1
) 3416, 2975, 2932, 1669, 1443, 1404, 1365, 1332, 1272, 1252, 1161, 1128, 
1102, 1065, 1018, 939, 898, 862. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.20 (br s, 3H), 3.80 (s, 2H), 
2.60 (br s, 1H), 1.40 (s, 9H), 1.18 (d, J = 6.7 Hz, 6H). 
 
13C NMR (126 MHz, CDCl3) δ 155.7 (C), 82.0 (C), 80.0 (C), 79.9 (C), 51.0 (CH2), 47.5 
(CH), 31.5 (CH2), 28.4 (CH3), 20.5 (CH3). 
 
HRMS (ESI+) calculated for C12H21O3NNa [M+Na]
+
: 250.1414, found: 250.1415. 
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tert-Butyl isopropyl(4-methoxybut-2-yn-1-yl)carbamate: (2.52) 
 
 
 
To dimethyl sulfoxide (35 mL) was added powder potassium hydroxide (3.24 g, 57.69 
mmol). After stirring the suspension for 5 minutes a solution of propargylic alcohol 2.51 (4.0 
g, 14.42 mmol) in dimethyl sulfoxide (15 mL) was added, followed by immediate addition of 
methyl iodide (4.09 g, 1.79 ml, 28.85 mmol). The resultant solution was left to stir at rt for 16 
hours. Subsequently, the reaction mixture was quenched with water. The phases were 
separated and the aqueous phase was extracted three times with ethyl acetate. The organic 
layers were combined, washed once with brine, dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure to give a dark yellow oil. The crude product 
2.52 was purified by flash chromatography on a silica gel column eluting with 20% diethyl 
ether in hexanes to give the title compound 2.52 (2.99 g, 86%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2976, 2933, 1690, 1443, 1401, 1365, 1330, 1271, 1251, 1213, 1162, 1125, 
1093, 1065, 1002, 941, 901, 863. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 4.20 (br s, 1H), 4.05 (s, 2H), 
3.92 (br s, 2H), 3.33 (s, 3H), 1.45 (s, 9H), 1.17 (d, J = 6.8 Hz, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 154.7 (C), 84.3 (C), 79.7 (C), 77.4 (C), 59.9 (CH2), 57.2 
(CH3), 47.3 (CH), 31.7 (CH2), 28.4 (CH3), 20.5 (CH3). 
 
HRMS (ESI+) calculated for C13H23NO3Na [M+Na]
+
: 264.1627, found: 264.1632. 
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3-(But-3-en-1-yldimethylsilyl)-N-isopropyl-N-(4-methoxybut-2-yn-1-yl)propiolamide: 
(2.46) 
 
 
 
To a stirred solution of N-Boc amine 2.52 (2.6 g, 10.77 mmol) in dry CH2Cl2 (40 mL) at 0 °C 
was added a 4.0 M solution of HCl in dioxane (64.62 mL, 258.48 mmol). The reaction was 
allowed to warm to rt and left to stir for 4 hours, during which time the formation of brown 
precipitates were observed. The solvent was removed in vacuo to afford a pale brown solid. 
This solid was triturated with diethyl ether to afford a dark brown solid which was collected 
by filtration and washed well with diethyl ether, after drying under high vacuum the title 
product obtained was a brown solid. The crude product 2.53 was used directly in the next step 
without future purifications (2.47, 74%). 
To a stirred solution of carboxylic acid 2.4 (1.78 g, 9.75 mmol) and 4 drops of DMF in dry 
CH2Cl2 (40 mL) at 0 °C was added oxalyl chloride (1.30 g, 0.88 mL, 10.24 mmol). The 
solution was allowed to warm to rt and left to stir for 2 hours. This was added to a solution of 
propargylic amine 2.53 (2.6 g, 14.63 mmol) and 2,6-lutidine (3.13 g, 3.39 mL, 29.25 mmol) 
in dry CH2Cl2 (20 mL) which had been stirring for 30 minutes. The resultant cloudy solution 
was allowed to warm to rt and left to stir for 16 hours. The reaction mixture was then 
quenched with water. The phases were separated and the aqueous phase was extracted three 
times with ethyl acetate. The organic layers were combined, washed once with 10% aqueous 
citric acid solution, washed once with 10% aqueous K2CO3 solution, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude product 2.46 was purified by flash chromatography on a silica gel column eluting with 
20% diethyl ether in hexanes to give the title compound 2.46 (2.08 g, 70%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2972, 2950, 2923, 2249, 1685, 1636, 1409, 1365, 1331, 1249, 1201, 1187, 
1128, 1097, 1077, 1059, 906, 843 
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1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) Rotamer A: δ 5.87 (ddt, J = 16.6, 
10.1, 6.3 Hz, 1H), 5.01 (dd, J = 17.0, 1.5 Hz, 1H), 4.92 (dd, J = 10.1, 1.0 Hz, 1H), 4.72 – 4.62 
(m, 1H), 4.11 (s, 1H), 4.05 (s, 1H), 3.33 (s, 1.5H), 2.20 – 2.12 (m, 2H), 1.31 (d, J = 6.8 Hz, 
3H), 0.81 – 0.77 (m, 2H), 0.23 (s, 3H), 0.22 (s, 3H); Rotamer B: δ 4.29 (s, 1H), 4.08 (br s, 
1H), 3.35 (app. d, J = 3.9 Hz, 1.5H), 1.23 (d, J = 6.8 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) Rotamer A: δ 153.2 (C), 140.5 
(CH), 113.4 (CH2), 97.0 (C), 96.2 (C), 82.5 (C), 78.1 (C), 59.8 (CH2), 57.4 (CH3), 50.6 (CH), 
29.1 (CH2), 27.7 (CH2), 20.9 (CH3), 14.6 (CH2), - 0.7 (CH3), - 2.2 (CH3); Rotamer B: 153.5 
(C), 140.6 (CH), 113.3 (CH2), 97.0 (C), 96.0 (C), 82.6 (C), 79.3 (C), 59.7 (CH2), 45.6 (CH), 
34.2 (CH2), 27.6 (CH2), 19.9 (CH3). 
 
HRMS (ESI+) calculated for C17H27NO2SiNa [M+Na]
+
: 328.1722, found: 328.1714. 
 
 
 
 
 
3-Methyl-3-(prop-2-yn-1-yloxy)but-1-ene: (2.62) 
 
 
 
To a stirred suspension of sodium hydride (60% w/w in mineral oil; 5.57 g, 139.32 mmol) in 
dry THF (100 mL) was added 2-methylbut-3-en-2-ol 2.61 (10.0 g, 116.10 mmol) in dry THF 
(20 mL). The resultant solution was cooled to 0 °C before the addition of propargyl bromide 
2.49 (13.81, 10.31 mL, 116.10 mmol). The reaction mixture was then allowed to warm to rt 
and left to stir for 16 hours. Subsequently, it was added to a stirring biphasic mixture of 10% 
aqueous K2CO3 solution and diethyl ether. The phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with water, washed once with brine, dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure to give a brown liquid. The crude product 2.62 was 
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purified by flash chromatography on a silica gel column eluting with 30% diethyl ether in 
hexanes to give the title compound 2.62 (9.37 g, 65%) as a brown oil. 
 
IR (neat) v (cm
-1
) 3306, 2980, 2927, 2857, 1640, 1414, 1377, 1362, 1147, 1061, 1002, 925, 
871, 657, 625. 
 
1
H NMR (500 MHz, CDCl3) δ 5.84 (dd, J = 17.6, 10.9 Hz, 1H), 5.20 (d, J = 7.4 Hz, 1H), 5.17 
(s, 1H), 4.00 (d, J = 2.3 Hz, 2H), 2.38 (t, J = 2.2 Hz, 1H), 1.33 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 142.7 (CH), 114.7 (CH2), 81.5 (C), 76.6 (C), 73.0 (CH), 51.1 
(CH2), 25.7 (CH3). 
 
Ion not found 
 
 
 
 
 
4-((2-Methylbut-3-en-2-yl)oxy)but-2-yn-1-ol: (2.63) 
 
 
 
To a stirred solution of alkyne 2.62 (4.0 g, 32.21 mmol) in dry THF (60 mL) at -78 ºC was 
added n-BuLi (2.4 M solution in hexanes, 14.09 mL, 33.82 mmol). The reaction was stirred 
10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of powdered paraformaldehyde (1.93 g, 64.42 mmol). The reaction 
mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to give a yellow liquid. 
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The crude product 2.63 was purified by flash chromatography on a silica gel column eluting 
with 30% diethyl ether in hexanes to give the title compound 2.63 (4.02 g, 81%) as a yellow 
oil. 
 
IR (neat) v (cm
-1
) 3394, 2979, 2931, 2865, 1640, 1414, 1377, 1361, 1206, 1136, 1003, 926, 
878, 836, 690. 
 
1
H NMR (500 MHz, CDCl3) δ 5.83 (dd, J = 17.8, 10.7 Hz, 1H), 5.19 (d, J = 4.8 Hz, 1H), 5.16 
(s, 1H), 4.30 (s, 2H), 4.03 (s, 2H), 1.32 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 142.7 (CH), 114.8 (CH2), 83.3 (C), 83.2 (C), 76.4 (C), 51.35 
(CH2), 51.2 (CH2), 25.7 (CH3). 
 
HRMS (ESI+) calculated for C9H14O2Na [M+Na]
+
: 177.0886, found: 177.0883. 
 
 
 
 
 
3-(Trimethylsilyl)propiolic acid: (2.65) 
 
 
 
To a stirred solution of ethynyltrimethylsilane 2.64 (12.5 g, 17.98 mL, 127.0 mmol) in dry 
diethyl ether (50 mL) at -78 ºC was added MeLi (1.6 M solution in hexanes, 83.34 mL, 
133.35 mmol). The reaction was stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The 
resultant solution was cooled to -78 °C before the addition of previously crushed solid CO2 
pellets (50 g) via the side-arm solid addition funnel. The reaction mixture was allowed to 
warm to rt and left to stir for 16 hours. The reaction mixture was then quenched at 0 °C with 
1.0 M aqueous HCl solution. The phases were separated and the aqueous phase was extracted 
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three times with diethyl ether. The organic layers were combined, washed once with brine, 
dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to 
give a yellowish liquid. The residue was purified via short-path distillation to give the title 
compound 2.65 as a clear colourless oil (15.89 g, 88%).  
 
b.p.: 62 °C (0.2 Torr). 
 
IR (neat) v (cm
-1
) 2965, 2904, 2626, 2178, 1694, 1517, 1404, 1254, 921, 847. 
 
1
H (500 MHz, CDCl3, broadened signals were observed) δ 11.36 (br s, 1H), 0.24 (s, 9H).  
 
13
C (126 MHz, CDCl3) δ 157.8 (C), 97.4 (C), 93.7 (C), -1.1 (CH3). 
 
m/z (EI+) 127, 99, 83. 
 
 
 
 
 
4-((2-Methylbut-3-en-2-yl)oxy)but-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.60) 
 
 
 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (2.0 g, 10.97 mmol) and 4 drops 
of DMF in dry CH2Cl2 (30 mL) at 0 °C was added oxalyl chloride (1.46 g, 0.98 mL, 11.52 
mmol). The solution was allowed to warm to rt and left to stir for 2 hours. This was added to 
a solution of propargylic alcohol 2.63 (2.5 g, 16.45 mmol) and 2,6-lutidine (3.53 g, 3.81 mL, 
32.91 mmol) in dry CH2Cl2 (15 mL) which had been stirring for 30 minutes. The resultant 
cloudy solution was allowed to warm to rt and left to stir for 16 hours. The reaction mixture 
was then quenched with water. The phases were separated and the aqueous phase was 
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extracted three times with ethyl acetate. The organic layers were combined, washed once 
with 10% aqueous citric acid solution, washed once with 10% aqueous K2CO3 solution, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.60 was purified by flash chromatography on a silica gel 
column eluting with 20% diethyl ether in hexanes to give the title compound 2.60 (2.15 g, 
74%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2977, 2898, 2857, 2175, 1716, 1414, 1365, 1252, 1144, 1204, 1057, 1002, 
929, 842, 760, 751. 
 
1
H NMR (400 MHz, CDCl3) δ 5.88 – 5.79 (m, 2H), 5.21 (d, J = 1.0 Hz, 1H), 5.17 (d, J = 4.2 
Hz, 1H), 4.81 (s, 2H), 4.05 (s, 2H), 1.33 (s, 6H), 0.26 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.1 (C), 142.6 (CH), 114.9 (CH2), 95.3 (C), 93.7 (C), 85.3 
(C), 77.9 (C), 76.5 (C), 53.7 (CH2), 51.3 (CH2), 25.7 (CH3), -0.9 (CH3). 
 
HRMS (ESI+) calculated for C15H22O3SiNa [M+Na]
+
: 301.1236, found: 301.1250. 
 
 
 
 
 
6,6-dimethyl-4-(trimethylsilyl)-4,5,5a,6-tetrahydrobenzo[1,2-c:3,4-c']difuran-3(1H)-one 
(2.66) 
 
 
 
A solution of 4-((2-methylbut-3-en-2-yl)oxy)but-2-yn-1-yl 3-(trimethylsilyl)propiolate 2.60 
(450 mg, 1.62 mmol) in de-gassed toluene (16.2 mL) was heated at reflux for 1 hour. After 
cooling to rt the solvent was removed in vacuo and the crude product  was purified by flash 
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chromatography on a silica gel column eluting with 20% diethyl ether in hexanes to give the 
title compound 2.66 (432 mg, 96%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2959, 2927, 2874, 1737, 1629, 1457, 1348, 1246, 1157, 1136, 1089, 1065, 
1032, 905, 835, 808, 766, 743. 
 
1
H NMR (500 MHz, CDCl3) δ 6.54 (s, 1H), 4.88 (s, 2H), 2.89 (d, J = 13.0 Hz, 1H), 2.26 (d, J 
= 5.4 Hz, 1H), 1.94 (dd, J = 12.3, 4.1 Hz, 1H), 1.69 – 1.60 (m, 1H), 1.56 (s, 3H), 1.15 (s, 3H), 
0.09 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 173.4 (C), 147.6 (C), 141.5 (CH), 124.0 (C), 110.6 (C), 90.4 
(C), 68.4 (CH2), 48.3 (CH), 27.9 (CH3), 24.2 (CH2), 23.5 (CH), 21.7 (CH3), -1.2 (CH3). 
 
HRMS (ESI+) calculated for C15H23O3Si [M+H]
+
: 279.1416, found: 279.1431. 
 
 
 
 
 
2-Methyl-6-((2-methylbut-3-en-2-yl)oxy)hex-4-yn-3-ol: (2.69) 
 
 
 
To a stirred solution of alkyne 2.62 (4.0 g, 32.21 mmol) in dry THF (60 mL) at -78 ºC was 
added n-BuLi (2.5 M solution in hexanes, 13.52 mL, 33.82 mmol). The reaction was stirred 
10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of iso-butyraldehyde (4.44 g, 3.09 ml, 33.82 mmol). The reaction mixture 
was allowed to warm to rt and left to stir for 8 hours. The reaction was then quenched at 0 °C 
with water. The phases were separated and the aqueous phase was extracted three times with 
ethyl acetate. The organic layers were combined, washed once with brine, dried over 
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anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a yellow 
liquid. The crude product 2.69 was purified by flash chromatography on a silica gel column 
eluting with 30% diethyl ether in hexanes to give the title compound 2.69 (6.07 g, 96%) as a 
yellow oil. 
 
IR (neat) v (cm
-1
) 3413, 2975, 2872, 1467, 1414, 1377, 1255, 1144, 1109, 1030, 1001, 925, 
880, 838, 690. 
 
1
H NMR (500 MHz, CDCl3) δ 5.80 (dd, J = 17.6, 10.8 Hz, 1H), 5.15 (d, J = 9.3 Hz, 1H), 5.12 
(s, 1H), 4.16 (d, J = 3.8 Hz, 1H), 4.01 (s, 2H), 1.88 – 1.78 (m, 1H), 1.28 (s, 6H), 0.98 – 0.94 
(m, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 142.9 (CH), 114.5 (CH2), 84.8 (C) 83.1 (C), 76.5 (C), 67.8 
(CH), 51.3 (CH2), 34.3 (CH), 25.8 (CH3), 25.7 (CH3), 18.0 (CH3), 17.5 (CH3). 
 
HRMS (ESI+) calculated for C12H20O2Na [M+Na]
+
: 219.1356, found: 219.1352. 
 
 
 
 
 
2-Methyl-6-((2-methylbut-3-en-2-yl)oxy)hex-4-yn-3-yl 3-(trimethylsilyl)propiolate: 
(2.67) 
 
 
 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (1.69 g, 11.89 mmol) and 4 drops 
of DMF in dry CH2Cl2 (40 mL) at 0 °C was added oxalyl chloride (1.58 g, 1.07 mL, 12.48 
mmol). The solution was allowed to warm to rt and left to stir for 2 hours. This was added to 
a solution of propargylic alcohol 2.69 (3.5 g, 17.83 mmol) and 2,6-lutidine (3.53 g, 3.81 mL, 
32.91 mmol) in dry CH2Cl2 (20 mL) which had been stirring for 30 minutes. The resulting 
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cloudy solution was then allowed to warm to rt and left to stir for 16 hours. Subsequently, the 
reaction mixture was quenched with water. The phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with 10% aqueous citric acid solution, washed once with 10% aqueous K2CO3 solution, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.67 was purified by flash chromatography on a silica gel 
column eluting with 15% diethyl ether in hexanes to give the title compound 2.67 (2.15 g, 
74%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2969, 2938, 2905, 2178, 1713, 1469, 1414, 1377, 1360, 1333, 1253, 1212, 
1147, 1079, 1057, 987, 931, 910, 842, 761, 750. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 5.81 (dd, J = 17.6, 10.8 Hz, 
1H), 5.29 (dd, J = 5.7, 0.9 Hz, 1H), 5.16 (d, J = 8.3 Hz, 1H), 5.13 (br s, 1H), 4.03 (s, 2H), 
2.07 – 1.97 (m, 1H), 1.29 (s, 6H), 1.02 (d, J = 6.7 Hz, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.23 (s, 
9H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.0 (C), 142.92(CH), 114.64(CH2), 94.5 (C), 94.2 (C), 84.8 
(C), 79.9 (C), 76.5 (C), 70.7 (CH), 51.3 (CH2), 32.3 (CH), 25.8 (CH3), 25.7 (CH3), 18.1 
(CH3), 17.5 (CH3), -0.9 (CH3). 
 
HRMS (ESI+) calculated for C18H28O3SiNa [M+Na]
+
: 343.1700, found: 343.1690. 
 
 
 
 
1-isopropyl-6,6-dimethyl-4-(trimethylsilyl)-4,5,5a,6-tetrahydrobenzo[1,2-c:3,4-
c']difuran-3(1H)-one: (2.70a-b) 
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A solution of 2-methyl-6-((2-methylbut-3-en-2-yl)oxy)hex-4-yn-3-yl-3-(trimethylsilyl) 
propiolate  2.67 (0.5 g, 1.56 mmol) in de-gassed toluene (15.6 mL) was heated at reflux for 
30 minutes. After cooling to rt the solvent was removed in vacuo and the crude product was 
purified by flash chromatography on a silica gel column eluting with 40% diethyl ether in 
hexanes to give the title compound 2.70a-b (475 mg, 95% diastereoisomer A+B, combined 
yield) as a yellow oil. 
 
Diastereoisomer A: 
 
Rf (hexane/Et2O, 6/4) = 0.47 
 
IR (neat) v (cm
-1
) 2961, 2930, 1734, 1629, 1461, 1368, 1347, 1293, 1214, 1251, 1163, 1135, 
1096, 1066, 1032, 1008, 955, 902, 834, 808, 753. 
 
1
H NMR (500 MHz, CDCl3) δ 6.55 (d, J = 2.0 Hz, 1H), 5.00 (d, J = 2.0 Hz, 1H), 2.88 (ddd, J 
= 13.4, 4.1, 2.3 Hz, 1H), 2.28 (d, J = 5.5 Hz, 1H), 2.11 – 2.02 (m, 1H), 1.93 (dd, J = 12.3, 4.2 
Hz, 1H),, 1.62 – 1.57 (m, 1H), 1.55 (s, 3H), 1.23 (d, J = 6.9 Hz, 3H), 1.13 (s, 3H), 0.68 (d, J = 
6.8 Hz, 3H), 0.09 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 173.1 (C), 149.7 (C), 141.6 (CH), 125.3 (C), 110.7 (C), 90.0 
(C), 84.2 (CH), 48.8 (CH), 31.9 (CH), 27.6 (CH3), 24.2 (CH2), 23.4 (CH), 21.4 (CH3), 19.9 
(CH3), 13.2 (CH3), -1.2 (CH3). 
 
 
Diastereoisomer B: 
 
Rf (hexane/Et2O, 6/4) = 0.38 
 
IR (neat) v (cm
-1
) 2963, 2926, 1729, 1630, 1462, 1384, 1371, 1299, 1247, 1216, 1160, 1137, 
1091, 1066, 1036, 1003, 958, 900, 837, 809, 771. 
 
1
H NMR (500 MHz, CDCl3) δ 6.51 (d, J = 2.0 Hz, 1H), 4.95 (t, J = 2.5 Hz, 1H), 2.88 (ddd, J 
= 13.3, 4.2, 2.2 Hz, 1H), 2.25 (d, J = 6.0 Hz, 1H), 2.08 – 1.98 (m, 1H), 1.93 (dd, J = 12.4, 4.2 
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Hz, 1H), 1.67 – 1.60 (m, 1H), 1.56 (s, 3H), 1.19 (d, J = 7.0 Hz, 3H), 1.14 (s, 3H), 0.78 (d, J = 
6.8 Hz, 3H), 0.10 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 173.3 (C), 150.0 (C), 141.8 (CH), 124.9 (C), 110.8 (C), 90.2 
(C), 84.3 (CH), 48.3 (CH), 31.7 (CH), 27.9 (CH3), 24.2 (CH2), 23.4 (CH), 21.8 (CH3), 19.7 
(CH3), 14.5 (CH3), -1.0 (CH3). 
 
HRMS (ESI+) calculated for C18H29O2Si [M+H]
+
: 321.1880, found: 321.1882. 
 
 
 
 
 
3-Methyl-1-(vinyloxy)but-2-ene: (2.73) 
 
 
 
To a solution of 3-methyl-2-buten-ol 2.71 (10.0 g, 0.116 mol) in ethyl vinyl ether (111 mL, 
1.16 mol), mecury(II) acetate (37.0 g, 0.116 mol) was added.. The resulting mixture was 
stirred at room temperature for 2 days. After that, the reaction mixture was washed with 
water and brine. The organic layer dried by anhydrous MgSO4 and evaporated. The residue 
oil was filtered via a short silica gel column that was then washed with copious compatible 
eluent. The filtrate was concentrated and distilled under reduced pressure to give the desire 
compound 2.73 as a colourless liquid (8.58 g, 66%).  
Spectroscopic data are in agreement with the literature values
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b.p.: 114 - 115 °C (760 Torr). 
 
1
H NMR (500 MHz, CDCl3) δ 6.47 (dd, J = 14.2, 6.8 Hz, 1H), 5.50 – 5.30 (m, 1H), 4.34 – 
4.16 (m, 3H), 3.99 (dd, J = 6.8, 1.7 Hz, 1H), 1.77 (s, 3H), 1.70 (s, 3H). 
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13
C NMR (126 MHz, CDCl3) δ 151.6 (CH), 137.9 (C), 119.5 (CH), 86.6 (CH2), 64.8 (CH2), 
25.7 (CH3), 18.0 (CH3). 
 
 
 
 
 
3,3-Dimethylpent-4-enal: (2.74) 
 
 
 
The 3-methyl-1-(vinyloxy)but-2-ene 2.73 (7.3 g, 65 mmol) was heated at reflux under argon 
for 24 hours and cooled to rt to obtain the pure title aldehyde 2.74 (7.08 g, 97%). The 
temperature of the reaction mixture increased gradually during the reflux period and reached 
141 °C, a constant temperature after 20 hours.  
Spectroscopic data are in agreement with the literature values.
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b.p.: 53 - 54 °C (55 Torr). 
 
IR (neat) v (cm
-1
) 3086, 2964, 2736, 1720, 1649, 1469, 1413, 1366, 1161, 1040, 1001, 915, 
682.  
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 9.68 (t, J = 3.1 Hz, 1H), 
5.88 (dd, J = 15.6, 10.7, 1H), 5.00 (br s, 1H), 4.99 (d, J = 4.0 Hz, 1H), 2.33 (d, J = 3.1 Hz, 
2H), 1.12 (s, 6H). 
 
13
C NMR (125 MHz, CDCl3) δ 202.9 (CH), 146.2 (CH), 111.7 (CH2), 54.5 (CH2), 35.8 (C), 
27.2 (CH3). 
 
HRMS (ESI+) calculated for C14H25O2 [2M+H]
+
: 225.1849, found: 225.1858. 
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1-((tert-Butyldimethylsilyl)oxy)-6,6-dimethyloct-7-en-2-yn-4-ol: (2.75) 
 
 
 
To a stirred solution of tert-butyldimethyl(prop-2-yn-1-yloxy)silane 2.16 (9.4 g, 55.19 mmol) 
in dry THF (125 mL) at -78 ºC was added n-BuLi (2.3 M solution in hexanes, 25.19 mL, 
57.95 mmol). The reaction was stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The 
resultant solution was cooled to -78 °C before the addition of 3,3-dimethylpent-4-enal 2.74 
(6.5 g, 57.95 mmol). The reaction mixture was allowed to warm to rt and left to stir for 16 
hours. The reaction was then quenched at 0 °C with saturated aqueous NH4Cl solution. The 
phases were separated and the aqueous phase was extracted three times with ethyl acetate. 
The organic layers were combined, washed once with water, washed once with brine, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellowish liquid. The crude product 2.75 was purified by flash chromatography on a silica gel 
column eluting with 15% diethyl ether in hexanes to give the title compound 2.75 (14.5 g, 
93%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 3369, 2957, 2930, 2859, 1640, 1464, 1412, 1365, 1254, 1123, 1080, 1000, 
912, 777, 726. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 5.87 (dd, J = 17.5, 10.8 Hz, 
1H), 4.99 (dd, J = 9.4, 1.1 Hz, 1H), 4.97 (d, J = 1.3 Hz, 1H), 4.44 (br s, 1H), 4.33 (s, 2H), 
1.91 (br s, 1H, OH), 1.81 –1.76 (m, 2H), 1.09 (s, 3H), 1.08 (s, 3H), 0.91 (s, 9H), 0.12 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 147.8 (CH), 111.2 (CH2), 86.6 (C), 83.2 (C), 60.2 (CH), 51.7 
(CH2), 50.3 (CH2), 36.1 (C), 27.7 (CH3), 26.5 (CH3), 25.8 (CH3), 18.26 (C), -5.14 (CH3). 
 
HRMS (ESI+) calculated for C16H30O2SiNa [M+Na]
+
: 305.1907, found: 305.1901. 
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6,6-Dimethyloct-7-en-2-yne-1,4-diol: (2.76) 
 
 
 
To a stirred solution of TBS-protected alkyl silyl ether 2.75 (13.0 g, 46.02 mmol) in dry THF 
(25 mL) was added a 1.0 M solution of TBAF in THF (55.2 mL, 55.2 mmol). After stirring 
for 2 hours the reaction was concentrated under reduced pressure. The crude product 2.76 
was purified by flash chromatography on a silica gel column eluting with 30% diethyl ether 
in hexanes to give the title compound 2.76 (7.35 g, 95%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 3315, 2957, 2867, 1640, 1414, 1365, 1303, 1121, 1013, 909, 685. 
 
1
H NMR (500 MHz, CDCl3, broadened signals were observed) δ 5.87 (dd, J = 17.5, 10.8 Hz, 
1H), 5.03 – 5.00 (m, 1H), 4.99 (br s, 1H), 4.47 (br s, 1H), 4.29 (s, 2H), 2.32 (br s, 2H, OH), 
1.87 – 1.75 (m, 2H), 1.10 (s, 3H), 1.09 (s, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 147.8 (CH), 111.4 (CH2), 87.6 (C), 82.8 (C), 60.2 (CH), 50.9 
(CH2), 50.3 (CH2), 36.1 (C), 27.8 (CH3), 26.5 (CH3). 
 
HRMS (ESI) calculated for C10H18O3[M+H2O]
+
:  186.1494, found 186.2098 
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4-Hydroxy-6,6-dimethyloct-7-en-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.77) 
 
 
 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (3.95 g, 27.74 mmol) and 4 drops 
of DMF in dry CH2Cl2 (50 mL) at 0 °C was added oxalyl chloride (3.7 g, 2.5 mL, 29.13 
mmol). The solution was allowed to warm to rt and left to stir for 2 hours. This was added to 
a solution of propargylic alcohol 2.76 (7.0 g, 41.61 mmol) and 2,6-lutidine (8.92 g, 9.64 mL, 
83.22 mmol) in dry CH2Cl2 (30 mL) which had been stirring for 30 minutes. The resultant 
cloudy solution was then allowed to warm to rt and left to stir for 16 hours. Subsequently the 
reaction mixture was quenched with water. The phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with 10% aqueous citric acid solution, washed once with 10% aqueous K2CO3 solution, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.77 was purified by flash chromatography on a silica gel 
column eluting with 20% diethyl ether in hexanes to give the title compound 2.77 (5.68 g, 
70%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 3409, 2962, 2173, 1716, 1640, 1414, 1367, 1252, 1203, 1134, 1043, 999, 
914, 842, 760, 703. 
 
1
H NMR (500 MHz, CDCl3) δ 5.87 (dd, J = 17.4, 10.8 Hz, 1H), 5.01 (dd, J = 6.3, 0.9 Hz, 
1H), 4.98 (br s, 1H), 4.77 (d, J = 1.6 Hz, 2H), 4.46 (td, J = 5.3, 1.7 Hz, 1H), 1.94 (br s, 1H, 
OH), 1.85 – 1.74 (m, 2H), 1.10 (s, 3H), 1.09 (s, 3H),  0.25 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.1 (C), 147.6 (CH), 111.4 (CH2), 95.4 (C), 93.7 (C), 89.4 
(C), 77.5 (C), 60.1 (CH), 53.4 (CH2), 50.0 (CH2), 36.1 (C), 27.7 (CH3), 26.5 (CH3), -0.9 
(CH3) 
 
HRMS (ESI) calculated for C16H25O3Si [M+H]
+
 293.1573, found 293.1579 
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6,6-dimethyl-4-(trimethylsilyl)-5,5a,6,7-tetrahydro-1H-indeno[4,5-c]furan-3,8(4H,8aH)-
dione: (2.78) 
 
 
 
A solution of 4-hydroxy-6,6-dimethyloct-7-en-2-yn-1-yl 3-(trimethylsilyl)propiolate 2.77 
(500 mg, 1.71 mmol) in de-gassed toluene (171 mL) was heated at reflux for 4 hours. After 
cooling to rt the solvent was removed in vacuo and the crude product was purified by flash 
chromatography on a silica gel column eluting with 20% diethyl ether in hexanes to give the 
title compound 2.78 (410 mg, 82%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2957, 2900, 2870, 1732, 1666, 1447, 1386, 1369, 1330, 1301, 1244, 1166, 
1135, 1114, 1088, 1059, 1036, 1021, 999, 975, 840, 782. 
 
1
H NMR (500 MHz, CDCl3) δ 5.21 – 5.15 (m, 1H), 4.82 – 4.76 (m, 1H), 3.31 (d, J = 7.2 Hz, 
1H,), 2.29 (d, J = 18.7 Hz, 1H, CH2), 2.21 – 2.09 (m, 4H), 1.45 – 1.36 (m, 1H, CH2), 1.21 (s, 
3H), 1.19 (s, 3H), 0.10 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 213.6 (C), 172.9 (C), 151.7 (C), 130.1 (C), 71.3 (CH2), 49.2 
(CH), 48.4 (CH2), 43.8 (CH), 36.9 (C), 29.8 (CH3), 25.5 (CH2), 24.5 (CH3), 22.0 (CH), -1.1 
(CH3). 
 
HRMS (ESI+) calculated for C16H24O3SiNa [M+Na]
+
: 315.1567, found: 315.1387. 
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6,6-Dimethyl-4-oxooct-7-en-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.81) 
 
 
 
To a stirred solution of alcohol 2.77 (2.0 g, 6.84 mmol) in acetone (15 mL) at 0 °C was 
slowly added Jones’ reagent (3.0M solution, 6.84 mL, 20.52 mmol). The resultant mixture 
was stirred at 0 °C for 1 hour, it was then allowed to warm to rt and stirred for a further 3 
hours. Subsequently, the reaction mixture was quenched with water, the phases were 
separated and the aqueous phase was extracted twice with diethyl ether. The organic layers 
were combined, dried over anhydrous sodium sulfate, filtered and concentrated under 
reduced pressure to give a yellow liquid. The crude product 2.81 was purified by flash 
chromatography on a silica gel column eluting with 20% diethyl ether in hexanes to give the 
title compound 2.81 (1.75 g, 88%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 2963, 2929, 2877, 2183, 1720, 1671, 1426, 1366, 1265, 1253, 1195, 1127, 
916, 868, 843, 761, 681  
 
1
H NMR (500 MHz, CDCl3) δ 5.91 (dd, J = 17.3, 10.8 Hz, 1H), 4.99 (d, J = 7.2 Hz, 1H), 4.97 
(br s, 1H), 4.88 (s, 2H), 2.59 (s, 2H), 1.15 (s, 6H), 0.27 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 185.4 (C), 151.7 (C), 146.2 (CH), 111.3 (CH2), 96.4 (C), 93.2 
(C), 86.8 (C), 83.6 (C), 56.5 (CH2), 52.5 (CH2), 36.9 (C), 26.9 (CH3), -0.9 (CH3). 
 
HRMS (ESI+) calculated for C16H22O3SiNa [M+Na]
+
: 313.1230, found: 313.1222. 
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4-(4,4-Dimethylhex-5-en-1-yn-1-yl)furan-2(5H)-one: (2.82) 
 
 
 
A solution of 6,6-dimethyl-4-oxooct-7-en-2-yn-1-yl 3-(trimethylsilyl)propiolate 2.81 (0.5 g, 
1.72 mmol) in de-gassed toluene (172 mL) was heated at reflux for 4 hours. After cooling to 
rt the solvent was removed in vacuo and the crude product was purified by flash 
chromatography on a silica gel column eluting with 10% diethyl ether in hexanes to give the 
title compound 2.82 (150 mg, 30%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2962, 2926, 2862, 2225, 1779, 1750, 1611, 1449, 1365, 1290, 1259, 1144, 
1091, 1041, 1019, 909, 855, 798, 730. 
 
1
H NMR (500 MHz, CDCl3) δ 6.10 (s, 1H), 5.85 (dd, J = 17.4, 10.7 Hz, 1H), 5.03 (d, J = 
12.9 Hz, 1H), 5.01 (d, J = 6.2 Hz, 1H), 4.77 (d, J = 1.6 Hz, 2H), 2.45 (s, 2H), 1.14 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 173.5 (C), 147.9 (C), 145.9 (CH), 121.5 (CH), 111.6 (CH2), 
105.8 (C), 73.1 (CH2), 73.1 (C), 36.95 (C), 33.36 (CH2), 26.52 (CH3). 
 
HRMS (ESI+) calculated for C12H14O2Na [M+Na]
+
: 213.0886, found: 213.0884. 
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2-(But-3-yn-2-yloxy)tetrahydro-2H-pyran: (2.89) 
 
 
 
To a stirred solution of 3,4-dihydro-2H-pyran (18.00 g, 19.52 mL, 214 mmol) and para-
toluenesulphonic acid monohydrate (270 mg) in CH2Cl2 (175 mL) at 0 °C was added but-3-
yn-2-ol 2.88 (10.0 g, 10.63 mL, 142.67 mmol). The reaction was allowed to warm to rt and 
left to stir for 4 hours. Subsequently, the solution was diluted with diethyl ether and washed 
once with half-saturated brine to remove the catalyst, dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The crude 
product 2.89 was purified by flash chromatography on a silica gel column eluting with 5% 
ethyl acetate in pentane to give the title compound 2.89 (21.34 g, 97% diastereoisomers A+B, 
combined yield) as a pale yellow oil. 
Spectroscopic data are in agreement with the literature values.
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Diastereoisomer A: 
1
H NMR (500 MHz, CDCl3) δ 4.77 (t, J = 3.2 Hz, 1H), 4.45 (qd, J = 6.5, 2.0 Hz, 1H), 4.02 – 
3.97 (m, 1H), 3.56 – 3.50 (m, 1H), 2.42 (d, J = 2.0 Hz, 1H), 1.88 – 1.49 (m, 6H), 1.44 (d, J = 
6.6 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 97.3 (CH), 84.9 (C), 72.3 (CH), 62.2 (CH), 62.1 (CH2), 30.7 
(CH2), 25.5 (CH2), 21.9 (CH3), 19.2 (CH2). 
 
Diastereoisomer B: 
1
H NMR (500 MHz, CDCl3) δ 4.93 (t, J = 3.5 Hz, 1H), 4.56 (qd, J = 6.5, 2.0 Hz, 1H), 3.82 – 
3.78 (m, 1H), 3.56 – 3.50 (m, 1H), 2.40 (d, J = 2.0 Hz, 1H), 1.88 – 1.49 (m, 6H), 1.47 (d, J = 
6.6 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 96.0 (CH), 84.0 (C), 73.0 (CH), 62.5 (CH), 61.1 (CH2), 30.7 
(CH2), 25.6 (CH2), 22.2 (CH3), 19.4 (CH2). 
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Mixture of Diastereoisomers (A+B): 
IR (neat) v (cm
-1
) 3290, 2943, 2878, 2111, 1443, 1375, 1320, 1202, 1185, 1117, 1094, 1076, 
1032, 983, 889, 873, 813. 
 
HRMS (ESI+) calculated for C9H14O2Na [M+Na]
+
: 177.0886, found: 177.0885. 
 
 
 
 
 
4-((Tetrahydro-2H-pyran-2-yl)oxy)pent-2-yn-1-ol: (2.90) 
 
 
 
To a stirred solution of alkyne 2.89 (diastereoisomer A; 8.0 g, 51.88 mmol) in dry THF (80 
mL) at -78 ºC was added n-BuLi (2.3 M solution in hexanes, 23.68 mL, 54.47 mmol). The 
reaction was stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution 
was cooled to -78 °C before the addition of powdered paraformaldehyde (3.11 g, 103.76 
mmol). The reaction mixture was allowed to warm to rt and left to stir for 16 hours. The 
reaction was then quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were 
separated and the aqueous phase was extracted three times with ethyl acetate. The organic 
layers were combined, washed once with water, washed once with brine, dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give a 
yellowish liquid. The crude product 2.90 was purified by flash chromatography on a silica gel 
column eluting with 30% diethyl ether in hexanes to give the title compound 2.90 (7.93 g, 
83%) as a pale yellow oil. 
 
IR (neat) v (cm
-1
) 3411, 2939, 2869, 1442, 1371, 1333, 1261, 1202, 1185, 1164, 1115, 1073, 
1017, 998, 968, 932, 904, 872, 812. 
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1
H NMR (500 MHz, CDCl3) δ 4.73 (t, J = 3.0 Hz, 1H), 4.44 (qt, J = 6.5, 1.5 Hz, 1H), 4.24 
(dd, J = 6.0, 1.5 Hz, 2H), 3.98 – 3.90 (m, 1H), 3.52 – 3.47 (m, 1H), 1.84 – 1.44 (m, 6H), 1.37 
(d, J = 6.6 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 97.0 (CH), 85.9 (C), 82.5 (C), 62.6 (CH), 62.1 (CH2), 50.7 
(CH2), 30.5 (CH2), 25.2 (CH2), 21.7 (CH3), 19.0 (CH2).   
 
HRMS (ESI+) calculated for C10H16O3Na [M+Na]
+
: 207.0991, found: 207.0986. 
 
 
 
 
 
4-((Tetrahydro-2H-pyran-2-yl)oxy)pent-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.91) 
 
 
 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (3.34 g, 23.52 mmol) and 4 drops 
of DMF in dry CH2Cl2 (40 mL) at 0 °C was added oxalyl chloride (3.13 g, 2.53 mL, 24.69 
mmol). The solution was allowed to warm to rt and left to stir for 2 hours. This was added to 
a solution of propargylic alcohol 2.90 (6.50 g, 35.28 mmol) and 2,6-lutidine (7.56 g, 8.17 mL, 
70.56 mmol) in dry CH2Cl2 (30 mL) which had been stirring for 30 minutes. The resultant 
cloudy solution was allowed to warm to rt and left to stir for 16 hours. The reaction mixture 
was then quenched with water. The phases were separated and the aqueous phase was 
extracted three times with ethyl acetate. The organic layers were combined, washed once 
with 10% aqueous citric acid solution, washed once with 10% aqueous K2CO3 solution, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.91 was purified by flash chromatography on a silica gel 
column eluting with 20% diethyl ether in hexanes to give the title compound 2.91 (5.95 g, 
82%) as a yellow oil. 
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IR (neat) v (cm
-1
) 2944, 2174, 1716, 1440, 1369, 1334, 1252, 1202, 1167, 1117, 1073, 1020, 
982, 843, 761. 
 
1
H NMR (500 MHz, CDCl3) δ 4.75 (d, J = 1.6 Hz, 2H), 4.71 (t, J = 3.3 Hz, 1H), 4.44 (q, J = 
6.6 Hz, 1H), 3.95 – 3.88 (m, 1H), 3.51 – 3.45 (m, 1H), 1.85 – 1.45 (m, 6H), 1.38 (d, J = 6.7 
Hz, 3H), 0.20 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.0 (C), 97.1 (CH), 95.1 (C), 93.8 (C), 88.4 (C), 76.7 (C), 
62.3 (CH), 62.1 (CH2), 53.5 (CH2), 30.4 (CH2), 25.3 (CH2) 21.5 (CH3), 19.0 (CH2), -0.9 
(CH3). 
 
HRMS (ESI+) calculated for C16H24O4SiNa [M+Na]
+
 331.1318, found 331.1322. 
 
 
 
 
 
4-Hydroxypent-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.92) 
 
 
 
To a stirred solution of tetrahydropyranyl ether 2.91 (1.90 g, 6.16 mmol) in methanol (10 
mL) at 0 °C was added pyridinium para-toluenesulfonate (PPTS; 0.02 g). The reaction 
mixture was allowed to warm to rt and left to stir for 6 hours. The resultant solution was then 
quenched with saturated aqueous NaHCO3 solution. The phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed once with water, washed once with brine, dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure to give a dark yellow oil. The crude 
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product 2.92 was purified by flash chromatography on a silica gel column eluting with 30% 
diethyl ether in hexanes to give the title compound 2.92 (1.02 g, 78%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 3414, 2963, 2173, 1712, 1372, 1336, 1212, 1160, 1058, 1110, 1058, 1020, 
953, 841, 759. 
 
1
H NMR (500 MHz, CDCl3) δ 4.76 (d, J = 1.5 Hz, 2H), 4.55 (q, J = 6.6 Hz, 1H), 1.44 (d, J = 
6.6 Hz, 3H), 0.23 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 152.1 (C), 95.5 (C), 93.7 (C), 89.4 (C), 76.8 (C), 58.1 (CH), 
53.4 (CH2), 23.8 (CH3), -0.9 (CH3). 
 
HRMS (ESI) calculated for C11H16O3SiNa [M+Na]
+
 247.0887, found 247.0884. 
 
 
 
 
 
4-Oxopent-2-yn-1-yl 3-(trimethylsilyl)propiolate: (2.87) 
 
 
 
To a stirred solution of alcohol 2.92 (1.6 g, 7.13 mmol) in dry CH2Cl2 (30 mL) at 0 °C was 
added DMP (4.54 g, 10.69 mmol). The reaction mixture was allowed to warm to rt and left to 
stir for 16 hours. The reaction mixture was then quenched with 10% aqueous Na2S2O3 
solution. The phases were separated and the aqueous phase was extracted three times with 
ethyl acetate. The organic layers were combined, washed once with 10% aqueous K2CO3 
solution, washed once with water, washed once with brine, dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The crude 
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product 2.87 was purified by flash chromatography on a silica gel column eluting with 20% 
diethyl ether in hexanes to give the title compound 2.87 (1.31 g, 83%) as a pale yellow oil. 
 
1
H NMR (500 MHz, CDCl3) δ 4.89 (s, 2H), 2.35 (s, 3H), 0.26 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 183.2 (C), 151.6 (C), 96.5 (C), 93.2 (C), 85.8 (C), 83.4 (C), 
52.4 (CH2), 32.3 (CH3), -1.0 (CH3). 
 
HRMS (ESI+) calculated for C11H14O3SiNa [M+Na]
+
: 245.0685, found: 245.0683. 
 
 
 
 
 
1,1,1-Triisopropyl-N-methyl-N-(prop-2-yn-1-yl)silanamine: (2.104) 
 
 
 
To a stirred solution of N-methylpropargylamine 2.7 (5.0 g, 72.35 mmol) and triethylamine 
(10.97 g, 15.1 mL, 108.53 mmol) in dry CH2Cl2 (80 mL) at 0 °C was added neat 
triisopropylsilyl trifluoromethanesulfonate (23.28 g, 75.97 mmol). The resultant solution was 
allowed to warm to rt and left to stir for 16 hours. Subsequently the reaction mixture was 
quenched with water, the phases were separated and the aqueous phase was extracted three 
times with ethyl acetate. The organic layers were combined, washed once with 10% aqueous 
K2CO3 solution, washed once with brine and dried over anhydrous sodium sulfate, filtered 
and concentrated under reduced pressure to give a pale yellow liquid. Distillation under 
reduced pressure afforded 15.49 g (96%) of clear colourless liquid. 
Spectroscopic data are in agreement with the literature values.
144
  
 
b.p.: 84 – 85 °C (1.6 Torr) 
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IR (neat) v (cm
-1
) 3311, 2944, 2865, 1463, 1142.  
 
1
H NMR (500 MHz, CDCl3) δ 3.58 (d, J = 2.1 Hz, 2H), 2.62 (s, 3H), 2.15 (t, J = 2.3 Hz, 1H), 
1.20 – 1.11 (m, 3H), 1.07 (d, J = 7.0 Hz, 18H). 
 
13
C NMR (126 MHz, CDCl3) δ 83.2 (C), 70.0 (CH), 40.6 (CH2), 36.1 (CH3), 18.2 (CH3), 12.2 
(CH). 
 
HRMS (ESI+) calculated for C13H28NSi [M+H]
+
: 226.1986, found: 226.1982. 
 
 
 
 
 
4-(Methyl(triisopropylsilyl)amino)-1-phenylbut-2-yn-1-ol: (2.105) 
 
 
 
To a stirred solution of alkyne 2.104 (10.0 g, 44.35 mmol) in dry THF (100 mL) at -78 ºC 
was added n-BuLi (2.5 M solution in hexanes, 18.62 mL, 46.57 mmol). The reaction was 
stirred 10 minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -
78 °C before the addition of benzaldehyde (4.94 g, 4.75 mL 46.57 mmol). The reaction 
mixture was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched at 0 °C with saturated aqueous NH4Cl solution. The phases were separated and the 
aqueous phase was extracted three times with ethyl acetate. The organic layers were 
combined, washed twice with 10% aqueous K2CO3 solution, washed twice with 10% aqueous 
NaSO3H solution, washed once with water, dried over anhydrous magnesium sulfate, filtered 
and concentrated under reduced pressure to give a yellowish liquid. The crude product 2.105 
was used directly in the next step without future purifications (14.12 g, 96%). 
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IR (neat) v (cm
-1
) 3348, 2943, 2864, 1462, 1141, 1006. 
 
1
H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.4 Hz, 2H), 7.38 (t, J = 7.4 Hz, 2H), 7.33 (t, J = 
7.3 Hz, 1H), 5.49 (s, 1H), 3.46 (d, J = 1.4 Hz, 2H), 2.46 (s, 3H), 2.25 (br s, 1H, OH), 1.21 – 
1.10 (m, 3H), 1.10 – 1.02 (m, 18H). 
 
13
C NMR (126 MHz, CDCl3) δ 141.0 (C), 128.5 (CH), 128.2 (CH), 126.5 (CH), 84.3 (C), 
83.6 (C), 64.4 (CH), 40.2 (CH2), 35.2 (CH3), 17.1 (CH3), 12.0 (CH). 
 
HRMS (ESI+) calculated for C20H34NOSi [M+H]
+
: 332.2391, found: 332.2404. 
 
 
 
 
 
N-(4-Hydroxy-4-phenylbut-2-yn-1-yl)-N-methyl-3-(trimethylsilyl)propiolamide: (2.99) 
 
 
 
To a stirred solution of 4-(methyl(triisopropylsilyl)amino)-1-phenylbut-2-yn-1-ol 2.105 (7.7 
g, 22.05 mmol) in MeCN (50 mL) in a PTFE container was added 40% aqueous HF (25 mL) 
in one portion via PTFE pipette. After stirring for 30 minutes, the reaction was quenched 
carefully with 10% aqueous K2CO3 solution. The aqueous phase was saturated with NaCl and 
extracted three times with ethyl acetate. The organic layers were combined, dried over 
anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a brown 
liquid. The crude product 2.98 was used directly in the next step without future purifications 
(3.67 g, 95%). 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (1.89 g, 13.32 mmol) and 4 drops 
of DMF in dry CH2Cl2 (20 mL) at 0 °C was added oxalyl chloride (1.77 g, 1.19 mL, 13.98 
mmol). The solution was allowed to warm to rt and left to stir for 2 hours. This was added to 
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a solution of 4-(methylamino)-1-phenylbut-2-yn-1-ol 2.98 (3.5 g, 19.97 mmol) and 2,6-
lutidine (4.23 g, 3.96 mL, 39.94 mmol) in dry CH2Cl2 (40 mL) which had been stirring for 30 
minutes. The resultant cloudy solution was allowed to warm to rt and left to stir for 16 hours. 
The reaction was then quenched with water, the phases were separated and the aqueous phase 
was extracted three times with ethyl acetate. The organic layers were combined, washed once 
with 10% aqueous citric acid solution, washed once with 10% aqueous K2CO3 solution, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.99 was purified by flash chromatography on a silica gel 
column eluting with 30% diethyl ether in hexanes to give the title compound 2.99 (7.79 g, 
80%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 3387, 2960, 2164, 1623, 1400, 1252, 1123. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) Rotamer A; δ 7.54 – 7.48 (m, 2H), 
7.42 – 7.30 (m, 3H), 5.49 (d, J = 16.9 Hz, 1H), 4.33 (d, J = 3.2 Hz, 1.1H), 3.27 (s, 1.6H), 0.25 
(dd, J = 5.0, 3.6 Hz, 9H); Rotamer B; δ 4.49 (d, J = 3.2 Hz, 0.9H), 3.02 (s, 1.4H), 
 
13
C NMR (126 MHz, CDCl3, Mixture of Rotamers A+B) δ 153.6 (C), 140.3 (C), 128.6 (CH), 
128.6 (CH), 128.5 (CH), 128.4 (CH), 126.5 (CH), 126.5 (CH), 98.2 (C), 95.5 (C), 84.0 (C), 
80.4 (C), 80.2 (C), 64.51 (CH), 40.9 (CH2), 35.5 (CH3), 35.5 (CH2), 31.6 (CH3), -0.7 (CH3). 
 
HRMS (ESI+) calculated for C17H21NO2SiNa [M+Na]
+
: 322.1239, found: 322.1234.  
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N-Methyl-N-(4-oxo-4-phenylbut-2-yn-1-yl)-3-(trimethylsilyl)propiolamide: (2.94) 
 
 
 
 
Preparation of wet CH2Cl2:   
 
H2O (0.1 mL, 5.5 mmol) was solvated in 100 mL of CH2Cl2 by drawing the solvent mixture 
into and expelling it from a disposable pipet several times. 
 
The wet CH2Cl2 (100 mL) was added slowly via the dropping funnel to a stirred solution of 
alcohol 2.99 (1.5 g, 5.0 mmol) and DMP (2.12 g, 5.0 mmol) in CH2Cl2 (30 mL). The clear 
solution grew cloudy towards the end of the wet CH2Cl2 addition, which required 30 minutes. 
The mixture was diluted with diethyl ether and then concentrated into a few mL of solvent by 
rotary evaporator. The residue was taken up in 100 mL of ether and then washed once with 
10% aqueous Na2S203 solution, washed once with saturated aqueous NaHC03 solution, 
washed once with water and washed once with brine. The combined organic layers were 
dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 
a yellow oil. The crude product 2.94 was purified by flash chromatography on a silica gel 
column eluting with 15% diethyl ether in hexanes to give the title compound 2.94 (1.35 g, 
91%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2962, 2917, 2232, 1711, 1639, 1396, 1259. 
 
1
H NMR (500 MHz, CDCl3, resolved signals of rotamers) Rotamer A; δ 8.11 (d, J = 7.3 Hz, 
2H), 7.67 – 7.61 (m, 1H), 7.50 (td, J = 7.5, 3.7 Hz, 2H), 4.55 (s, 1.2H), 3.36 (s, 1.8H), 0.26 
(d, J = 5.0 Hz, 9H); Rotamer B; δ 4.71 (s, 0.8H), 3.12 (s, 1.2H). 
 
13
C NMR (126 MHz, CDCl3, resolved signals of rotamers) Rotamer A; δ 177.3 (C), 153.7 
(C), 136.3 (C), 134.3 (CH), 129.6 (CH), 128.6 (CH), 98.9 (C), 95.1 (C), 87.7 (C), 81.8 (C), 
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35.9 (CH3), 35.6 (CH2), -0.7 (CH3); Rotamer B; δ 177.1 (C), 136.2 (C), 134.4 (CH), 129.5 
(CH), 128.7 (CH), 99.0 (C), 95.0 (C), 87.3 (C), 82.4 (C), 41.0 (CH2), 32.1 (CH3). 
 
HRMS (ESI+) calculated for C17H20NO2Si [M+H]
+
: 298.1263, found: 298.12. 
 
 
 
 
 
Dimethyl 2-(2-bromoallyl)malonate: (2.108) 
 
 
 
To a stirred suspension of sodium hydride (60% w/w in mineral oil; 0.61 g, 15.14 mmol) in 
dry THF (40 mL) was added dimethyl malonate 2.107 (2.0 g, 15.14 mmol) in dry THF (15 
mL). The resultant solution was cooled to 0 °C before the addition of 2,3-dibromo 
propene (3.02 g, 15.14 mmol). The reaction mixture was allowed to warm to rt and left to stir 
for 16 hours. The reaction was then quenched with saturated aqueous NH4Cl solution. The 
phases were separated and the aqueous phase was extracted three times with ethyl acetate. 
The organic layers were combined, washed once with water, washed once with brine, dried 
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a 
yellow oil. The crude product 2.108 was purified by flash chromatography on a silica gel 
column eluting with 10% ethyl acetate in hexanes to give the title compound 2.108 (2.05 g, 
54%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2955, 2943, 2864, 1733, 1631, 1462, 1261, 1185, 1164, 1006, 968, 876. 
 
1
H NMR (500 MHz, CDCl3) δ 5.67 (d, J = 0.6 Hz, 1H), 5.46 (d, J = 1.6 Hz, 1H), 3.80 (t, J = 
7.5 Hz, 1H), 3.73 (s, 6H), 3.00 (d, J = 7.5 Hz, 2H). 
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13
C NMR (126 MHz, CDCl3) δ 168.4 (C), 129.2 (C), 119.7 (CH2), 52.6 (CH3), 50.3 (CH), 
40.4 (CH2). 
 
HRMS (ESI+) calculated for C8H11BrO4Na [M+Na]
+
: 274.9733, found: 274.9741. 
 
 
 
 
 
Dimethyl 2-(2-bromoallyl)-2-(prop-2-yn-1-yl)malonate: (2.109) 
 
 
 
To a stirred suspension of sodium hydride (60% w/w in mineral oil; 0.16 g, 4.0 mmol) in dry 
THF (10 mL) was added dimethyl 2-(2-bromoallyl)malonate 2.108 (1.0 g, 4.0 mmol) in dry 
THF (10 mL). The resultant solution was cooled to 0 °C before the addition of propargyl 
bromide 2.49 (0.47 g, 0.3 mL, 4.0 mmol). The reaction mixture was then allowed to warm to 
rt and left to stir for 16 hours. The reaction was then quenched with saturated aqueous NH4Cl 
solution. The phases were separated and the aqueous phase was extracted three times with 
ethyl acetate. The organic layers were combined, washed once with water, washed once with 
brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure to give a pale yellow liquid. The crude product 2.109 was purified by flash 
chromatography on a silica gel column eluting with 5% diethyl ether in hexanes to give the 
title compound 2.109 (1.1 g, 96%) as a white solid. 
 
m.p.: 40.5 - 41.5 °C 
 
IR (neat) v (cm
-1
) 3292, 2954, 2864, 1735, 1625, 1462, 1261, 1185, 1164, 1006, 968, 876. 
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1
H NMR (500 MHz, CDCl3) δ 5.84 (d, J = 0.5 Hz, 1H), 5.64 (d, J = 1.5 Hz, 1H), 3.77 (s, 6H), 
3.32 (s, 2H), 2.94 (d, J = 2.6 Hz, 2H), 2.06 (t, J = 2.7 Hz, 1H). 
 
13
C NMR (126 MHz, CDCl3) δ 169.4 (C), 126.1 (C), 122.8 (CH2), 78.6 (C), 72.0 (CH), 55.9 
(C), 53.0 (CH3), 42.88 (CH2), 22.24 (CH2). 
 
HRMS (ESI+) calculated for C11H13BrO4Na [M+Na]
+
: 310.9889; found: 310.9874 
 
 
 
 
 
Dimethyl 2-(2-bromoallyl)-2-(4-hydroxypent-2-yn-1-yl)malonate: (2.110) 
 
 
 
To a stirred solution of alkyne 2.109 (0.5 g, 1.73 mmol) in dry THF (20 mL) at -78 ºC was 
added n-BuLi (2.5 M solution in hexanes, 0.73 mL, 1.82 mmol) The reaction was stirred 10 
minutes at -78 °C and 15 minutes at -10 °C. The resultant solution was cooled to -78 °C 
before the addition of acetaldehyde (80 mg, 0.1 mL, 1.82 mmol). The reaction mixture was 
allowed to warm to rt and left to stir for 8 hours. The reaction was then quenched at 0 °C with 
cold water. The phases were separated and the aqueous phase was extracted three times with 
ethyl acetate. The organic layers were combined, washed once with brine, dried over 
anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a yellow 
oil. The crude product 2.110 was purified by flash chromatography on a silica gel column 
eluting with 30% diethyl ether in hexanes to give the title compound 2.110 (0.55 g, 96%) as a 
yellow oil. 
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IR (neat) v (cm
-1
) 3428, 2984, 2958, 1731, 1626, 1435, 1371, 1325, 1291, 1253, 1202, 1145, 
1068, 1002, 900, 850. 
 
1
H NMR (500 MHz, CDCl3) δ 5.80 (d, J = 1.5 Hz, 1H), 5.62 (d, J = 1.5 Hz, 1H), 4.46 (qt, J = 
6.5, 1.9 Hz, 1H), 3.75 (s, 6H), 3.29 (s, 2H) 2.96 (d, J = 1.9 Hz, 2H), 1.83 (br s, 1H), 1.45 (d, J 
= 6.5 Hz, 3H). 
 
13
C NMR (126 MHz, CDCl3) δ 169.3 (C), 125.9 (C), 122.8 (CH2), 86.9 (C), 78.6 (C), 58.3 
(CH), 55.9 (C), 53.4 (CH3) 42.5 (CH2), 24.4 (CH3), 22.7 (CH2). 
 
HRMS (ESI+) calculated for C13H17BrO5Na [M+Na]
+
: 355.0152, found: 355.0153. 
 
 
 
 
 
 
Dimethyl2-(2-bromoallyl)-2-(4-((3-(trimethylsilyl)propioloyl)oxy)pent-2-yn-1 
ylmalonate: (2.111) 
 
 
 
To a stirred solution of 3-(trimethylsilyl)propiolic acid 2.65 (0.2 g, 1.43 mmol) and 4 drops of 
DMF in dry CH2Cl2 (40 mL) at 0 °C was added oxalyl chloride (0.19 g, 0.12 mL, 1.5 mmol). 
The solution was allowed to warm to rt and left to stir for 2 hours. This was added to a 
solution of propargylic alcohol 2.110 (0.5 g, 1.5 mmol) and 2,6-lutidine (0.46 g, 0.49 mL, 
4.29 mmol) in dry CH2Cl2 (20 mL) which had been stirring for 30 minutes. The resultant 
cloudy solution was allowed to warm to rt and left to stir for 16 hours. The reaction was then 
quenched with water, the phases were separated and the aqueous phase was extracted three 
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times with ethyl acetate. The organic layers were combined, washed once with 10% aqueous 
citric acid solution, washed once with 10% aqueous K2CO3 solution, dried over anhydrous 
sodium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The 
crude product 2.111 was purified by flash chromatography on a silica gel column eluting with 
15% diethyl ether in hexanes to give the title compound 2.111 (0.65 g, 70%) as a yellow oil. 
 
IR (neat) v (cm
-1
) 2954, 2150, 1737, 1627, 1251, 1200. 
 
1
H NMR (500 MHz, CDCl3) δ 5.81 (d, J = 1.5 Hz, 1H), 5.63 (d, J = 1.5 Hz, 1H), 4.47 (qt, J = 
6.5, 1.7 Hz, 1H), 3.73 (s, 6H), 3.28 (s, 2H), 2.94 (d, J = 1.9 Hz, 2H), 1.37 (d, J = 6.5 Hz, 3H), 
0.15 (s, 9H). 
 
13
C NMR (126 MHz, CDCl3) δ 169.5 (C), 169.4 (C), 126.3 (C), 122.6 (CH2), 86,5 (C), 86.3 
(C), 78.6 (C), 77.7 (C), 58.5 (CH), 56.0 (C), 52.9 (CH3), 42.9 (CH2), 25,7 (CH3), 22.6 (CH2), 
-0.07 (CH3). 
 
 
 
 
 
Allylmagnesium bromide (ethereal complex solution) 
 
 
 
Prepared following the literature procedure.
220
  
 
 
Allylmagnesium bromide (THF complex solution) 
 
 
 
Prepared following the literature procedure.
220
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2-Iodoxybenzoic acid (IBX) 
 
 
 
Prepared following the literature procedure.
221
  
 
 
1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one (DMP) 
 
 
 
Prepared following the literature procedure.
221
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